id	sid	tid	token	lemma	pos
dpc-3921	1	1	dermatology	dermatology	NOUN
dpc-3921	1	2	:	:	PUNCT
dpc-3921	1	3	practical	practical	ADJ
dpc-3921	1	4	and	and	CCONJ
dpc-3921	1	5	conceptual	conceptual	ADJ
dpc-3921	1	6	review	review	NOUN
dpc-3921	1	7	|	|	ADV
dpc-3921	1	8	dermatol	dermatol	ADJ
dpc-3921	1	9	pract	pract	NOUN
dpc-3921	1	10	concept	concept	NOUN
dpc-3921	1	11	.	.	PUNCT
dpc-3921	2	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-3921	2	2	:	:	PUNCT
dpc-3921	2	3	e2023314s	e2023314s	PROPN
dpc-3921	2	4	1	1	NUM
dpc-3921	2	5	aetiopathogenesis	aetiopathogenesis	NOUN
dpc-3921	2	6	of	of	ADP
dpc-3921	2	7	vitiligo	vitiligo	PROPN
dpc-3921	2	8	katia	katia	PROPN
dpc-3921	2	9	boniface1	boniface1	PROPN
dpc-3921	3	1	1	1	NUM
dpc-3921	3	2	university	university	NOUN
dpc-3921	3	3	of	of	ADP
dpc-3921	3	4	bordeaux	bordeaux	NOUN
dpc-3921	3	5	,	,	PUNCT
dpc-3921	3	6	cnrs	cnrs	NOUN
dpc-3921	3	7	,	,	PUNCT
dpc-3921	3	8	immuno	immuno	ADJ
dpc-3921	3	9	concept	concept	NOUN
dpc-3921	3	10	,	,	PUNCT
dpc-3921	3	11	umr	umr	PROPN
dpc-3921	3	12	5164	5164	NUM
dpc-3921	3	13	,	,	PUNCT
dpc-3921	3	14	bordeaux	bordeaux	NOUN
dpc-3921	3	15	,	,	PUNCT
dpc-3921	3	16	france	france	PROPN
dpc-3921	3	17	key	key	ADJ
dpc-3921	3	18	words	word	NOUN
dpc-3921	3	19	:	:	PUNCT
dpc-3921	3	20	vitiligo	vitiligo	NOUN
dpc-3921	3	21	,	,	PUNCT
dpc-3921	3	22	melanocytes	melanocyte	NOUN
dpc-3921	3	23	,	,	PUNCT
dpc-3921	3	24	keratinocytes	keratinocyte	NOUN
dpc-3921	3	25	,	,	PUNCT
dpc-3921	3	26	fibroblasts	fibroblast	NOUN
dpc-3921	3	27	,	,	PUNCT
dpc-3921	3	28	immune	immune	ADJ
dpc-3921	3	29	cells	cell	NOUN
dpc-3921	3	30	,	,	PUNCT
dpc-3921	3	31	resident	resident	NOUN
dpc-3921	3	32	memory	memory	NOUN
dpc-3921	3	33	t	t	PROPN
dpc-3921	3	34	cells	cell	NOUN
dpc-3921	3	35	,	,	PUNCT
dpc-3921	3	36	cytokines	cytokine	VERB
dpc-3921	3	37	citation	citation	NOUN
dpc-3921	3	38	:	:	PUNCT
dpc-3921	3	39	boniface	boniface	PROPN
dpc-3921	3	40	k.	k.	PROPN
dpc-3921	3	41	aetiopathogenesis	aetiopathogenesis	PROPN
dpc-3921	3	42	of	of	ADP
dpc-3921	3	43	vitiligo	vitiligo	NOUN
dpc-3921	3	44	.	.	PUNCT
dpc-3921	4	1	dermatol	dermatol	NOUN
dpc-3921	4	2	pract	pract	PROPN
dpc-3921	4	3	concept.2023;13(4)s2	concept.2023;13(4)s2	PROPN
dpc-3921	4	4	:	:	PUNCT
dpc-3921	4	5	e2023314s	e2023314s	PROPN
dpc-3921	4	6	.	.	PROPN
dpc-3921	4	7	doi	doi	PROPN
dpc-3921	4	8	:	:	PUNCT
dpc-3921	4	9	https://doi.org/10.5826/	https://doi.org/10.5826/	PROPN
dpc-3921	4	10	dpc.1304s2a314s	dpc.1304s2a314s	PROPN
dpc-3921	4	11	accepted	accept	VERB
dpc-3921	4	12	:	:	PUNCT
dpc-3921	4	13	december	december	PROPN
dpc-3921	4	14	11	11	NUM
dpc-3921	4	15	,	,	PUNCT
dpc-3921	4	16	2023	2023	NUM
dpc-3921	4	17	;	;	PUNCT
dpc-3921	4	18	published	publish	VERB
dpc-3921	4	19	:	:	PUNCT
dpc-3921	5	1	december	december	PROPN
dpc-3921	5	2	2023	2023	NUM
dpc-3921	5	3	copyright	copyright	NOUN
dpc-3921	5	4	:	:	PUNCT
dpc-3921	5	5	©	©	PROPN
dpc-3921	5	6	2023	2023	NUM
dpc-3921	5	7	boniface	boniface	NOUN
dpc-3921	5	8	.	.	PUNCT
dpc-3921	6	1	this	this	PRON
dpc-3921	6	2	is	be	AUX
dpc-3921	6	3	an	an	DET
dpc-3921	6	4	open	open	ADJ
dpc-3921	6	5	-	-	PUNCT
dpc-3921	6	6	access	access	NOUN
dpc-3921	6	7	article	article	NOUN
dpc-3921	6	8	distributed	distribute	VERB
dpc-3921	6	9	under	under	ADP
dpc-3921	6	10	the	the	DET
dpc-3921	6	11	terms	term	NOUN
dpc-3921	6	12	of	of	ADP
dpc-3921	6	13	the	the	DET
dpc-3921	6	14	creative	creative	ADJ
dpc-3921	6	15	commons	common	NOUN
dpc-3921	6	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-3921	6	17	license	license	NOUN
dpc-3921	6	18	(	(	PUNCT
dpc-3921	6	19	by	by	ADP
dpc-3921	6	20	-	-	PUNCT
dpc-3921	6	21	nc-4.0	nc-4.0	NOUN
dpc-3921	6	22	)	)	PUNCT
dpc-3921	6	23	,	,	PUNCT
dpc-3921	6	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-3921	6	25	,	,	PUNCT
dpc-3921	6	26	which	which	PRON
dpc-3921	6	27	permits	permit	VERB
dpc-3921	6	28	unrestricted	unrestricted	ADJ
dpc-3921	6	29	noncommercial	noncommercial	ADJ
dpc-3921	6	30	use	use	NOUN
dpc-3921	6	31	,	,	PUNCT
dpc-3921	6	32	distribution	distribution	NOUN
dpc-3921	6	33	,	,	PUNCT
dpc-3921	6	34	and	and	CCONJ
dpc-3921	6	35	reproduction	reproduction	NOUN
dpc-3921	6	36	in	in	ADP
dpc-3921	6	37	any	any	DET
dpc-3921	6	38	medium	medium	NOUN
dpc-3921	6	39	,	,	PUNCT
dpc-3921	6	40	provided	provide	VERB
dpc-3921	6	41	the	the	DET
dpc-3921	6	42	original	original	ADJ
dpc-3921	6	43	authors	author	NOUN
dpc-3921	6	44	and	and	CCONJ
dpc-3921	6	45	source	source	NOUN
dpc-3921	6	46	are	be	AUX
dpc-3921	6	47	credited	credit	VERB
dpc-3921	6	48	.	.	PUNCT
dpc-3921	7	1	funding	funding	NOUN
dpc-3921	7	2	:	:	PUNCT
dpc-3921	7	3	none	none	NOUN
dpc-3921	7	4	.	.	PUNCT
dpc-3921	8	1	competing	compete	VERB
dpc-3921	8	2	interests	interest	NOUN
dpc-3921	8	3	:	:	PUNCT
dpc-3921	8	4	katia	katia	PROPN
dpc-3921	8	5	boniface	boniface	PROPN
dpc-3921	8	6	received	receive	VERB
dpc-3921	8	7	grants	grant	NOUN
dpc-3921	8	8	from	from	ADP
dpc-3921	8	9	calypso	calypso	PROPN
dpc-3921	8	10	biotech	biotech	NOUN
dpc-3921	8	11	,	,	PUNCT
dpc-3921	8	12	leo	leo	PROPN
dpc-3921	8	13	pharma	pharma	PROPN
dpc-3921	8	14	,	,	PUNCT
dpc-3921	8	15	pfizer	pfizer	NOUN
dpc-3921	8	16	,	,	PUNCT
dpc-3921	8	17	pierre	pierre	PROPN
dpc-3921	8	18	fabre	fabre	PROPN
dpc-3921	8	19	,	,	PUNCT
dpc-3921	8	20	sanofi	sanofi	PROPN
dpc-3921	8	21	,	,	PUNCT
dpc-3921	8	22	and	and	CCONJ
dpc-3921	8	23	has	have	VERB
dpc-3921	8	24	a	a	DET
dpc-3921	8	25	patent	patent	NOUN
dpc-3921	8	26	on	on	ADP
dpc-3921	8	27	mmp9	mmp9	ADJ
dpc-3921	8	28	inhibitors	inhibitor	NOUN
dpc-3921	8	29	and	and	CCONJ
dpc-3921	8	30	uses	use	VERB
dpc-3921	8	31	thereof	thereof	ADV
dpc-3921	8	32	in	in	ADP
dpc-3921	8	33	the	the	DET
dpc-3921	8	34	prevention	prevention	NOUN
dpc-3921	8	35	or	or	CCONJ
dpc-3921	8	36	treatment	treatment	NOUN
dpc-3921	8	37	of	of	ADP
dpc-3921	8	38	a	a	DET
dpc-3921	8	39	depigmenting	depigmente	VERB
dpc-3921	8	40	disorder	disorder	NOUN
dpc-3921	8	41	and	and	CCONJ
dpc-3921	8	42	three	three	NUM
dpc-3921	8	43	-	-	PUNCT
dpc-3921	8	44	dimensional	dimensional	ADJ
dpc-3921	8	45	model	model	NOUN
dpc-3921	8	46	of	of	ADP
dpc-3921	8	47	depigmenting	depigmente	VERB
dpc-3921	8	48	disorder	disorder	NOUN
dpc-3921	8	49	.	.	PUNCT
dpc-3921	9	1	corresponding	correspond	VERB
dpc-3921	9	2	author	author	NOUN
dpc-3921	9	3	:	:	PUNCT
dpc-3921	9	4	katia	katia	PROPN
dpc-3921	9	5	boniface	boniface	PROPN
dpc-3921	9	6	:	:	PUNCT
dpc-3921	9	7	bordeaux	bordeaux	PROPN
dpc-3921	9	8	university	university	NOUN
dpc-3921	9	9	,	,	PUNCT
dpc-3921	9	10	cnrs	cnrs	NOUN
dpc-3921	9	11	,	,	PUNCT
dpc-3921	9	12	immunoconcept	immunoconcept	NOUN
dpc-3921	9	13	,	,	PUNCT
dpc-3921	9	14	umr	umr	PROPN
dpc-3921	9	15	5164	5164	NUM
dpc-3921	9	16	,	,	PUNCT
dpc-3921	9	17	f-33000	f-33000	NUM
dpc-3921	9	18	bordeaux	bordeaux	NOUN
dpc-3921	9	19	,	,	PUNCT
dpc-3921	9	20	france	france	PROPN
dpc-3921	9	21	katia	katia	PROPN
dpc-3921	9	22	.	.	PUNCT
dpc-3921	10	1	boniface@u-bordeaux.fr	boniface@u-bordeaux.fr	PROPN
dpc-3921	10	2	vitiligo	vitiligo	PROPN
dpc-3921	10	3	is	be	AUX
dpc-3921	10	4	a	a	DET
dpc-3921	10	5	chronic	chronic	ADJ
dpc-3921	10	6	auto	auto	NOUN
dpc-3921	10	7	-	-	PUNCT
dpc-3921	10	8	immune	immune	ADJ
dpc-3921	10	9	disease	disease	NOUN
dpc-3921	10	10	characterized	characterize	VERB
dpc-3921	10	11	by	by	ADP
dpc-3921	10	12	skin	skin	NOUN
dpc-3921	10	13	depigmentation	depigmentation	NOUN
dpc-3921	10	14	due	due	ADP
dpc-3921	10	15	to	to	ADP
dpc-3921	10	16	the	the	DET
dpc-3921	10	17	loss	loss	NOUN
dpc-3921	10	18	of	of	ADP
dpc-3921	10	19	melanocytes	melanocyte	NOUN
dpc-3921	10	20	.	.	PUNCT
dpc-3921	11	1	the	the	DET
dpc-3921	11	2	better	well	ADJ
dpc-3921	11	3	understanding	understanding	NOUN
dpc-3921	11	4	of	of	ADP
dpc-3921	11	5	the	the	DET
dpc-3921	11	6	disease	disease	NOUN
dpc-3921	11	7	mechanisms	mechanism	NOUN
dpc-3921	11	8	is	be	AUX
dpc-3921	11	9	currently	currently	ADV
dpc-3921	11	10	undergoing	undergo	VERB
dpc-3921	11	11	a	a	DET
dpc-3921	11	12	significant	significant	ADJ
dpc-3921	11	13	dynamism	dynamism	NOUN
dpc-3921	11	14	,	,	PUNCT
dpc-3921	11	15	opening	open	VERB
dpc-3921	11	16	a	a	DET
dpc-3921	11	17	new	new	ADJ
dpc-3921	11	18	era	era	NOUN
dpc-3921	11	19	in	in	ADP
dpc-3921	11	20	therapeutic	therapeutic	ADJ
dpc-3921	11	21	development	development	NOUN
dpc-3921	11	22	.	.	PUNCT
dpc-3921	12	1	the	the	DET
dpc-3921	12	2	pathophysiology	pathophysiology	NOUN
dpc-3921	12	3	of	of	ADP
dpc-3921	12	4	vitiligo	vitiligo	NOUN
dpc-3921	12	5	has	have	AUX
dpc-3921	12	6	attracted	attract	VERB
dpc-3921	12	7	the	the	DET
dpc-3921	12	8	attention	attention	NOUN
dpc-3921	12	9	of	of	ADP
dpc-3921	12	10	researchers	researcher	NOUN
dpc-3921	12	11	for	for	ADP
dpc-3921	12	12	years	year	NOUN
dpc-3921	12	13	and	and	CCONJ
dpc-3921	12	14	many	many	ADJ
dpc-3921	12	15	advances	advance	NOUN
dpc-3921	12	16	have	have	AUX
dpc-3921	12	17	been	be	AUX
dpc-3921	12	18	made	make	VERB
dpc-3921	12	19	in	in	ADP
dpc-3921	12	20	clarifying	clarify	VERB
dpc-3921	12	21	the	the	DET
dpc-3921	12	22	crosstalk	crosstalk	NOUN
dpc-3921	12	23	between	between	ADP
dpc-3921	12	24	the	the	DET
dpc-3921	12	25	cellular	cellular	ADJ
dpc-3921	12	26	players	player	NOUN
dpc-3921	12	27	involved	involve	VERB
dpc-3921	12	28	in	in	ADP
dpc-3921	12	29	the	the	DET
dpc-3921	12	30	development	development	NOUN
dpc-3921	12	31	of	of	ADP
dpc-3921	12	32	vitiligo	vitiligo	ADJ
dpc-3921	12	33	lesions	lesion	NOUN
dpc-3921	12	34	.	.	PUNCT
dpc-3921	13	1	the	the	DET
dpc-3921	13	2	understanding	understanding	NOUN
dpc-3921	13	3	of	of	ADP
dpc-3921	13	4	the	the	DET
dpc-3921	13	5	complex	complex	ADJ
dpc-3921	13	6	interactions	interaction	NOUN
dpc-3921	13	7	between	between	ADP
dpc-3921	13	8	epidermal	epidermal	ADJ
dpc-3921	13	9	cells	cell	NOUN
dpc-3921	13	10	(	(	PUNCT
dpc-3921	13	11	i.e.	i.e.	X
dpc-3921	13	12	melanocytes	melanocyte	NOUN
dpc-3921	13	13	and	and	CCONJ
dpc-3921	13	14	keratinocytes	keratinocyte	NOUN
dpc-3921	13	15	)	)	PUNCT
dpc-3921	13	16	,	,	PUNCT
dpc-3921	13	17	dermal	dermal	NOUN
dpc-3921	13	18	fibroblasts	fibroblast	NOUN
dpc-3921	13	19	,	,	PUNCT
dpc-3921	13	20	and	and	CCONJ
dpc-3921	13	21	immune	immune	ADJ
dpc-3921	13	22	cells	cell	NOUN
dpc-3921	13	23	,	,	PUNCT
dpc-3921	13	24	led	lead	VERB
dpc-3921	13	25	to	to	ADP
dpc-3921	13	26	a	a	DET
dpc-3921	13	27	better	well	ADJ
dpc-3921	13	28	characterization	characterization	NOUN
dpc-3921	13	29	of	of	ADP
dpc-3921	13	30	the	the	DET
dpc-3921	13	31	signals	signal	NOUN
dpc-3921	13	32	leading	lead	VERB
dpc-3921	13	33	to	to	ADP
dpc-3921	13	34	the	the	DET
dpc-3921	13	35	loss	loss	NOUN
dpc-3921	13	36	of	of	ADP
dpc-3921	13	37	melanocytes	melanocyte	NOUN
dpc-3921	13	38	.	.	PUNCT
dpc-3921	14	1	recent	recent	ADJ
dpc-3921	14	2	advances	advance	NOUN
dpc-3921	14	3	highlighted	highlight	VERB
dpc-3921	14	4	the	the	DET
dpc-3921	14	5	role	role	NOUN
dpc-3921	14	6	resident	resident	NOUN
dpc-3921	14	7	t	t	PROPN
dpc-3921	14	8	memory	memory	NOUN
dpc-3921	14	9	cells	cell	NOUN
dpc-3921	14	10	in	in	ADP
dpc-3921	14	11	the	the	DET
dpc-3921	14	12	development	development	NOUN
dpc-3921	14	13	and	and	CCONJ
dpc-3921	14	14	recurrence	recurrence	NOUN
dpc-3921	14	15	of	of	ADP
dpc-3921	14	16	lesions	lesion	NOUN
dpc-3921	14	17	.	.	PUNCT
dpc-3921	15	1	this	this	DET
dpc-3921	15	2	narrative	narrative	NOUN
dpc-3921	15	3	review	review	NOUN
dpc-3921	15	4	aims	aim	VERB
dpc-3921	15	5	to	to	PART
dpc-3921	15	6	give	give	VERB
dpc-3921	15	7	an	an	DET
dpc-3921	15	8	overview	overview	NOUN
dpc-3921	15	9	of	of	ADP
dpc-3921	15	10	the	the	DET
dpc-3921	15	11	mechanisms	mechanism	NOUN
dpc-3921	15	12	leading	lead	VERB
dpc-3921	15	13	to	to	ADP
dpc-3921	15	14	melanocyte	melanocyte	NOUN
dpc-3921	15	15	disappearance	disappearance	NOUN
dpc-3921	15	16	in	in	ADP
dpc-3921	15	17	vitiligo	vitiligo	NOUN
dpc-3921	15	18	,	,	PUNCT
dpc-3921	15	19	with	with	ADP
dpc-3921	15	20	a	a	DET
dpc-3921	15	21	focus	focus	NOUN
dpc-3921	15	22	on	on	ADP
dpc-3921	15	23	the	the	DET
dpc-3921	15	24	intercellular	intercellular	ADJ
dpc-3921	15	25	interaction	interaction	NOUN
dpc-3921	15	26	network	network	NOUN
dpc-3921	15	27	involved	involve	VERB
dpc-3921	15	28	in	in	ADP
dpc-3921	15	29	the	the	DET
dpc-3921	15	30	activation	activation	NOUN
dpc-3921	15	31	of	of	ADP
dpc-3921	15	32	the	the	DET
dpc-3921	15	33	local	local	ADJ
dpc-3921	15	34	skin	skin	NOUN
dpc-3921	15	35	immune	immune	ADJ
dpc-3921	15	36	response	response	NOUN
dpc-3921	15	37	.	.	PUNCT
dpc-3921	16	1	abstract	abstract	ADJ
dpc-3921	16	2	introduction	introduction	NOUN
dpc-3921	16	3	the	the	DET
dpc-3921	16	4	pathophysiology	pathophysiology	NOUN
dpc-3921	16	5	of	of	ADP
dpc-3921	16	6	vitiligo	vitiligo	NOUN
dpc-3921	16	7	is	be	AUX
dpc-3921	16	8	complex	complex	ADJ
dpc-3921	16	9	and	and	CCONJ
dpc-3921	16	10	involves	involve	VERB
dpc-3921	16	11	combinatorial	combinatorial	ADJ
dpc-3921	16	12	factors	factor	NOUN
dpc-3921	16	13	(	(	PUNCT
dpc-3921	16	14	genetic	genetic	ADJ
dpc-3921	16	15	predisposition	predisposition	NOUN
dpc-3921	16	16	,	,	PUNCT
dpc-3921	16	17	environmental	environmental	ADJ
dpc-3921	16	18	triggers	trigger	NOUN
dpc-3921	16	19	,	,	PUNCT
dpc-3921	16	20	intrinsic	intrinsic	ADJ
dpc-3921	16	21	melanocyte	melanocyte	NOUN
dpc-3921	16	22	abnormalities	abnormality	NOUN
dpc-3921	16	23	,	,	PUNCT
dpc-3921	16	24	oxidative	oxidative	ADJ
dpc-3921	16	25	stress	stress	NOUN
dpc-3921	16	26	)	)	PUNCT
dpc-3921	16	27	,	,	PUNCT
dpc-3921	16	28	leading	lead	VERB
dpc-3921	16	29	to	to	ADP
dpc-3921	16	30	an	an	DET
dpc-3921	16	31	exaggerated	exaggerated	ADJ
dpc-3921	16	32	activation	activation	NOUN
dpc-3921	16	33	of	of	ADP
dpc-3921	16	34	the	the	DET
dpc-3921	16	35	innate	innate	ADJ
dpc-3921	16	36	and	and	CCONJ
dpc-3921	16	37	adaptive	adaptive	ADJ
dpc-3921	16	38	immune	immune	ADJ
dpc-3921	16	39	response	response	NOUN
dpc-3921	16	40	(	(	PUNCT
dpc-3921	16	41	fig	fig	NOUN
dpc-3921	16	42	.	.	NOUN
dpc-3921	17	1	1	1	NUM
dpc-3921	17	2	)	)	PUNCT
dpc-3921	18	1	[	[	X
dpc-3921	18	2	1	1	NUM
dpc-3921	18	3	]	]	PUNCT
dpc-3921	18	4	.	.	PUNCT
dpc-3921	19	1	genome	genome	NOUN
dpc-3921	19	2	wide	wide	ADJ
dpc-3921	19	3	association	association	NOUN
dpc-3921	19	4	studies	study	NOUN
dpc-3921	19	5	(	(	PUNCT
dpc-3921	19	6	gwas	gwas	PROPN
dpc-3921	19	7	)	)	PUNCT
dpc-3921	19	8	have	have	AUX
dpc-3921	19	9	improved	improve	VERB
dpc-3921	19	10	the	the	DET
dpc-3921	19	11	understanding	understanding	NOUN
dpc-3921	19	12	of	of	ADP
dpc-3921	19	13	the	the	DET
dpc-3921	19	14	genetic	genetic	ADJ
dpc-3921	19	15	architecture	architecture	NOUN
dpc-3921	19	16	of	of	ADP
dpc-3921	19	17	vitiligo	vitiligo	NOUN
dpc-3921	19	18	.	.	PUNCT
dpc-3921	20	1	it	it	PRON
dpc-3921	20	2	is	be	AUX
dpc-3921	20	3	considered	consider	VERB
dpc-3921	20	4	that	that	SCONJ
dpc-3921	20	5	the	the	DET
dpc-3921	20	6	overall	overall	ADJ
dpc-3921	20	7	risk	risk	NOUN
dpc-3921	20	8	of	of	ADP
dpc-3921	20	9	vitiligo	vitiligo	NOUN
dpc-3921	20	10	linked	link	VERB
dpc-3921	20	11	to	to	ADP
dpc-3921	20	12	genetic	genetic	ADJ
dpc-3921	20	13	determinants	determinant	NOUN
dpc-3921	20	14	is	be	AUX
dpc-3921	20	15	high	high	ADJ
dpc-3921	20	16	,	,	PUNCT
dpc-3921	20	17	corresponding	correspond	VERB
dpc-3921	20	18	to	to	ADP
dpc-3921	20	19	about	about	ADV
dpc-3921	20	20	80	80	NUM
dpc-3921	20	21	%	%	NOUN
dpc-3921	20	22	of	of	ADP
dpc-3921	20	23	the	the	DET
dpc-3921	20	24	risk	risk	NOUN
dpc-3921	20	25	,	,	PUNCT
dpc-3921	20	26	whereas	whereas	SCONJ
dpc-3921	20	27	environmental	environmental	ADJ
dpc-3921	20	28	factors	factor	NOUN
dpc-3921	20	29	account	account	VERB
dpc-3921	20	30	for	for	ADP
dpc-3921	20	31	20	20	NUM
dpc-3921	20	32	%	%	NOUN
dpc-3921	21	1	[	[	X
dpc-3921	21	2	2,3	2,3	NUM
dpc-3921	21	3	]	]	PUNCT
dpc-3921	21	4	.	.	PUNCT
dpc-3921	22	1	indeed	indeed	ADV
dpc-3921	22	2	,	,	PUNCT
dpc-3921	22	3	four	four	NUM
dpc-3921	22	4	large	large	ADJ
dpc-3921	22	5	-	-	PUNCT
dpc-3921	22	6	scale	scale	NOUN
dpc-3921	22	7	gwas	gwas	NOUN
dpc-3921	22	8	,	,	PUNCT
dpc-3921	22	9	three	three	NUM
dpc-3921	22	10	of	of	ADP
dpc-3921	22	11	which	which	PRON
dpc-3921	22	12	were	be	AUX
dpc-3921	22	13	carried	carry	VERB
dpc-3921	22	14	out	out	ADP
dpc-3921	22	15	on	on	ADP
dpc-3921	22	16	european	european	ADJ
dpc-3921	22	17	and	and	CCONJ
dpc-3921	22	18	north	north	ADJ
dpc-3921	22	19	american	american	ADJ
dpc-3921	22	20	populations	population	NOUN
dpc-3921	22	21	and	and	CCONJ
dpc-3921	22	22	one	one	NUM
dpc-3921	22	23	on	on	ADP
dpc-3921	22	24	an	an	DET
dpc-3921	22	25	asian	asian	ADJ
dpc-3921	22	26	(	(	PUNCT
dpc-3921	22	27	chinese	chinese	ADJ
dpc-3921	22	28	)	)	PUNCT
dpc-3921	22	29	populations	population	NOUN
dpc-3921	22	30	,	,	PUNCT
dpc-3921	22	31	identified	identify	VERB
dpc-3921	22	32	more	more	ADJ
dpc-3921	22	33	than	than	ADP
dpc-3921	22	34	fifty	fifty	NUM
dpc-3921	22	35	vitiligo	vitiligo	NOUN
dpc-3921	22	36	susceptibility	susceptibility	NOUN
dpc-3921	22	37	genes	gene	NOUN
dpc-3921	23	1	[	[	X
dpc-3921	23	2	4–7	4–7	NOUN
dpc-3921	23	3	]	]	X
dpc-3921	23	4	.	.	PUNCT
dpc-3921	24	1	interestingly	interestingly	ADV
dpc-3921	24	2	,	,	PUNCT
dpc-3921	24	3	most	most	ADJ
dpc-3921	24	4	of	of	ADP
dpc-3921	24	5	these	these	DET
dpc-3921	24	6	genes	gene	NOUN
dpc-3921	24	7	are	be	AUX
dpc-3921	24	8	associated	associate	VERB
dpc-3921	24	9	with	with	ADP
dpc-3921	24	10	proteins	protein	NOUN
dpc-3921	24	11	related	relate	VERB
dpc-3921	24	12	to	to	AUX
dpc-3921	24	13	innate	innate	VERB
dpc-3921	24	14	,	,	PUNCT
dpc-3921	24	15	adaptive	adaptive	ADJ
dpc-3921	24	16	or	or	CCONJ
dpc-3921	24	17	regulatory	regulatory	ADJ
dpc-3921	24	18	immune	immune	ADJ
dpc-3921	24	19	responses	response	NOUN
dpc-3921	24	20	.	.	PUNCT
dpc-3921	25	1	others	other	NOUN
dpc-3921	25	2	regulate	regulate	VERB
dpc-3921	25	3	cell	cell	NOUN
dpc-3921	25	4	apoptosis	apoptosis	NOUN
dpc-3921	25	5	and	and	CCONJ
dpc-3921	25	6	some	some	DET
dpc-3921	25	7	genes	gene	NOUN
dpc-3921	25	8	are	be	AUX
dpc-3921	25	9	related	relate	VERB
dpc-3921	25	10	to	to	ADP
dpc-3921	25	11	proteins	protein	NOUN
dpc-3921	25	12	regulating	regulate	VERB
dpc-3921	25	13	melanocyte	melanocyte	NOUN
dpc-3921	25	14	function	function	NOUN
dpc-3921	25	15	.	.	PUNCT
dpc-3921	26	1	this	this	DET
dpc-3921	26	2	review	review	NOUN
dpc-3921	26	3	discusses	discuss	VERB
dpc-3921	26	4	how	how	SCONJ
dpc-3921	26	5	the	the	DET
dpc-3921	26	6	crosstalk	crosstalk	NOUN
dpc-3921	26	7	between	between	ADP
dpc-3921	26	8	2	2	NUM
dpc-3921	26	9	review	review	NOUN
dpc-3921	26	10	|	|	ADV
dpc-3921	26	11	dermatol	dermatol	ADJ
dpc-3921	26	12	pract	pract	NOUN
dpc-3921	26	13	concept	concept	NOUN
dpc-3921	26	14	.	.	PUNCT
dpc-3921	27	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-3921	27	2	:	:	PUNCT
dpc-3921	27	3	e2023314s	e2023314s	X
dpc-3921	27	4	epidermal	epidermal	ADJ
dpc-3921	27	5	,	,	PUNCT
dpc-3921	27	6	dermal	dermal	ADJ
dpc-3921	27	7	,	,	PUNCT
dpc-3921	27	8	and	and	CCONJ
dpc-3921	27	9	immune	immune	ADJ
dpc-3921	27	10	cells	cell	NOUN
dpc-3921	27	11	leads	lead	VERB
dpc-3921	27	12	to	to	ADP
dpc-3921	27	13	melanocyte	melanocyte	NOUN
dpc-3921	27	14	disappearance	disappearance	NOUN
dpc-3921	27	15	in	in	ADP
dpc-3921	27	16	vitiligo	vitiligo	NOUN
dpc-3921	27	17	.	.	PUNCT
dpc-3921	28	1	initiation	initiation	NOUN
dpc-3921	28	2	of	of	ADP
dpc-3921	28	3	the	the	DET
dpc-3921	28	4	disease	disease	NOUN
dpc-3921	28	5	:	:	PUNCT
dpc-3921	28	6	bridging	bridge	VERB
dpc-3921	28	7	oxidative	oxidative	ADJ
dpc-3921	28	8	stress	stress	NOUN
dpc-3921	28	9	,	,	PUNCT
dpc-3921	28	10	epidermal	epidermal	ADJ
dpc-3921	28	11	,	,	PUNCT
dpc-3921	28	12	dermal	dermal	ADJ
dpc-3921	28	13	cells	cell	NOUN
dpc-3921	28	14	and	and	CCONJ
dpc-3921	28	15	the	the	DET
dpc-3921	28	16	activation	activation	NOUN
dpc-3921	28	17	of	of	ADP
dpc-3921	28	18	the	the	DET
dpc-3921	28	19	innate	innate	ADJ
dpc-3921	28	20	immune	immune	ADJ
dpc-3921	28	21	response	response	NOUN
dpc-3921	28	22	for	for	ADP
dpc-3921	28	23	many	many	ADJ
dpc-3921	28	24	years	year	NOUN
dpc-3921	28	25	,	,	PUNCT
dpc-3921	28	26	it	it	PRON
dpc-3921	28	27	has	have	AUX
dpc-3921	28	28	been	be	AUX
dpc-3921	28	29	considered	consider	VERB
dpc-3921	28	30	that	that	SCONJ
dpc-3921	28	31	melanocytes	melanocyte	NOUN
dpc-3921	28	32	located	locate	VERB
dpc-3921	28	33	in	in	ADP
dpc-3921	28	34	the	the	DET
dpc-3921	28	35	non	non	ADJ
dpc-3921	28	36	-	-	ADJ
dpc-3921	28	37	lesional	lesional	ADJ
dpc-3921	28	38	pigmented	pigmented	ADJ
dpc-3921	28	39	skin	skin	NOUN
dpc-3921	28	40	of	of	ADP
dpc-3921	28	41	vitiligo	vitiligo	ADJ
dpc-3921	28	42	patients	patient	NOUN
dpc-3921	28	43	are	be	AUX
dpc-3921	28	44	more	more	ADV
dpc-3921	28	45	sensitive	sensitive	ADJ
dpc-3921	28	46	to	to	PART
dpc-3921	28	47	oxidative	oxidative	ADJ
dpc-3921	28	48	stress	stress	NOUN
dpc-3921	28	49	by	by	ADP
dpc-3921	28	50	releasing	release	VERB
dpc-3921	28	51	elevated	elevated	ADJ
dpc-3921	28	52	levels	level	NOUN
dpc-3921	28	53	of	of	ADP
dpc-3921	28	54	reactive	reactive	ADJ
dpc-3921	28	55	oxygen	oxygen	NOUN
dpc-3921	28	56	species	specie	NOUN
dpc-3921	28	57	(	(	PUNCT
dpc-3921	28	58	ros	ros	PROPN
dpc-3921	28	59	)	)	PUNCT
dpc-3921	28	60	,	,	PUNCT
dpc-3921	28	61	associated	associate	VERB
dpc-3921	28	62	with	with	ADP
dpc-3921	28	63	an	an	DET
dpc-3921	28	64	imbalance	imbalance	NOUN
dpc-3921	28	65	in	in	ADP
dpc-3921	28	66	the	the	DET
dpc-3921	28	67	antioxidant	antioxidant	ADJ
dpc-3921	28	68	system	system	NOUN
dpc-3921	28	69	[	[	X
dpc-3921	28	70	8	8	NUM
dpc-3921	28	71	]	]	PUNCT
dpc-3921	28	72	.	.	PUNCT
dpc-3921	29	1	keratinocytes	keratinocyte	NOUN
dpc-3921	29	2	and	and	CCONJ
dpc-3921	29	3	fibroblasts	fibroblast	NOUN
dpc-3921	29	4	also	also	ADV
dpc-3921	29	5	display	display	VERB
dpc-3921	29	6	increased	increase	VERB
dpc-3921	29	7	levels	level	NOUN
dpc-3921	29	8	of	of	ADP
dpc-3921	29	9	ros	ros	PROPN
dpc-3921	30	1	[	[	X
dpc-3921	30	2	9	9	NUM
dpc-3921	30	3	]	]	PUNCT
dpc-3921	30	4	.	.	PUNCT
dpc-3921	31	1	this	this	DET
dpc-3921	31	2	accumulation	accumulation	NOUN
dpc-3921	31	3	of	of	ADP
dpc-3921	31	4	ros	ros	PROPN
dpc-3921	31	5	leads	lead	VERB
dpc-3921	31	6	to	to	ADP
dpc-3921	31	7	several	several	ADJ
dpc-3921	31	8	intracellular	intracellular	ADJ
dpc-3921	31	9	events	event	NOUN
dpc-3921	31	10	such	such	ADJ
dpc-3921	31	11	as	as	ADP
dpc-3921	31	12	dna	dna	PROPN
dpc-3921	31	13	abnormalities	abnormality	NOUN
dpc-3921	31	14	and	and	CCONJ
dpc-3921	31	15	premature	premature	ADJ
dpc-3921	31	16	apoptosis	apoptosis	NOUN
dpc-3921	31	17	that	that	PRON
dpc-3921	31	18	induce	induce	VERB
dpc-3921	31	19	the	the	DET
dpc-3921	31	20	release	release	NOUN
dpc-3921	31	21	of	of	ADP
dpc-3921	31	22	several	several	ADJ
dpc-3921	31	23	melanocyte	melanocyte	NOUN
dpc-3921	31	24	peptides	peptide	NOUN
dpc-3921	31	25	as	as	ADV
dpc-3921	31	26	well	well	ADV
dpc-3921	31	27	as	as	ADP
dpc-3921	31	28	abnormal	abnormal	ADJ
dpc-3921	31	29	melanocyte	melanocyte	NOUN
dpc-3921	31	30	function	function	NOUN
dpc-3921	31	31	and	and	CCONJ
dpc-3921	31	32	melanin	melanin	NOUN
dpc-3921	31	33	production	production	NOUN
dpc-3921	31	34	[	[	X
dpc-3921	31	35	8	8	NUM
dpc-3921	31	36	]	]	PUNCT
dpc-3921	31	37	.	.	PUNCT
dpc-3921	32	1	melanocytes	melanocyte	NOUN
dpc-3921	32	2	produce	produce	VERB
dpc-3921	32	3	pro	pro	ADJ
dpc-3921	32	4	-	-	ADJ
dpc-3921	32	5	inflammatory	inflammatory	ADJ
dpc-3921	32	6	signals	signal	NOUN
dpc-3921	32	7	such	such	ADJ
dpc-3921	32	8	as	as	ADP
dpc-3921	32	9	damage	damage	NOUN
dpc-3921	32	10	-	-	PUNCT
dpc-3921	32	11	associated	associate	VERB
dpc-3921	32	12	-	-	PUNCT
dpc-3921	32	13	molecular	molecular	ADJ
dpc-3921	32	14	patterns	pattern	NOUN
dpc-3921	32	15	(	(	PUNCT
dpc-3921	32	16	damps	damps	VERB
dpc-3921	32	17	)	)	PUNCT
dpc-3921	32	18	and	and	CCONJ
dpc-3921	32	19	chemokines	chemokine	NOUN
dpc-3921	32	20	,	,	PUNCT
dpc-3921	32	21	leading	lead	VERB
dpc-3921	32	22	to	to	ADP
dpc-3921	32	23	the	the	DET
dpc-3921	32	24	activation	activation	NOUN
dpc-3921	32	25	of	of	ADP
dpc-3921	32	26	the	the	DET
dpc-3921	32	27	immune	immune	ADJ
dpc-3921	32	28	response	response	NOUN
dpc-3921	32	29	and	and	CCONJ
dpc-3921	32	30	the	the	DET
dpc-3921	32	31	recruitment	recruitment	NOUN
dpc-3921	32	32	of	of	ADP
dpc-3921	32	33	immune	immune	ADJ
dpc-3921	32	34	cells	cell	NOUN
dpc-3921	32	35	.	.	PUNCT
dpc-3921	33	1	among	among	ADP
dpc-3921	33	2	these	these	DET
dpc-3921	33	3	danger	danger	NOUN
dpc-3921	33	4	signals	signal	NOUN
dpc-3921	33	5	,	,	PUNCT
dpc-3921	33	6	inducible	inducible	ADJ
dpc-3921	33	7	heat	heat	NOUN
dpc-3921	33	8	shock	shock	NOUN
dpc-3921	33	9	protein	protein	NOUN
dpc-3921	33	10	70	70	NUM
dpc-3921	33	11	(	(	PUNCT
dpc-3921	33	12	hsp70i	hsp70i	PROPN
dpc-3921	33	13	)	)	PUNCT
dpc-3921	33	14	,	,	PUNCT
dpc-3921	33	15	calreticulin	calreticulin	PROPN
dpc-3921	33	16	(	(	PUNCT
dpc-3921	33	17	crt	crt	ADJ
dpc-3921	33	18	)	)	PUNCT
dpc-3921	33	19	or	or	CCONJ
dpc-3921	33	20	high	high	ADJ
dpc-3921	33	21	mobility	mobility	NOUN
dpc-3921	33	22	group	group	NOUN
dpc-3921	33	23	b1	b1	NOUN
dpc-3921	33	24	(	(	PUNCT
dpc-3921	33	25	hmgb1	hmgb1	PROPN
dpc-3921	33	26	)	)	PUNCT
dpc-3921	33	27	proteins	protein	NOUN
dpc-3921	33	28	are	be	AUX
dpc-3921	33	29	the	the	DET
dpc-3921	33	30	most	most	ADV
dpc-3921	33	31	evaluated	evaluated	ADJ
dpc-3921	33	32	in	in	ADP
dpc-3921	33	33	vitiligo	vitiligo	NOUN
dpc-3921	33	34	[	[	X
dpc-3921	33	35	10–14	10–14	NUM
dpc-3921	33	36	]	]	PUNCT
dpc-3921	33	37	.	.	PUNCT
dpc-3921	34	1	these	these	PRON
dpc-3921	34	2	damps	damp	VERB
dpc-3921	34	3	released	release	VERB
dpc-3921	34	4	in	in	ADP
dpc-3921	34	5	the	the	DET
dpc-3921	34	6	extracellular	extracellular	ADJ
dpc-3921	34	7	environment	environment	NOUN
dpc-3921	34	8	are	be	AUX
dpc-3921	34	9	likely	likely	ADV
dpc-3921	34	10	bridging	bridge	VERB
dpc-3921	34	11	cellular	cellular	ADJ
dpc-3921	34	12	stress	stress	NOUN
dpc-3921	34	13	and	and	CCONJ
dpc-3921	34	14	the	the	DET
dpc-3921	34	15	autoimmune	autoimmune	ADJ
dpc-3921	34	16	response	response	NOUN
dpc-3921	34	17	directed	direct	VERB
dpc-3921	34	18	against	against	ADP
dpc-3921	34	19	melanocytes	melanocyte	NOUN
dpc-3921	34	20	in	in	ADP
dpc-3921	34	21	vitiligo	vitiligo	NOUN
dpc-3921	34	22	,	,	PUNCT
dpc-3921	34	23	and	and	CCONJ
dpc-3921	34	24	could	could	AUX
dpc-3921	34	25	therefore	therefore	ADV
dpc-3921	34	26	represent	represent	VERB
dpc-3921	34	27	interesting	interesting	ADJ
dpc-3921	34	28	potential	potential	ADJ
dpc-3921	34	29	targets	target	NOUN
dpc-3921	34	30	to	to	PART
dpc-3921	34	31	prevent	prevent	VERB
dpc-3921	34	32	the	the	DET
dpc-3921	34	33	initiation	initiation	NOUN
dpc-3921	34	34	of	of	ADP
dpc-3921	34	35	disease	disease	NOUN
dpc-3921	34	36	-	-	PUNCT
dpc-3921	34	37	causing	cause	VERB
dpc-3921	34	38	autoimmunity	autoimmunity	NOUN
dpc-3921	34	39	[	[	X
dpc-3921	34	40	15	15	NUM
dpc-3921	34	41	]	]	PUNCT
dpc-3921	34	42	.	.	PUNCT
dpc-3921	35	1	indeed	indeed	ADV
dpc-3921	35	2	,	,	PUNCT
dpc-3921	35	3	hmgb1	hmgb1	PROPN
dpc-3921	35	4	can	can	AUX
dpc-3921	35	5	induce	induce	VERB
dpc-3921	35	6	the	the	DET
dpc-3921	35	7	production	production	NOUN
dpc-3921	35	8	of	of	ADP
dpc-3921	35	9	chemokines	chemokine	NOUN
dpc-3921	35	10	,	,	PUNCT
dpc-3921	35	11	such	such	ADJ
dpc-3921	35	12	as	as	ADP
dpc-3921	35	13	ligand	ligand	NOUN
dpc-3921	35	14	(	(	PUNCT
dpc-3921	35	15	c	c	NOUN
dpc-3921	35	16	-	-	PUNCT
dpc-3921	35	17	x	x	NOUN
dpc-3921	35	18	-	-	NOUN
dpc-3921	35	19	c	c	NOUN
dpc-3921	35	20	motif	motif	NOUN
dpc-3921	35	21	)	)	PUNCT
dpc-3921	35	22	cxcl16	cxcl16	NOUN
dpc-3921	35	23	or	or	CCONJ
dpc-3921	35	24	interleukin	interleukin	NOUN
dpc-3921	35	25	(	(	PUNCT
dpc-3921	35	26	il)-8	il)-8	ADJ
dpc-3921	35	27	by	by	ADP
dpc-3921	35	28	epidermal	epidermal	ADJ
dpc-3921	35	29	cells	cell	NOUN
dpc-3921	35	30	(	(	PUNCT
dpc-3921	35	31	melanocytes	melanocyte	NOUN
dpc-3921	35	32	and	and	CCONJ
dpc-3921	35	33	keratinocytes	keratinocyte	NOUN
dpc-3921	35	34	)	)	PUNCT
dpc-3921	35	35	,	,	PUNCT
dpc-3921	35	36	which	which	PRON
dpc-3921	35	37	are	be	AUX
dpc-3921	35	38	important	important	ADJ
dpc-3921	35	39	for	for	ADP
dpc-3921	35	40	the	the	DET
dpc-3921	35	41	recruitment	recruitment	NOUN
dpc-3921	35	42	of	of	ADP
dpc-3921	35	43	immune	immune	ADJ
dpc-3921	35	44	cells	cell	NOUN
dpc-3921	35	45	[	[	X
dpc-3921	35	46	11	11	NUM
dpc-3921	35	47	]	]	PUNCT
dpc-3921	35	48	.	.	PUNCT
dpc-3921	36	1	crt	crt	PROPN
dpc-3921	36	2	may	may	AUX
dpc-3921	36	3	induce	induce	VERB
dpc-3921	36	4	apoptosis	apoptosis	NOUN
dpc-3921	36	5	of	of	ADP
dpc-3921	36	6	melanocytes	melanocyte	NOUN
dpc-3921	36	7	and	and	CCONJ
dpc-3921	36	8	the	the	DET
dpc-3921	36	9	release	release	NOUN
dpc-3921	36	10	of	of	ADP
dpc-3921	36	11	membrane	membrane	NOUN
dpc-3921	36	12	debris	debris	NOUN
dpc-3921	36	13	important	important	ADJ
dpc-3921	36	14	for	for	ADP
dpc-3921	36	15	immunogenicity	immunogenicity	NOUN
dpc-3921	36	16	[	[	X
dpc-3921	36	17	10	10	NUM
dpc-3921	36	18	]	]	PUNCT
dpc-3921	36	19	.	.	PUNCT
dpc-3921	37	1	lastly	lastly	ADV
dpc-3921	37	2	,	,	PUNCT
dpc-3921	37	3	several	several	ADJ
dpc-3921	37	4	studies	study	NOUN
dpc-3921	37	5	from	from	ADP
dpc-3921	37	6	the	the	DET
dpc-3921	37	7	group	group	NOUN
dpc-3921	37	8	of	of	ADP
dpc-3921	37	9	le	le	PROPN
dpc-3921	37	10	poole	poole	PROPN
dpc-3921	37	11	emphasized	emphasize	VERB
dpc-3921	37	12	the	the	DET
dpc-3921	37	13	role	role	NOUN
dpc-3921	37	14	of	of	ADP
dpc-3921	37	15	hsp70i	hsp70i	PROPN
dpc-3921	37	16	in	in	ADP
dpc-3921	37	17	vitiligo	vitiligo	NOUN
dpc-3921	37	18	[	[	X
dpc-3921	37	19	13,16–18	13,16–18	NUM
dpc-3921	37	20	]	]	X
dpc-3921	37	21	,	,	PUNCT
dpc-3921	37	22	and	and	CCONJ
dpc-3921	37	23	our	our	PRON
dpc-3921	37	24	group	group	NOUN
dpc-3921	37	25	showed	show	VERB
dpc-3921	37	26	its	its	PRON
dpc-3921	37	27	involvement	involvement	NOUN
dpc-3921	37	28	in	in	ADP
dpc-3921	37	29	the	the	DET
dpc-3921	37	30	activation	activation	NOUN
dpc-3921	37	31	of	of	ADP
dpc-3921	37	32	innate	innate	ADJ
dpc-3921	37	33	immunity	immunity	NOUN
dpc-3921	37	34	and	and	CCONJ
dpc-3921	37	35	the	the	DET
dpc-3921	37	36	production	production	NOUN
dpc-3921	37	37	of	of	ADP
dpc-3921	37	38	type	type	NOUN
dpc-3921	37	39	i	i	PRON
dpc-3921	37	40	interferon	interferon	ADJ
dpc-3921	37	41	(	(	PUNCT
dpc-3921	37	42	ifn	ifn	PROPN
dpc-3921	37	43	)	)	PUNCT
dpc-3921	38	1	[	[	X
dpc-3921	38	2	14	14	NUM
dpc-3921	38	3	]	]	PUNCT
dpc-3921	38	4	.	.	PUNCT
dpc-3921	39	1	keratinocytes	keratinocyte	NOUN
dpc-3921	39	2	also	also	ADV
dpc-3921	39	3	play	play	VERB
dpc-3921	39	4	an	an	DET
dpc-3921	39	5	important	important	ADJ
dpc-3921	39	6	role	role	NOUN
dpc-3921	39	7	in	in	ADP
dpc-3921	39	8	the	the	DET
dpc-3921	39	9	physiopathology	physiopathology	NOUN
dpc-3921	39	10	of	of	ADP
dpc-3921	39	11	vitiligo	vitiligo	NOUN
dpc-3921	39	12	.	.	PUNCT
dpc-3921	40	1	structural	structural	ADJ
dpc-3921	40	2	alterations	alteration	NOUN
dpc-3921	40	3	of	of	ADP
dpc-3921	40	4	keratinocytes	keratinocyte	NOUN
dpc-3921	40	5	have	have	AUX
dpc-3921	40	6	been	be	AUX
dpc-3921	40	7	observed	observe	VERB
dpc-3921	40	8	in	in	ADP
dpc-3921	40	9	the	the	DET
dpc-3921	40	10	non	non	ADJ
dpc-3921	40	11	-	-	ADJ
dpc-3921	40	12	lesional	lesional	ADJ
dpc-3921	40	13	skin	skin	NOUN
dpc-3921	40	14	of	of	ADP
dpc-3921	40	15	patients	patient	NOUN
dpc-3921	40	16	,	,	PUNCT
dpc-3921	40	17	with	with	ADP
dpc-3921	40	18	abnormal	abnormal	ADJ
dpc-3921	40	19	thickening	thickening	NOUN
dpc-3921	40	20	of	of	ADP
dpc-3921	40	21	the	the	DET
dpc-3921	40	22	epidermis	epidermis	NOUN
dpc-3921	40	23	due	due	ADP
dpc-3921	40	24	to	to	ADP
dpc-3921	40	25	an	an	DET
dpc-3921	40	26	increase	increase	NOUN
dpc-3921	40	27	in	in	ADP
dpc-3921	40	28	the	the	DET
dpc-3921	40	29	spinous	spinous	ADJ
dpc-3921	40	30	layer	layer	NOUN
dpc-3921	40	31	[	[	X
dpc-3921	40	32	19	19	NUM
dpc-3921	40	33	]	]	PUNCT
dpc-3921	40	34	.	.	PUNCT
dpc-3921	41	1	alterations	alteration	NOUN
dpc-3921	41	2	of	of	ADP
dpc-3921	41	3	basal	basal	NOUN
dpc-3921	41	4	and	and	CCONJ
dpc-3921	41	5	suprabasal	suprabasal	NOUN
dpc-3921	41	6	keratinocytes	keratinocyte	NOUN
dpc-3921	41	7	,	,	PUNCT
dpc-3921	41	8	in	in	ADP
dpc-3921	41	9	particular	particular	ADJ
dpc-3921	41	10	vacuolar	vacuolar	ADJ
dpc-3921	41	11	degeneration	degeneration	NOUN
dpc-3921	41	12	and	and	CCONJ
dpc-3921	41	13	spongiosis	spongiosis	NOUN
dpc-3921	41	14	,	,	PUNCT
dpc-3921	41	15	are	be	AUX
dpc-3921	41	16	sometimes	sometimes	ADV
dpc-3921	41	17	found	find	VERB
dpc-3921	41	18	[	[	X
dpc-3921	41	19	20	20	NUM
dpc-3921	41	20	]	]	PUNCT
dpc-3921	41	21	.	.	PUNCT
dpc-3921	42	1	at	at	ADP
dpc-3921	42	2	the	the	DET
dpc-3921	42	3	peri	peri	ADJ
dpc-3921	42	4	-	-	PUNCT
dpc-3921	42	5	lesional	lesional	ADJ
dpc-3921	42	6	site	site	NOUN
dpc-3921	42	7	(	(	PUNCT
dpc-3921	42	8	at	at	ADP
dpc-3921	42	9	the	the	DET
dpc-3921	42	10	edge	edge	NOUN
dpc-3921	42	11	of	of	ADP
dpc-3921	42	12	the	the	DET
dpc-3921	42	13	lesions	lesion	NOUN
dpc-3921	42	14	,	,	PUNCT
dpc-3921	42	15	where	where	SCONJ
dpc-3921	42	16	melanocytes	melanocyte	NOUN
dpc-3921	42	17	are	be	AUX
dpc-3921	42	18	still	still	ADV
dpc-3921	42	19	present	present	ADJ
dpc-3921	42	20	)	)	PUNCT
dpc-3921	42	21	,	,	PUNCT
dpc-3921	42	22	keratinocytes	keratinocyte	NOUN
dpc-3921	42	23	have	have	VERB
dpc-3921	42	24	the	the	DET
dpc-3921	42	25	capacity	capacity	NOUN
dpc-3921	42	26	to	to	PART
dpc-3921	42	27	produce	produce	VERB
dpc-3921	42	28	several	several	ADJ
dpc-3921	42	29	factors	factor	NOUN
dpc-3921	42	30	that	that	PRON
dpc-3921	42	31	contribute	contribute	VERB
dpc-3921	42	32	to	to	ADP
dpc-3921	42	33	the	the	DET
dpc-3921	42	34	generation	generation	NOUN
dpc-3921	42	35	of	of	ADP
dpc-3921	42	36	a	a	DET
dpc-3921	42	37	pro	pro	ADJ
dpc-3921	42	38	-	-	ADJ
dpc-3921	42	39	inflammatory	inflammatory	ADJ
dpc-3921	42	40	environment	environment	NOUN
dpc-3921	42	41	,	,	PUNCT
dpc-3921	42	42	such	such	ADJ
dpc-3921	42	43	as	as	ADP
dpc-3921	42	44	stem	stem	NOUN
dpc-3921	42	45	cell	cell	NOUN
dpc-3921	42	46	factor	factor	NOUN
dpc-3921	42	47	(	(	PUNCT
dpc-3921	42	48	scf	scf	PROPN
dpc-3921	42	49	)	)	PUNCT
dpc-3921	42	50	,	,	PUNCT
dpc-3921	42	51	endothelin-1	endothelin-1	PRON
dpc-3921	42	52	(	(	PUNCT
dpc-3921	42	53	et-1	et-1	X
dpc-3921	42	54	)	)	PUNCT
dpc-3921	42	55	,	,	PUNCT
dpc-3921	42	56	and	and	CCONJ
dpc-3921	42	57	pro	pro	ADJ
dpc-3921	42	58	-	-	ADJ
dpc-3921	42	59	inflammatory	inflammatory	ADJ
dpc-3921	42	60	cytokines	cytokine	NOUN
dpc-3921	42	61	like	like	ADP
dpc-3921	42	62	il-1β	il-1β	PROPN
dpc-3921	42	63	,	,	PUNCT
dpc-3921	42	64	il-6	il-6	NOUN
dpc-3921	42	65	,	,	PUNCT
dpc-3921	42	66	and	and	CCONJ
dpc-3921	42	67	tumor	tumor	NOUN
dpc-3921	42	68	necrosis	necrosis	NOUN
dpc-3921	42	69	factor	factor	NOUN
dpc-3921	42	70	(	(	PUNCT
dpc-3921	42	71	tnf)-α	tnf)-α	PROPN
dpc-3921	42	72	.	.	PUNCT
dpc-3921	43	1	danger	danger	NOUN
dpc-3921	43	2	signals	signal	NOUN
dpc-3921	43	3	produced	produce	VERB
dpc-3921	43	4	locally	locally	ADV
dpc-3921	43	5	in	in	ADP
dpc-3921	43	6	the	the	DET
dpc-3921	43	7	skin	skin	NOUN
dpc-3921	43	8	are	be	AUX
dpc-3921	43	9	responsible	responsible	ADJ
dpc-3921	43	10	for	for	ADP
dpc-3921	43	11	the	the	DET
dpc-3921	43	12	activation	activation	NOUN
dpc-3921	43	13	of	of	ADP
dpc-3921	43	14	the	the	DET
dpc-3921	43	15	pyrin	pyrin	NOUN
dpc-3921	43	16	domain	domain	NOUN
dpc-3921	43	17	of	of	ADP
dpc-3921	43	18	nod	nod	NOUN
dpc-3921	43	19	like	like	ADP
dpc-3921	43	20	receptor	receptor	NOUN
dpc-3921	43	21	(	(	PUNCT
dpc-3921	43	22	nlr	nlr	PROPN
dpc-3921	43	23	)	)	PUNCT
dpc-3921	43	24	proteins	protein	NOUN
dpc-3921	43	25	,	,	PUNCT
dpc-3921	43	26	such	such	ADJ
dpc-3921	43	27	figure	figure	NOUN
dpc-3921	43	28	1	1	NUM
dpc-3921	43	29	.	.	PUNCT
dpc-3921	43	30	pathophysiological	pathophysiological	ADJ
dpc-3921	43	31	mechanisms	mechanism	NOUN
dpc-3921	43	32	of	of	ADP
dpc-3921	43	33	vitiligo	vitiligo	NOUN
dpc-3921	43	34	.	.	PUNCT
dpc-3921	44	1	in	in	ADP
dpc-3921	44	2	a	a	DET
dpc-3921	44	3	genetically	genetically	ADV
dpc-3921	44	4	predisposed	predispose	VERB
dpc-3921	44	5	individual	individual	NOUN
dpc-3921	44	6	and	and	CCONJ
dpc-3921	44	7	under	under	ADP
dpc-3921	44	8	environmental	environmental	ADJ
dpc-3921	44	9	triggers	trigger	NOUN
dpc-3921	44	10	,	,	PUNCT
dpc-3921	44	11	epidermal	epidermal	ADJ
dpc-3921	44	12	cells	cell	NOUN
dpc-3921	44	13	(	(	PUNCT
dpc-3921	44	14	keratinocytes	keratinocyte	NOUN
dpc-3921	44	15	and	and	CCONJ
dpc-3921	44	16	melanocytes	melanocyte	NOUN
dpc-3921	44	17	)	)	PUNCT
dpc-3921	44	18	will	will	AUX
dpc-3921	44	19	release	release	VERB
dpc-3921	44	20	danger	danger	NOUN
dpc-3921	44	21	signals	signal	NOUN
dpc-3921	44	22	(	(	PUNCT
dpc-3921	44	23	e	e	NOUN
dpc-3921	44	24	.g	.g	PROPN
dpc-3921	44	25	.	.	PUNCT
dpc-3921	44	26	:	:	PUNCT
dpc-3921	45	1	hsp70	hsp70	NOUN
dpc-3921	45	2	)	)	PUNCT
dpc-3921	45	3	,	,	PUNCT
dpc-3921	45	4	leading	lead	VERB
dpc-3921	45	5	to	to	ADP
dpc-3921	45	6	the	the	DET
dpc-3921	45	7	activation	activation	NOUN
dpc-3921	45	8	of	of	ADP
dpc-3921	45	9	the	the	DET
dpc-3921	45	10	innate	innate	ADJ
dpc-3921	45	11	immune	immune	ADJ
dpc-3921	45	12	system	system	NOUN
dpc-3921	45	13	.	.	PUNCT
dpc-3921	46	1	ifnγ	ifnγ	NOUN
dpc-3921	46	2	-	-	PUNCT
dpc-3921	46	3	producing	produce	VERB
dpc-3921	46	4	innate	innate	ADJ
dpc-3921	46	5	lymphoid	lymphoid	NOUN
dpc-3921	46	6	cells	cell	NOUN
dpc-3921	46	7	(	(	PUNCT
dpc-3921	46	8	ilc1	ilc1	PROPN
dpc-3921	46	9	)	)	PUNCT
dpc-3921	46	10	or	or	CCONJ
dpc-3921	46	11	ifnα	ifnα	NOUN
dpc-3921	46	12	-	-	PUNCT
dpc-3921	46	13	producing	produce	VERB
dpc-3921	46	14	plasmacytoid	plasmacytoid	NOUN
dpc-3921	46	15	dendritic	dendritic	ADJ
dpc-3921	46	16	cells	cell	NOUN
dpc-3921	46	17	will	will	AUX
dpc-3921	46	18	induce	induce	VERB
dpc-3921	46	19	the	the	DET
dpc-3921	46	20	production	production	NOUN
dpc-3921	46	21	of	of	ADP
dpc-3921	46	22	chemokines	chemokine	NOUN
dpc-3921	46	23	,	,	PUNCT
dpc-3921	46	24	such	such	ADJ
dpc-3921	46	25	as	as	ADP
dpc-3921	46	26	cxcl9	cxcl9	NOUN
dpc-3921	46	27	,	,	PUNCT
dpc-3921	46	28	cxcl10	cxcl10	NOUN
dpc-3921	46	29	,	,	PUNCT
dpc-3921	46	30	or	or	CCONJ
dpc-3921	46	31	cxcl16	cxcl16	NOUN
dpc-3921	46	32	by	by	ADP
dpc-3921	46	33	epidermal	epidermal	ADJ
dpc-3921	46	34	and	and	CCONJ
dpc-3921	46	35	dermal	dermal	ADJ
dpc-3921	46	36	cells	cell	NOUN
dpc-3921	46	37	.	.	PUNCT
dpc-3921	47	1	melanocytes	melanocyte	NOUN
dpc-3921	47	2	expressing	express	VERB
dpc-3921	47	3	the	the	DET
dpc-3921	47	4	cxcr3b	cxcr3b	NOUN
dpc-3921	47	5	subunit	subunit	NOUN
dpc-3921	47	6	can	can	AUX
dpc-3921	47	7	be	be	AUX
dpc-3921	47	8	impacted	impact	VERB
dpc-3921	47	9	by	by	ADP
dpc-3921	47	10	the	the	DET
dpc-3921	47	11	interaction	interaction	NOUN
dpc-3921	47	12	with	with	ADP
dpc-3921	47	13	these	these	DET
dpc-3921	47	14	ligands	ligand	NOUN
dpc-3921	47	15	.	.	PUNCT
dpc-3921	48	1	together	together	ADV
dpc-3921	48	2	,	,	PUNCT
dpc-3921	48	3	these	these	DET
dpc-3921	48	4	events	event	NOUN
dpc-3921	48	5	will	will	AUX
dpc-3921	48	6	induce	induce	VERB
dpc-3921	48	7	local	local	ADJ
dpc-3921	48	8	activation	activation	NOUN
dpc-3921	48	9	of	of	ADP
dpc-3921	48	10	resident	resident	ADJ
dpc-3921	48	11	memory	memory	NOUN
dpc-3921	48	12	t	t	NOUN
dpc-3921	48	13	cells	cell	NOUN
dpc-3921	48	14	and	and	CCONJ
dpc-3921	48	15	the	the	DET
dpc-3921	48	16	recruitment	recruitment	NOUN
dpc-3921	48	17	of	of	ADP
dpc-3921	48	18	circulating	circulate	VERB
dpc-3921	48	19	t	t	NOUN
dpc-3921	48	20	cells	cell	NOUN
dpc-3921	48	21	expressing	express	VERB
dpc-3921	48	22	cxcr3	cxcr3	NOUN
dpc-3921	48	23	and	and	CCONJ
dpc-3921	48	24	nkg2d	nkg2d	PROPN
dpc-3921	48	25	and	and	CCONJ
dpc-3921	48	26	producing	produce	VERB
dpc-3921	48	27	elevated	elevated	ADJ
dpc-3921	48	28	levels	level	NOUN
dpc-3921	48	29	ifnγ	ifnγ	NOUN
dpc-3921	48	30	and	and	CCONJ
dpc-3921	48	31	tnfα	tnfα	NOUN
dpc-3921	48	32	,	,	PUNCT
dpc-3921	48	33	leading	lead	VERB
dpc-3921	48	34	to	to	ADP
dpc-3921	48	35	the	the	DET
dpc-3921	48	36	loss	loss	NOUN
dpc-3921	48	37	of	of	ADP
dpc-3921	48	38	melanocytes	melanocyte	NOUN
dpc-3921	48	39	and	and	CCONJ
dpc-3921	48	40	depigmentation	depigmentation	NOUN
dpc-3921	48	41	.	.	PUNCT
dpc-3921	49	1	review	review	NOUN
dpc-3921	49	2	|	|	ADV
dpc-3921	49	3	dermatol	dermatol	ADJ
dpc-3921	49	4	pract	pract	NOUN
dpc-3921	49	5	concept	concept	NOUN
dpc-3921	49	6	.	.	PUNCT
dpc-3921	50	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-3921	50	2	:	:	PUNCT
dpc-3921	50	3	e2023314s	e2023314s	PROPN
dpc-3921	50	4	3	3	NUM
dpc-3921	50	5	as	as	ADP
dpc-3921	50	6	nlrp3	nlrp3	NOUN
dpc-3921	50	7	,	,	PUNCT
dpc-3921	50	8	an	an	DET
dpc-3921	50	9	inflammasome	inflammasome	NOUN
dpc-3921	50	10	activating	activate	VERB
dpc-3921	50	11	protein	protein	NOUN
dpc-3921	50	12	,	,	PUNCT
dpc-3921	50	13	promoting	promote	VERB
dpc-3921	50	14	the	the	DET
dpc-3921	50	15	secretion	secretion	NOUN
dpc-3921	50	16	of	of	ADP
dpc-3921	50	17	il-1β	il-1β	PROPN
dpc-3921	50	18	and	and	CCONJ
dpc-3921	50	19	il-18	il-18	NOUN
dpc-3921	50	20	[	[	X
dpc-3921	50	21	21	21	NUM
dpc-3921	50	22	]	]	PUNCT
dpc-3921	50	23	.	.	PUNCT
dpc-3921	51	1	in	in	ADP
dpc-3921	51	2	addition	addition	NOUN
dpc-3921	51	3	,	,	PUNCT
dpc-3921	51	4	keratinocytes	keratinocyte	NOUN
dpc-3921	51	5	from	from	ADP
dpc-3921	51	6	vitiligo	vitiligo	PROPN
dpc-3921	51	7	non	non	ADJ
dpc-3921	51	8	-	-	ADJ
dpc-3921	51	9	lesional	lesional	ADJ
dpc-3921	51	10	and	and	CCONJ
dpc-3921	51	11	peri	peri	NOUN
dpc-3921	51	12	-	-	PUNCT
dpc-3921	51	13	lesional	lesional	ADJ
dpc-3921	51	14	skin	skin	NOUN
dpc-3921	51	15	release	release	NOUN
dpc-3921	51	16	chemokines	chemokine	NOUN
dpc-3921	51	17	involved	involve	VERB
dpc-3921	51	18	in	in	ADP
dpc-3921	51	19	the	the	DET
dpc-3921	51	20	recruitment	recruitment	NOUN
dpc-3921	51	21	of	of	ADP
dpc-3921	51	22	t	t	PROPN
dpc-3921	51	23	cells	cell	NOUN
dpc-3921	51	24	in	in	ADP
dpc-3921	51	25	the	the	DET
dpc-3921	51	26	skin	skin	NOUN
dpc-3921	51	27	,	,	PUNCT
dpc-3921	51	28	like	like	ADP
dpc-3921	51	29	cxcl9	cxcl9	NOUN
dpc-3921	51	30	,	,	PUNCT
dpc-3921	51	31	cxcl10	cxcl10	NOUN
dpc-3921	51	32	,	,	PUNCT
dpc-3921	51	33	and	and	CCONJ
dpc-3921	51	34	cxcl16	cxcl16	NOUN
dpc-3921	51	35	.	.	PUNCT
dpc-3921	52	1	cxcl9	cxcl9	NOUN
dpc-3921	52	2	and	and	CCONJ
dpc-3921	52	3	cxcl10	cxcl10	NOUN
dpc-3921	52	4	,	,	PUNCT
dpc-3921	52	5	induced	induce	VERB
dpc-3921	52	6	by	by	ADP
dpc-3921	52	7	ifnγ	ifnγ	NOUN
dpc-3921	52	8	(	(	PUNCT
dpc-3921	52	9	an	an	DET
dpc-3921	52	10	important	important	ADJ
dpc-3921	52	11	cytokine	cytokine	NOUN
dpc-3921	52	12	in	in	ADP
dpc-3921	52	13	the	the	DET
dpc-3921	52	14	physiopathology	physiopathology	NOUN
dpc-3921	52	15	of	of	ADP
dpc-3921	52	16	vitiligo	vitiligo	NOUN
dpc-3921	52	17	)	)	PUNCT
dpc-3921	52	18	,	,	PUNCT
dpc-3921	52	19	bind	bind	VERB
dpc-3921	52	20	to	to	ADP
dpc-3921	52	21	their	their	PRON
dpc-3921	52	22	cognate	cognate	NOUN
dpc-3921	52	23	receptor	receptor	NOUN
dpc-3921	52	24	cxcr3	cxcr3	NOUN
dpc-3921	52	25	expressed	express	VERB
dpc-3921	52	26	on	on	ADP
dpc-3921	52	27	immune	immune	ADJ
dpc-3921	52	28	cells	cell	NOUN
dpc-3921	52	29	,	,	PUNCT
dpc-3921	52	30	and	and	CCONJ
dpc-3921	52	31	most	most	ADJ
dpc-3921	52	32	t	t	NOUN
dpc-3921	52	33	cells	cell	NOUN
dpc-3921	52	34	in	in	ADP
dpc-3921	52	35	vitiligo	vitiligo	NOUN
dpc-3921	52	36	patients	patient	NOUN
dpc-3921	52	37	skin	skin	NOUN
dpc-3921	52	38	express	express	ADJ
dpc-3921	52	39	cxcr3	cxcr3	NOUN
dpc-3921	53	1	[	[	X
dpc-3921	53	2	14,22–24	14,22–24	NOUN
dpc-3921	53	3	]	]	X
dpc-3921	53	4	.	.	PUNCT
dpc-3921	54	1	in	in	ADP
dpc-3921	54	2	addition	addition	NOUN
dpc-3921	54	3	,	,	PUNCT
dpc-3921	54	4	xu	xu	PROPN
dpc-3921	54	5	et	et	PROPN
dpc-3921	54	6	al	al	PROPN
dpc-3921	54	7	.	.	PROPN
dpc-3921	54	8	recently	recently	ADV
dpc-3921	54	9	showed	show	VERB
dpc-3921	54	10	in	in	ADP
dpc-3921	54	11	a	a	DET
dpc-3921	54	12	mouse	mouse	NOUN
dpc-3921	54	13	model	model	NOUN
dpc-3921	54	14	of	of	ADP
dpc-3921	54	15	vitiligo	vitiligo	NOUN
dpc-3921	54	16	that	that	SCONJ
dpc-3921	54	17	ifnγ	ifnγ	NOUN
dpc-3921	54	18	-	-	PUNCT
dpc-3921	54	19	responsive	responsive	ADJ
dpc-3921	54	20	dermal	dermal	NOUN
dpc-3921	54	21	fibroblasts	fibroblast	NOUN
dpc-3921	54	22	,	,	PUNCT
dpc-3921	54	23	through	through	ADP
dpc-3921	54	24	their	their	PRON
dpc-3921	54	25	release	release	NOUN
dpc-3921	54	26	of	of	ADP
dpc-3921	54	27	chemokines	chemokine	NOUN
dpc-3921	54	28	,	,	PUNCT
dpc-3921	54	29	are	be	AUX
dpc-3921	54	30	active	active	ADJ
dpc-3921	54	31	players	player	NOUN
dpc-3921	54	32	in	in	ADP
dpc-3921	54	33	the	the	DET
dpc-3921	54	34	homing	homing	NOUN
dpc-3921	54	35	of	of	ADP
dpc-3921	54	36	cd8	cd8	PROPN
dpc-3921	54	37	t	t	PROPN
dpc-3921	54	38	cells	cell	NOUN
dpc-3921	54	39	to	to	ADP
dpc-3921	54	40	the	the	DET
dpc-3921	54	41	skin	skin	NOUN
dpc-3921	54	42	[	[	X
dpc-3921	54	43	25	25	NUM
dpc-3921	54	44	]	]	PUNCT
dpc-3921	54	45	.	.	PUNCT
dpc-3921	55	1	another	another	DET
dpc-3921	55	2	innate	innate	ADJ
dpc-3921	55	3	inflammatory	inflammatory	ADJ
dpc-3921	55	4	signature	signature	NOUN
dpc-3921	55	5	found	find	VERB
dpc-3921	55	6	increased	increase	VERB
dpc-3921	55	7	in	in	ADP
dpc-3921	55	8	peri	peri	NOUN
dpc-3921	55	9	-	-	PUNCT
dpc-3921	55	10	lesional	lesional	ADJ
dpc-3921	55	11	areas	area	NOUN
dpc-3921	55	12	of	of	ADP
dpc-3921	55	13	vitiligo	vitiligo	NOUN
dpc-3921	55	14	is	be	AUX
dpc-3921	55	15	the	the	DET
dpc-3921	55	16	ifnα	ifnα	ADJ
dpc-3921	55	17	pathway	pathway	NOUN
dpc-3921	55	18	,	,	PUNCT
dpc-3921	55	19	which	which	PRON
dpc-3921	55	20	contributes	contribute	VERB
dpc-3921	55	21	to	to	ADP
dpc-3921	55	22	the	the	DET
dpc-3921	55	23	activation	activation	NOUN
dpc-3921	55	24	of	of	ADP
dpc-3921	55	25	antigen	antigen	ADV
dpc-3921	55	26	-	-	PUNCT
dpc-3921	55	27	presenting	present	VERB
dpc-3921	55	28	cells	cell	NOUN
dpc-3921	55	29	in	in	ADP
dpc-3921	55	30	the	the	DET
dpc-3921	55	31	skin	skin	NOUN
dpc-3921	55	32	and	and	CCONJ
dpc-3921	55	33	the	the	DET
dpc-3921	55	34	production	production	NOUN
dpc-3921	55	35	of	of	ADP
dpc-3921	55	36	chemokines	chemokine	NOUN
dpc-3921	55	37	to	to	PART
dpc-3921	55	38	reinforce	reinforce	VERB
dpc-3921	55	39	the	the	DET
dpc-3921	55	40	recruitment	recruitment	NOUN
dpc-3921	55	41	of	of	ADP
dpc-3921	55	42	other	other	ADJ
dpc-3921	55	43	immune	immune	ADJ
dpc-3921	55	44	populations	population	NOUN
dpc-3921	55	45	at	at	ADP
dpc-3921	55	46	the	the	DET
dpc-3921	55	47	peri	peri	ADJ
dpc-3921	55	48	-	-	PUNCT
dpc-3921	55	49	lesional	lesional	ADJ
dpc-3921	55	50	site	site	NOUN
dpc-3921	55	51	[	[	X
dpc-3921	55	52	26,27	26,27	NUM
dpc-3921	55	53	]	]	PUNCT
dpc-3921	55	54	.	.	PUNCT
dpc-3921	56	1	ifnα	ifnα	ADJ
dpc-3921	56	2	production	production	NOUN
dpc-3921	56	3	is	be	AUX
dpc-3921	56	4	linked	link	VERB
dpc-3921	56	5	to	to	ADP
dpc-3921	56	6	the	the	DET
dpc-3921	56	7	presence	presence	NOUN
dpc-3921	56	8	of	of	ADP
dpc-3921	56	9	plasmacytoid	plasmacytoid	NOUN
dpc-3921	56	10	dendritic	dendritic	ADJ
dpc-3921	56	11	cells	cell	NOUN
dpc-3921	56	12	and	and	CCONJ
dpc-3921	56	13	induces	induce	VERB
dpc-3921	56	14	the	the	DET
dpc-3921	56	15	release	release	NOUN
dpc-3921	56	16	of	of	ADP
dpc-3921	56	17	chemokines	chemokine	NOUN
dpc-3921	56	18	such	such	ADJ
dpc-3921	56	19	as	as	ADP
dpc-3921	56	20	cxcl9	cxcl9	NOUN
dpc-3921	56	21	and	and	CCONJ
dpc-3921	56	22	cxcl10	cxcl10	NOUN
dpc-3921	56	23	by	by	ADP
dpc-3921	56	24	epidermal	epidermal	ADJ
dpc-3921	56	25	cells	cell	NOUN
dpc-3921	57	1	[	[	X
dpc-3921	57	2	14,26	14,26	NOUN
dpc-3921	57	3	]	]	PUNCT
dpc-3921	57	4	.	.	PUNCT
dpc-3921	58	1	in	in	ADP
dpc-3921	58	2	addition	addition	NOUN
dpc-3921	58	3	,	,	PUNCT
dpc-3921	58	4	the	the	DET
dpc-3921	58	5	presence	presence	NOUN
dpc-3921	58	6	of	of	ADP
dpc-3921	58	7	innate	innate	ADJ
dpc-3921	58	8	immune	immune	ADJ
dpc-3921	58	9	lymphoid	lymphoid	ADJ
dpc-3921	58	10	type	type	NOUN
dpc-3921	58	11	1	1	NUM
dpc-3921	58	12	cells	cell	NOUN
dpc-3921	58	13	(	(	PUNCT
dpc-3921	58	14	ilc1	ilc1	PROPN
dpc-3921	58	15	)	)	PUNCT
dpc-3921	58	16	in	in	ADP
dpc-3921	58	17	vitiligo	vitiligo	NOUN
dpc-3921	58	18	skin	skin	NOUN
dpc-3921	58	19	has	have	AUX
dpc-3921	58	20	been	be	AUX
dpc-3921	58	21	recently	recently	ADV
dpc-3921	58	22	demonstrated	demonstrate	VERB
dpc-3921	58	23	,	,	PUNCT
dpc-3921	58	24	which	which	PRON
dpc-3921	58	25	respond	respond	VERB
dpc-3921	58	26	to	to	ADP
dpc-3921	58	27	non	non	ADJ
dpc-3921	58	28	-	-	ADJ
dpc-3921	58	29	specific	specific	ADJ
dpc-3921	58	30	stimuli	stimulus	NOUN
dpc-3921	58	31	and	and	CCONJ
dpc-3921	58	32	produce	produce	VERB
dpc-3921	58	33	significant	significant	ADJ
dpc-3921	58	34	amounts	amount	NOUN
dpc-3921	58	35	of	of	ADP
dpc-3921	58	36	ifnγ	ifnγ	NOUN
dpc-3921	58	37	during	during	ADP
dpc-3921	58	38	the	the	DET
dpc-3921	58	39	initiation	initiation	NOUN
dpc-3921	58	40	of	of	ADP
dpc-3921	58	41	the	the	DET
dpc-3921	58	42	disease	disease	NOUN
dpc-3921	58	43	,	,	PUNCT
dpc-3921	58	44	leading	lead	VERB
dpc-3921	58	45	to	to	ADP
dpc-3921	58	46	early	early	ADJ
dpc-3921	58	47	melanocyte	melanocyte	NOUN
dpc-3921	58	48	apoptosis	apoptosis	NOUN
dpc-3921	59	1	[	[	X
dpc-3921	59	2	28	28	NUM
dpc-3921	59	3	]	]	PUNCT
dpc-3921	59	4	.	.	PUNCT
dpc-3921	60	1	progression	progression	NOUN
dpc-3921	60	2	phase	phase	NOUN
dpc-3921	60	3	of	of	ADP
dpc-3921	60	4	the	the	DET
dpc-3921	60	5	disease	disease	NOUN
dpc-3921	60	6	:	:	PUNCT
dpc-3921	60	7	involvement	involvement	NOUN
dpc-3921	60	8	of	of	ADP
dpc-3921	60	9	a	a	DET
dpc-3921	60	10	cutaneous	cutaneous	ADJ
dpc-3921	60	11	immune	immune	ADJ
dpc-3921	60	12	memory	memory	NOUN
dpc-3921	60	13	response	response	NOUN
dpc-3921	60	14	following	follow	VERB
dpc-3921	60	15	these	these	DET
dpc-3921	60	16	initial	initial	ADJ
dpc-3921	60	17	events	event	NOUN
dpc-3921	60	18	,	,	PUNCT
dpc-3921	60	19	vitiligo	vitiligo	ADJ
dpc-3921	60	20	skin	skin	NOUN
dpc-3921	60	21	is	be	AUX
dpc-3921	60	22	characterized	characterize	VERB
dpc-3921	60	23	by	by	ADP
dpc-3921	60	24	the	the	DET
dpc-3921	60	25	presence	presence	NOUN
dpc-3921	60	26	of	of	ADP
dpc-3921	60	27	a	a	DET
dpc-3921	60	28	localized	localize	VERB
dpc-3921	60	29	t	t	NOUN
dpc-3921	60	30	cell	cell	NOUN
dpc-3921	60	31	infiltrate	infiltrate	VERB
dpc-3921	60	32	close	close	ADV
dpc-3921	60	33	to	to	ADP
dpc-3921	60	34	the	the	DET
dpc-3921	60	35	epidermis	epidermis	NOUN
dpc-3921	60	36	and	and	CCONJ
dpc-3921	60	37	residual	residual	ADJ
dpc-3921	60	38	melanocytes	melanocyte	NOUN
dpc-3921	60	39	,	,	PUNCT
dpc-3921	60	40	mainly	mainly	ADV
dpc-3921	60	41	consisting	consist	VERB
dpc-3921	60	42	of	of	ADP
dpc-3921	60	43	cd8	cd8	PROPN
dpc-3921	60	44	t	t	PROPN
dpc-3921	60	45	cells	cell	NOUN
dpc-3921	60	46	.	.	PUNCT
dpc-3921	61	1	recent	recent	ADJ
dpc-3921	61	2	studies	study	NOUN
dpc-3921	61	3	highlighted	highlight	VERB
dpc-3921	61	4	the	the	DET
dpc-3921	61	5	involvement	involvement	NOUN
dpc-3921	61	6	of	of	ADP
dpc-3921	61	7	resident	resident	ADJ
dpc-3921	61	8	memory	memory	NOUN
dpc-3921	61	9	t	t	PROPN
dpc-3921	61	10	cells	cell	NOUN
dpc-3921	61	11	(	(	PUNCT
dpc-3921	61	12	trm	trm	NOUN
dpc-3921	61	13	)	)	PUNCT
dpc-3921	61	14	in	in	ADP
dpc-3921	61	15	disease	disease	NOUN
dpc-3921	61	16	pathogenesis	pathogenesis	NOUN
dpc-3921	61	17	[	[	X
dpc-3921	61	18	24,27,29–31	24,27,29–31	NUM
dpc-3921	61	19	]	]	PUNCT
dpc-3921	61	20	.	.	PUNCT
dpc-3921	62	1	trm	trm	PROPN
dpc-3921	62	2	are	be	AUX
dpc-3921	62	3	long	long	ADV
dpc-3921	62	4	-	-	PUNCT
dpc-3921	62	5	lived	live	VERB
dpc-3921	62	6	memory	memory	NOUN
dpc-3921	62	7	t	t	NOUN
dpc-3921	62	8	cells	cell	NOUN
dpc-3921	62	9	that	that	PRON
dpc-3921	62	10	persist	persist	VERB
dpc-3921	62	11	in	in	ADP
dpc-3921	62	12	tissues	tissue	NOUN
dpc-3921	62	13	like	like	ADP
dpc-3921	62	14	the	the	DET
dpc-3921	62	15	skin	skin	NOUN
dpc-3921	62	16	and	and	CCONJ
dpc-3921	62	17	are	be	AUX
dpc-3921	62	18	characterized	characterize	VERB
dpc-3921	62	19	by	by	ADP
dpc-3921	62	20	a	a	DET
dpc-3921	62	21	specific	specific	ADJ
dpc-3921	62	22	transcriptional	transcriptional	NOUN
dpc-3921	62	23	program	program	NOUN
dpc-3921	63	1	[	[	X
dpc-3921	63	2	32,33	32,33	NUM
dpc-3921	63	3	]	]	PUNCT
dpc-3921	63	4	.	.	PUNCT
dpc-3921	64	1	they	they	PRON
dpc-3921	64	2	express	express	VERB
dpc-3921	64	3	characteristic	characteristic	ADJ
dpc-3921	64	4	cell	cell	NOUN
dpc-3921	64	5	surface	surface	NOUN
dpc-3921	64	6	markers	marker	NOUN
dpc-3921	64	7	involved	involve	VERB
dpc-3921	64	8	in	in	ADP
dpc-3921	64	9	their	their	PRON
dpc-3921	64	10	retention	retention	NOUN
dpc-3921	64	11	in	in	ADP
dpc-3921	64	12	the	the	DET
dpc-3921	64	13	tissue	tissue	NOUN
dpc-3921	64	14	,	,	PUNCT
dpc-3921	64	15	such	such	ADJ
dpc-3921	64	16	as	as	ADP
dpc-3921	64	17	cd69	cd69	PROPN
dpc-3921	64	18	,	,	PUNCT
dpc-3921	64	19	cd103	cd103	NOUN
dpc-3921	64	20	,	,	PUNCT
dpc-3921	64	21	or	or	CCONJ
dpc-3921	64	22	cd49a	cd49a	ADV
dpc-3921	64	23	,	,	PUNCT
dpc-3921	64	24	the	the	DET
dpc-3921	64	25	latter	latter	ADJ
dpc-3921	64	26	marker	marker	NOUN
dpc-3921	64	27	defining	define	VERB
dpc-3921	64	28	a	a	DET
dpc-3921	64	29	subset	subset	NOUN
dpc-3921	64	30	of	of	ADP
dpc-3921	64	31	trm	trm	ADJ
dpc-3921	64	32	cells	cell	NOUN
dpc-3921	64	33	with	with	ADP
dpc-3921	64	34	cytotoxic	cytotoxic	ADJ
dpc-3921	64	35	properties	property	NOUN
dpc-3921	64	36	[	[	X
dpc-3921	64	37	29,34–36	29,34–36	X
dpc-3921	64	38	]	]	X
dpc-3921	64	39	.	.	PUNCT
dpc-3921	65	1	it	it	PRON
dpc-3921	65	2	is	be	AUX
dpc-3921	65	3	now	now	ADV
dpc-3921	65	4	clear	clear	ADJ
dpc-3921	65	5	that	that	SCONJ
dpc-3921	65	6	the	the	DET
dpc-3921	65	7	micro	micro	PROPN
dpc-3921	65	8	environment	environment	PROPN
dpc-3921	65	9	plays	play	VERB
dpc-3921	65	10	a	a	DET
dpc-3921	65	11	crucial	crucial	ADJ
dpc-3921	65	12	role	role	NOUN
dpc-3921	65	13	in	in	ADP
dpc-3921	65	14	the	the	DET
dpc-3921	65	15	formation	formation	NOUN
dpc-3921	65	16	and	and	CCONJ
dpc-3921	65	17	regulation	regulation	NOUN
dpc-3921	65	18	of	of	ADP
dpc-3921	65	19	trm	trm	PROPN
dpc-3921	65	20	.	.	PUNCT
dpc-3921	66	1	indeed	indeed	ADV
dpc-3921	66	2	,	,	PUNCT
dpc-3921	66	3	the	the	DET
dpc-3921	66	4	expression	expression	NOUN
dpc-3921	66	5	of	of	ADP
dpc-3921	66	6	cd103	cd103	PROPN
dpc-3921	66	7	is	be	AUX
dpc-3921	66	8	dependent	dependent	ADJ
dpc-3921	66	9	on	on	ADP
dpc-3921	66	10	transforming	transform	VERB
dpc-3921	66	11	growth	growth	NOUN
dpc-3921	66	12	factor	factor	NOUN
dpc-3921	66	13	(	(	PUNCT
dpc-3921	66	14	tgf)-β	tgf)-β	X
dpc-3921	66	15	[	[	X
dpc-3921	66	16	36	36	NUM
dpc-3921	66	17	]	]	PUNCT
dpc-3921	66	18	,	,	PUNCT
dpc-3921	66	19	and	and	CCONJ
dpc-3921	66	20	a	a	DET
dpc-3921	66	21	growing	grow	VERB
dpc-3921	66	22	number	number	NOUN
dpc-3921	66	23	of	of	ADP
dpc-3921	66	24	studies	study	NOUN
dpc-3921	66	25	reported	report	VERB
dpc-3921	66	26	the	the	DET
dpc-3921	66	27	involvement	involvement	NOUN
dpc-3921	66	28	of	of	ADP
dpc-3921	66	29	several	several	ADJ
dpc-3921	66	30	pro	pro	ADJ
dpc-3921	66	31	-	-	ADJ
dpc-3921	66	32	inflammatory	inflammatory	ADJ
dpc-3921	66	33	cytokines	cytokine	NOUN
dpc-3921	66	34	involved	involve	VERB
dpc-3921	66	35	in	in	ADP
dpc-3921	66	36	trm	trm	ADJ
dpc-3921	66	37	homeostasis	homeostasis	NOUN
dpc-3921	66	38	,	,	PUNCT
dpc-3921	66	39	such	such	ADJ
dpc-3921	66	40	as	as	ADP
dpc-3921	66	41	il-15	il-15	NOUN
dpc-3921	66	42	,	,	PUNCT
dpc-3921	66	43	il-12	il-12	NOUN
dpc-3921	66	44	,	,	PUNCT
dpc-3921	66	45	il-18	il-18	NUM
dpc-3921	66	46	,	,	PUNCT
dpc-3921	66	47	il-33	il-33	NUM
dpc-3921	66	48	,	,	PUNCT
dpc-3921	66	49	ifnγ	ifnγ	NOUN
dpc-3921	66	50	,	,	PUNCT
dpc-3921	66	51	tnfα	tnfα	NOUN
dpc-3921	66	52	[	[	X
dpc-3921	66	53	32	32	NUM
dpc-3921	66	54	]	]	PUNCT
dpc-3921	66	55	.	.	PUNCT
dpc-3921	67	1	the	the	DET
dpc-3921	67	2	presence	presence	NOUN
dpc-3921	67	3	of	of	ADP
dpc-3921	67	4	trm	trm	NOUN
dpc-3921	67	5	in	in	ADP
dpc-3921	67	6	vitiligo	vitiligo	NOUN
dpc-3921	67	7	skin	skin	NOUN
dpc-3921	67	8	is	be	AUX
dpc-3921	67	9	undoubtedly	undoubtedly	ADV
dpc-3921	67	10	linked	link	VERB
dpc-3921	67	11	to	to	ADP
dpc-3921	67	12	the	the	DET
dpc-3921	67	13	recurrence	recurrence	NOUN
dpc-3921	67	14	of	of	ADP
dpc-3921	67	15	lesions	lesion	NOUN
dpc-3921	67	16	on	on	ADP
dpc-3921	67	17	previously	previously	ADV
dpc-3921	67	18	affected	affect	VERB
dpc-3921	67	19	anatomical	anatomical	ADJ
dpc-3921	67	20	sites	site	NOUN
dpc-3921	67	21	that	that	PRON
dpc-3921	67	22	have	have	AUX
dpc-3921	67	23	repigmented	repigmente	VERB
dpc-3921	67	24	following	follow	VERB
dpc-3921	67	25	treatment	treatment	NOUN
dpc-3921	67	26	[	[	X
dpc-3921	67	27	37	37	NUM
dpc-3921	67	28	]	]	PUNCT
dpc-3921	67	29	,	,	PUNCT
dpc-3921	67	30	as	as	SCONJ
dpc-3921	67	31	shown	show	VERB
dpc-3921	67	32	in	in	ADP
dpc-3921	67	33	psoriasis	psoriasis	NOUN
dpc-3921	67	34	or	or	CCONJ
dpc-3921	67	35	atopic	atopic	NOUN
dpc-3921	67	36	dermatitis	dermatitis	NOUN
dpc-3921	67	37	[	[	X
dpc-3921	67	38	38–40	38–40	NUM
dpc-3921	67	39	]	]	PUNCT
dpc-3921	67	40	.	.	PUNCT
dpc-3921	68	1	therefore	therefore	ADV
dpc-3921	68	2	,	,	PUNCT
dpc-3921	68	3	owing	owe	VERB
dpc-3921	68	4	to	to	ADP
dpc-3921	68	5	their	their	PRON
dpc-3921	68	6	functional	functional	ADJ
dpc-3921	68	7	role	role	NOUN
dpc-3921	68	8	in	in	ADP
dpc-3921	68	9	the	the	DET
dpc-3921	68	10	pathogenesis	pathogenesis	NOUN
dpc-3921	68	11	of	of	ADP
dpc-3921	68	12	vitiligo	vitiligo	NOUN
dpc-3921	68	13	,	,	PUNCT
dpc-3921	68	14	targeting	target	VERB
dpc-3921	68	15	trm	trm	PROPN
dpc-3921	68	16	appears	appear	VERB
dpc-3921	68	17	as	as	ADP
dpc-3921	68	18	a	a	DET
dpc-3921	68	19	reliable	reliable	ADJ
dpc-3921	68	20	therapeutic	therapeutic	ADJ
dpc-3921	68	21	strategy	strategy	NOUN
dpc-3921	68	22	.	.	PUNCT
dpc-3921	69	1	vitiligo	vitiligo	VERB
dpc-3921	69	2	:	:	PUNCT
dpc-3921	69	3	mainly	mainly	ADV
dpc-3921	69	4	a	a	DET
dpc-3921	69	5	type	type	NOUN
dpc-3921	69	6	1	1	NUM
dpc-3921	69	7	skewed	skewed	ADJ
dpc-3921	69	8	immune	immune	ADJ
dpc-3921	69	9	response	response	NOUN
dpc-3921	69	10	analyses	analysis	NOUN
dpc-3921	69	11	of	of	ADP
dpc-3921	69	12	vitiligo	vitiligo	NOUN
dpc-3921	69	13	peri	peri	NOUN
dpc-3921	69	14	-	-	PUNCT
dpc-3921	69	15	lesional	lesional	ADJ
dpc-3921	69	16	and	and	CCONJ
dpc-3921	69	17	lesional	lesional	ADJ
dpc-3921	69	18	skin	skin	NOUN
dpc-3921	69	19	revealed	reveal	VERB
dpc-3921	69	20	upregulation	upregulation	NOUN
dpc-3921	69	21	of	of	ADP
dpc-3921	69	22	type-1	type-1	PROPN
dpc-3921	69	23	associated	associated	ADJ
dpc-3921	69	24	pathways	pathway	NOUN
dpc-3921	69	25	.	.	PUNCT
dpc-3921	70	1	vitiligo	vitiligo	PROPN
dpc-3921	70	2	is	be	AUX
dpc-3921	70	3	consistently	consistently	ADV
dpc-3921	70	4	associated	associate	VERB
dpc-3921	70	5	with	with	ADP
dpc-3921	70	6	an	an	DET
dpc-3921	70	7	infiltration	infiltration	NOUN
dpc-3921	70	8	of	of	ADP
dpc-3921	70	9	cd8	cd8	PROPN
dpc-3921	70	10	t	t	PROPN
dpc-3921	70	11	cells	cell	NOUN
dpc-3921	70	12	producing	produce	VERB
dpc-3921	70	13	high	high	ADJ
dpc-3921	70	14	levels	level	NOUN
dpc-3921	70	15	of	of	ADP
dpc-3921	70	16	ifnγ	ifnγ	NOUN
dpc-3921	70	17	and	and	CCONJ
dpc-3921	70	18	tnfα	tnfα	NOUN
dpc-3921	70	19	.	.	PUNCT
dpc-3921	71	1	these	these	DET
dpc-3921	71	2	t	t	PROPN
dpc-3921	71	3	cells	cell	NOUN
dpc-3921	71	4	are	be	AUX
dpc-3921	71	5	characterized	characterize	VERB
dpc-3921	71	6	by	by	ADP
dpc-3921	71	7	the	the	DET
dpc-3921	71	8	expression	expression	NOUN
dpc-3921	71	9	of	of	ADP
dpc-3921	71	10	the	the	DET
dpc-3921	71	11	receptor	receptor	NOUN
dpc-3921	71	12	cxcr3	cxcr3	NOUN
dpc-3921	72	1	that	that	PRON
dpc-3921	72	2	respond	respond	VERB
dpc-3921	72	3	cxcl9	cxcl9	NOUN
dpc-3921	72	4	and	and	CCONJ
dpc-3921	72	5	cxcl10	cxcl10	NOUN
dpc-3921	72	6	,	,	PUNCT
dpc-3921	72	7	which	which	PRON
dpc-3921	72	8	are	be	AUX
dpc-3921	72	9	highly	highly	ADV
dpc-3921	72	10	expressed	express	VERB
dpc-3921	72	11	in	in	ADP
dpc-3921	72	12	the	the	DET
dpc-3921	72	13	skin	skin	NOUN
dpc-3921	72	14	of	of	ADP
dpc-3921	72	15	patients	patient	NOUN
dpc-3921	72	16	[	[	X
dpc-3921	72	17	24,41–44	24,41–44	NUM
dpc-3921	72	18	]	]	PUNCT
dpc-3921	72	19	.	.	PUNCT
dpc-3921	73	1	targeting	target	VERB
dpc-3921	73	2	the	the	DET
dpc-3921	73	3	cxcr3	cxcr3	NOUN
dpc-3921	73	4	cxcl9	cxcl9	NOUN
dpc-3921	73	5	and	and	CCONJ
dpc-3921	73	6	cxcl10	cxcl10	NOUN
dpc-3921	73	7	axis	axis	ADJ
dpc-3921	73	8	in	in	ADP
dpc-3921	73	9	vitiligo	vitiligo	NOUN
dpc-3921	73	10	seems	seem	VERB
dpc-3921	73	11	to	to	PART
dpc-3921	73	12	be	be	AUX
dpc-3921	73	13	a	a	DET
dpc-3921	73	14	promising	promising	ADJ
dpc-3921	73	15	therapeutic	therapeutic	ADJ
dpc-3921	73	16	strategy	strategy	NOUN
dpc-3921	73	17	in	in	ADP
dpc-3921	73	18	vitiligo	vitiligo	PROPN
dpc-3921	73	19	[	[	X
dpc-3921	73	20	43,45	43,45	NOUN
dpc-3921	73	21	]	]	X
dpc-3921	73	22	.	.	PUNCT
dpc-3921	74	1	our	our	PRON
dpc-3921	74	2	group	group	NOUN
dpc-3921	74	3	showed	show	VERB
dpc-3921	74	4	that	that	SCONJ
dpc-3921	74	5	natural	natural	ADJ
dpc-3921	74	6	killer	killer	NOUN
dpc-3921	74	7	group	group	NOUN
dpc-3921	74	8	2	2	NUM
dpc-3921	74	9	member	member	NOUN
dpc-3921	74	10	d	d	PROPN
dpc-3921	74	11	(	(	PUNCT
dpc-3921	74	12	nkg2d	nkg2d	PROPN
dpc-3921	74	13	)	)	PUNCT
dpc-3921	74	14	defines	define	VERB
dpc-3921	74	15	a	a	DET
dpc-3921	74	16	subset	subset	NOUN
dpc-3921	74	17	of	of	ADP
dpc-3921	74	18	highly	highly	ADV
dpc-3921	74	19	functional	functional	ADJ
dpc-3921	74	20	memory	memory	NOUN
dpc-3921	74	21	cd8	cd8	PROPN
dpc-3921	74	22	t	t	PROPN
dpc-3921	74	23	cells	cell	NOUN
dpc-3921	74	24	in	in	ADP
dpc-3921	74	25	vitiligo	vitiligo	PROPN
dpc-3921	74	26	and	and	CCONJ
dpc-3921	74	27	may	may	AUX
dpc-3921	74	28	represent	represent	VERB
dpc-3921	74	29	a	a	DET
dpc-3921	74	30	potential	potential	ADJ
dpc-3921	74	31	therapeutic	therapeutic	ADJ
dpc-3921	74	32	target	target	NOUN
dpc-3921	74	33	[	[	X
dpc-3921	74	34	46	46	NUM
dpc-3921	74	35	]	]	PUNCT
dpc-3921	74	36	.	.	PUNCT
dpc-3921	75	1	this	this	DET
dpc-3921	75	2	type-1	type-1	NUM
dpc-3921	75	3	immune	immune	ADJ
dpc-3921	75	4	response	response	NOUN
dpc-3921	75	5	appears	appear	VERB
dpc-3921	75	6	to	to	PART
dpc-3921	75	7	be	be	AUX
dpc-3921	75	8	a	a	DET
dpc-3921	75	9	key	key	ADJ
dpc-3921	75	10	driver	driver	NOUN
dpc-3921	75	11	of	of	ADP
dpc-3921	75	12	melanocyte	melanocyte	NOUN
dpc-3921	75	13	loss	loss	NOUN
dpc-3921	75	14	in	in	ADP
dpc-3921	75	15	vitiligo	vitiligo	NOUN
dpc-3921	75	16	and	and	CCONJ
dpc-3921	75	17	participates	participate	VERB
dpc-3921	75	18	in	in	ADP
dpc-3921	75	19	every	every	DET
dpc-3921	75	20	stage	stage	NOUN
dpc-3921	75	21	of	of	ADP
dpc-3921	75	22	the	the	DET
dpc-3921	75	23	pathogenesis	pathogenesis	NOUN
dpc-3921	75	24	.	.	PUNCT
dpc-3921	76	1	to	to	ADP
dpc-3921	76	2	date	date	NOUN
dpc-3921	76	3	,	,	PUNCT
dpc-3921	76	4	ifnγ	ifnγ	NOUN
dpc-3921	76	5	and	and	CCONJ
dpc-3921	76	6	tnfα	tnfα	NOUN
dpc-3921	76	7	immune	immune	ADJ
dpc-3921	76	8	pathways	pathway	NOUN
dpc-3921	76	9	are	be	AUX
dpc-3921	76	10	the	the	DET
dpc-3921	76	11	most	most	ADV
dpc-3921	76	12	studied	study	VERB
dpc-3921	76	13	in	in	ADP
dpc-3921	76	14	vitiligo	vitiligo	NOUN
dpc-3921	76	15	.	.	PUNCT
dpc-3921	77	1	the	the	DET
dpc-3921	77	2	binding	binding	NOUN
dpc-3921	77	3	of	of	ADP
dpc-3921	77	4	ifnγ	ifnγ	NOUN
dpc-3921	77	5	to	to	ADP
dpc-3921	77	6	its	its	PRON
dpc-3921	77	7	receptor	receptor	NOUN
dpc-3921	77	8	induces	induce	VERB
dpc-3921	77	9	a	a	DET
dpc-3921	77	10	signaling	signal	VERB
dpc-3921	77	11	dependent	dependent	NOUN
dpc-3921	77	12	of	of	ADP
dpc-3921	77	13	the	the	DET
dpc-3921	77	14	janus	janus	PROPN
dpc-3921	77	15	kinase	kinase	PROPN
dpc-3921	77	16	(	(	PUNCT
dpc-3921	77	17	jak	jak	PROPN
dpc-3921	77	18	)	)	PUNCT
dpc-3921	77	19	and	and	CCONJ
dpc-3921	77	20	signal	signal	ADJ
dpc-3921	77	21	transducer	transducer	NOUN
dpc-3921	77	22	and	and	CCONJ
dpc-3921	77	23	activator	activator	NOUN
dpc-3921	77	24	of	of	ADP
dpc-3921	77	25	transcription	transcription	NOUN
dpc-3921	77	26	(	(	PUNCT
dpc-3921	77	27	stat	stat	NOUN
dpc-3921	77	28	)	)	PUNCT
dpc-3921	77	29	pathways	pathway	NOUN
dpc-3921	77	30	,	,	PUNCT
dpc-3921	77	31	in	in	ADP
dpc-3921	77	32	particular	particular	ADJ
dpc-3921	77	33	the	the	DET
dpc-3921	77	34	activation	activation	NOUN
dpc-3921	77	35	of	of	ADP
dpc-3921	77	36	jak1/2	jak1/2	PROPN
dpc-3921	77	37	and	and	CCONJ
dpc-3921	77	38	stat1	stat1	PROPN
dpc-3921	77	39	.	.	PUNCT
dpc-3921	78	1	interestingly	interestingly	ADV
dpc-3921	78	2	,	,	PUNCT
dpc-3921	78	3	jak	jak	PROPN
dpc-3921	78	4	inhibition	inhibition	NOUN
dpc-3921	78	5	appears	appear	VERB
dpc-3921	78	6	to	to	PART
dpc-3921	78	7	be	be	AUX
dpc-3921	78	8	a	a	DET
dpc-3921	78	9	reliable	reliable	ADJ
dpc-3921	78	10	strategy	strategy	NOUN
dpc-3921	78	11	to	to	PART
dpc-3921	78	12	treat	treat	VERB
dpc-3921	78	13	patients	patient	NOUN
dpc-3921	78	14	and	and	CCONJ
dpc-3921	78	15	ruxolitinib	ruxolitinib	NOUN
dpc-3921	78	16	cream	cream	NOUN
dpc-3921	78	17	(	(	PUNCT
dpc-3921	78	18	a	a	DET
dpc-3921	78	19	topical	topical	ADJ
dpc-3921	78	20	jak	jak	PROPN
dpc-3921	78	21	1	1	NUM
dpc-3921	78	22	and	and	CCONJ
dpc-3921	78	23	jak	jak	PROPN
dpc-3921	78	24	2	2	NUM
dpc-3921	78	25	inhibitor	inhibitor	NOUN
dpc-3921	78	26	)	)	PUNCT
dpc-3921	78	27	is	be	AUX
dpc-3921	78	28	now	now	ADV
dpc-3921	78	29	approved	approve	VERB
dpc-3921	78	30	both	both	CCONJ
dpc-3921	78	31	in	in	ADP
dpc-3921	78	32	us	we	PRON
dpc-3921	78	33	and	and	CCONJ
dpc-3921	78	34	eu	eu	PROPN
dpc-3921	78	35	for	for	ADP
dpc-3921	78	36	the	the	DET
dpc-3921	78	37	management	management	NOUN
dpc-3921	78	38	of	of	ADP
dpc-3921	78	39	vitiligo	vitiligo	NOUN
dpc-3921	79	1	[	[	X
dpc-3921	79	2	47–49	47–49	NUM
dpc-3921	79	3	]	]	PUNCT
dpc-3921	79	4	.	.	PUNCT
dpc-3921	80	1	ifnγ	ifnγ	NOUN
dpc-3921	80	2	induces	induce	VERB
dpc-3921	80	3	the	the	DET
dpc-3921	80	4	production	production	NOUN
dpc-3921	80	5	of	of	ADP
dpc-3921	80	6	cxcl9	cxcl9	NOUN
dpc-3921	80	7	and	and	CCONJ
dpc-3921	80	8	cxcl10	cxcl10	NOUN
dpc-3921	80	9	by	by	ADP
dpc-3921	80	10	keratinocytes	keratinocyte	NOUN
dpc-3921	80	11	,	,	PUNCT
dpc-3921	80	12	amplifying	amplify	VERB
dpc-3921	80	13	the	the	DET
dpc-3921	80	14	inflammation	inflammation	NOUN
dpc-3921	80	15	and	and	CCONJ
dpc-3921	80	16	the	the	DET
dpc-3921	80	17	recruitment	recruitment	NOUN
dpc-3921	80	18	of	of	ADP
dpc-3921	80	19	immune	immune	ADJ
dpc-3921	80	20	cells	cell	NOUN
dpc-3921	80	21	expressing	express	VERB
dpc-3921	80	22	cxcr3	cxcr3	NOUN
dpc-3921	80	23	which	which	PRON
dpc-3921	80	24	will	will	AUX
dpc-3921	80	25	promote	promote	VERB
dpc-3921	80	26	the	the	DET
dpc-3921	80	27	progression	progression	NOUN
dpc-3921	80	28	of	of	ADP
dpc-3921	80	29	vitiligo	vitiligo	NOUN
dpc-3921	80	30	[	[	X
dpc-3921	80	31	14	14	NUM
dpc-3921	80	32	]	]	SYM
dpc-3921	80	33	.	.	PUNCT
dpc-3921	81	1	ifnγ	ifnγ	NOUN
dpc-3921	81	2	and	and	CCONJ
dpc-3921	81	3	tnfα	tnfα	NOUN
dpc-3921	81	4	also	also	ADV
dpc-3921	81	5	have	have	VERB
dpc-3921	81	6	a	a	DET
dpc-3921	81	7	direct	direct	ADJ
dpc-3921	81	8	impact	impact	NOUN
dpc-3921	81	9	on	on	ADP
dpc-3921	81	10	the	the	DET
dpc-3921	81	11	function	function	NOUN
dpc-3921	81	12	of	of	ADP
dpc-3921	81	13	melanocytes	melanocyte	NOUN
dpc-3921	81	14	by	by	ADP
dpc-3921	81	15	decreasing	decrease	VERB
dpc-3921	81	16	the	the	DET
dpc-3921	81	17	pigmentation	pigmentation	NOUN
dpc-3921	81	18	process	process	NOUN
dpc-3921	81	19	[	[	X
dpc-3921	81	20	50–55	50–55	NUM
dpc-3921	81	21	]	]	PUNCT
dpc-3921	81	22	.	.	PUNCT
dpc-3921	82	1	we	we	PRON
dpc-3921	82	2	recently	recently	ADV
dpc-3921	82	3	demonstrated	demonstrate	VERB
dpc-3921	82	4	that	that	SCONJ
dpc-3921	82	5	the	the	DET
dpc-3921	82	6	combined	combined	ADJ
dpc-3921	82	7	activity	activity	NOUN
dpc-3921	82	8	of	of	ADP
dpc-3921	82	9	these	these	DET
dpc-3921	82	10	two	two	NUM
dpc-3921	82	11	cytokines	cytokine	NOUN
dpc-3921	82	12	induces	induce	VERB
dpc-3921	82	13	the	the	DET
dpc-3921	82	14	disruption	disruption	NOUN
dpc-3921	82	15	of	of	ADP
dpc-3921	82	16	e	e	NOUN
dpc-3921	82	17	-	-	NOUN
dpc-3921	82	18	cadherin	cadherin	NOUN
dpc-3921	82	19	expression	expression	NOUN
dpc-3921	82	20	,	,	PUNCT
dpc-3921	82	21	the	the	DET
dpc-3921	82	22	main	main	ADJ
dpc-3921	82	23	protein	protein	NOUN
dpc-3921	82	24	responsible	responsible	ADJ
dpc-3921	82	25	for	for	ADP
dpc-3921	82	26	the	the	DET
dpc-3921	82	27	adhesion	adhesion	NOUN
dpc-3921	82	28	of	of	ADP
dpc-3921	82	29	melanocytes	melanocyte	NOUN
dpc-3921	82	30	to	to	ADP
dpc-3921	82	31	keratinocytes	keratinocyte	NOUN
dpc-3921	82	32	,	,	PUNCT
dpc-3921	82	33	leading	lead	VERB
dpc-3921	82	34	to	to	ADP
dpc-3921	82	35	their	their	PRON
dpc-3921	82	36	destabilization	destabilization	NOUN
dpc-3921	82	37	and	and	CCONJ
dpc-3921	82	38	detachment	detachment	NOUN
dpc-3921	83	1	[	[	X
dpc-3921	83	2	53	53	NUM
dpc-3921	83	3	]	]	PUNCT
dpc-3921	83	4	.	.	PUNCT
dpc-3921	84	1	in	in	ADP
dpc-3921	84	2	addition	addition	NOUN
dpc-3921	84	3	,	,	PUNCT
dpc-3921	84	4	tulic	tulic	NOUN
dpc-3921	84	5	et	et	PROPN
dpc-3921	84	6	al	al	PROPN
dpc-3921	84	7	.	.	PROPN
dpc-3921	84	8	showed	show	VERB
dpc-3921	84	9	that	that	SCONJ
dpc-3921	84	10	melanocytes	melanocyte	NOUN
dpc-3921	84	11	are	be	AUX
dpc-3921	84	12	able	able	ADJ
dpc-3921	84	13	to	to	PART
dpc-3921	84	14	express	express	VERB
dpc-3921	84	15	the	the	DET
dpc-3921	84	16	b	b	NOUN
dpc-3921	84	17	isoform	isoform	NOUN
dpc-3921	84	18	of	of	ADP
dpc-3921	84	19	cxcr3	cxcr3	NOUN
dpc-3921	84	20	in	in	ADP
dpc-3921	84	21	response	response	NOUN
dpc-3921	84	22	to	to	ADP
dpc-3921	84	23	ifnγ	ifnγ	NOUN
dpc-3921	84	24	,	,	PUNCT
dpc-3921	84	25	making	make	VERB
dpc-3921	84	26	them	they	PRON
dpc-3921	84	27	more	more	ADV
dpc-3921	84	28	susceptible	susceptible	ADJ
dpc-3921	84	29	to	to	ADP
dpc-3921	84	30	apoptosis	apoptosis	NOUN
dpc-3921	84	31	in	in	ADP
dpc-3921	84	32	response	response	NOUN
dpc-3921	84	33	to	to	ADP
dpc-3921	84	34	cxcl10	cxcl10	NOUN
dpc-3921	84	35	[	[	X
dpc-3921	84	36	28	28	NUM
dpc-3921	84	37	]	]	PUNCT
dpc-3921	84	38	.	.	PUNCT
dpc-3921	85	1	additional	additional	ADJ
dpc-3921	85	2	cytokines	cytokine	NOUN
dpc-3921	85	3	and	and	CCONJ
dpc-3921	85	4	signaling	signal	VERB
dpc-3921	85	5	pathways	pathway	NOUN
dpc-3921	85	6	may	may	AUX
dpc-3921	85	7	also	also	ADV
dpc-3921	85	8	be	be	AUX
dpc-3921	85	9	involved	involve	VERB
dpc-3921	85	10	in	in	ADP
dpc-3921	85	11	vitiligo	vitiligo	ADJ
dpc-3921	85	12	pathogenesis	pathogenesis	NOUN
dpc-3921	85	13	.	.	PUNCT
dpc-3921	86	1	for	for	ADP
dpc-3921	86	2	example	example	NOUN
dpc-3921	86	3	,	,	PUNCT
dpc-3921	86	4	elevated	elevated	ADJ
dpc-3921	86	5	levels	level	NOUN
dpc-3921	86	6	of	of	ADP
dpc-3921	86	7	il-17	il-17	NOUN
dpc-3921	86	8	and	and	CCONJ
dpc-3921	86	9	il-23	il-23	NOUN
dpc-3921	86	10	are	be	AUX
dpc-3921	86	11	found	find	VERB
dpc-3921	86	12	in	in	ADP
dpc-3921	86	13	the	the	DET
dpc-3921	86	14	serum	serum	NOUN
dpc-3921	86	15	and/or	and/or	CCONJ
dpc-3921	86	16	skin	skin	NOUN
dpc-3921	86	17	of	of	ADP
dpc-3921	86	18	vitiligo	vitiligo	ADJ
dpc-3921	86	19	patients	patient	NOUN
dpc-3921	86	20	,	,	PUNCT
dpc-3921	86	21	and	and	CCONJ
dpc-3921	86	22	il-17	il-17	PRON
dpc-3921	86	23	has	have	AUX
dpc-3921	86	24	been	be	AUX
dpc-3921	86	25	reported	report	VERB
dpc-3921	86	26	to	to	PART
dpc-3921	86	27	regulate	regulate	VERB
dpc-3921	86	28	melanocyte	melanocyte	NOUN
dpc-3921	86	29	function	function	NOUN
dpc-3921	86	30	and	and	CCONJ
dpc-3921	86	31	survival	survival	NOUN
dpc-3921	87	1	[	[	X
dpc-3921	87	2	56	56	NUM
dpc-3921	87	3	]	]	PUNCT
dpc-3921	87	4	.	.	PUNCT
dpc-3921	88	1	however	however	ADV
dpc-3921	88	2	,	,	PUNCT
dpc-3921	88	3	targeting	target	VERB
dpc-3921	88	4	il-17	il-17	X
dpc-3921	88	5	in	in	ADP
dpc-3921	88	6	vitiligo	vitiligo	ADJ
dpc-3921	88	7	patients	patient	NOUN
dpc-3921	88	8	did	do	AUX
dpc-3921	88	9	not	not	PART
dpc-3921	88	10	show	show	VERB
dpc-3921	88	11	a	a	DET
dpc-3921	88	12	major	major	ADJ
dpc-3921	88	13	benefit	benefit	NOUN
dpc-3921	88	14	[	[	X
dpc-3921	88	15	57	57	NUM
dpc-3921	88	16	]	]	PUNCT
dpc-3921	88	17	.	.	PUNCT
dpc-3921	89	1	type-2	type-2	VERB
dpc-3921	89	2	-	-	PUNCT
dpc-3921	89	3	related	relate	VERB
dpc-3921	89	4	cytokines	cytokine	NOUN
dpc-3921	89	5	have	have	AUX
dpc-3921	89	6	been	be	AUX
dpc-3921	89	7	reported	report	VERB
dpc-3921	89	8	increased	increase	VERB
dpc-3921	89	9	in	in	ADP
dpc-3921	89	10	vitiligo	vitiligo	NOUN
dpc-3921	89	11	patients	patient	NOUN
dpc-3921	89	12	’	'	PUNCT
dpc-3921	89	13	blood	blood	NOUN
dpc-3921	89	14	,	,	PUNCT
dpc-3921	89	15	and	and	CCONJ
dpc-3921	89	16	few	few	ADJ
dpc-3921	89	17	studies	study	NOUN
dpc-3921	89	18	showed	show	VERB
dpc-3921	89	19	an	an	DET
dpc-3921	89	20	inhibition	inhibition	NOUN
dpc-3921	89	21	of	of	ADP
dpc-3921	89	22	melanogenesis	melanogenesis	NOUN
dpc-3921	89	23	in	in	ADP
dpc-3921	89	24	response	response	NOUN
dpc-3921	89	25	to	to	ADP
dpc-3921	89	26	il-4	il-4	NOUN
dpc-3921	89	27	and	and	CCONJ
dpc-3921	89	28	il-13	il-13	X
dpc-3921	90	1	[	[	X
dpc-3921	90	2	58–62	58–62	NUM
dpc-3921	90	3	]	]	PUNCT
dpc-3921	90	4	.	.	PUNCT
dpc-3921	91	1	our	our	PRON
dpc-3921	91	2	group	group	NOUN
dpc-3921	91	3	found	find	VERB
dpc-3921	91	4	that	that	SCONJ
dpc-3921	91	5	vitiligo	vitiligo	NOUN
dpc-3921	91	6	skin	skin	NOUN
dpc-3921	91	7	is	be	AUX
dpc-3921	91	8	also	also	ADV
dpc-3921	91	9	associated	associate	VERB
dpc-3921	91	10	with	with	ADP
dpc-3921	91	11	a	a	DET
dpc-3921	91	12	type-2	type-2	NUM
dpc-3921	91	13	immune	immune	ADJ
dpc-3921	91	14	response	response	NOUN
dpc-3921	91	15	and	and	CCONJ
dpc-3921	91	16	an	an	DET
dpc-3921	91	17	increased	increase	VERB
dpc-3921	91	18	production	production	NOUN
dpc-3921	91	19	of	of	ADP
dpc-3921	91	20	il-13	il-13	PUNCT
dpc-3921	91	21	by	by	ADP
dpc-3921	91	22	t	t	PROPN
dpc-3921	91	23	cells	cell	NOUN
dpc-3921	91	24	[	[	X
dpc-3921	91	25	27	27	NUM
dpc-3921	91	26	]	]	PUNCT
dpc-3921	91	27	.	.	PUNCT
dpc-3921	92	1	in	in	ADP
dpc-3921	92	2	addition	addition	NOUN
dpc-3921	92	3	,	,	PUNCT
dpc-3921	92	4	jin	jin	PROPN
dpc-3921	92	5	et	et	PROPN
dpc-3921	92	6	al	al	PROPN
dpc-3921	92	7	.	.	PROPN
dpc-3921	92	8	reported	report	VERB
dpc-3921	92	9	that	that	SCONJ
dpc-3921	92	10	ifnγ	ifnγ	NOUN
dpc-3921	92	11	-	-	PUNCT
dpc-3921	92	12	induced	induce	VERB
dpc-3921	92	13	dermal	dermal	NOUN
dpc-3921	92	14	fibroblasts	fibroblast	NOUN
dpc-3921	92	15	to	to	PART
dpc-3921	92	16	release	release	VERB
dpc-3921	92	17	ccl2	ccl2	NOUN
dpc-3921	92	18	and	and	CCONJ
dpc-3921	92	19	ccl8	ccl8	PROPN
dpc-3921	92	20	,	,	PUNCT
dpc-3921	92	21	inducing	induce	VERB
dpc-3921	92	22	a	a	DET
dpc-3921	92	23	type-2	type-2	NUM
dpc-3921	92	24	cytokine	cytokine	ADJ
dpc-3921	92	25	profile	profile	NOUN
dpc-3921	92	26	in	in	ADP
dpc-3921	92	27	vitiligo	vitiligo	ADJ
dpc-3921	92	28	skin	skin	NOUN
dpc-3921	92	29	lesion	lesion	NOUN
dpc-3921	92	30	[	[	X
dpc-3921	92	31	63	63	NUM
dpc-3921	92	32	]	]	PUNCT
dpc-3921	92	33	.	.	PUNCT
dpc-3921	93	1	however	however	ADV
dpc-3921	93	2	,	,	PUNCT
dpc-3921	93	3	4	4	NUM
dpc-3921	93	4	review	review	NOUN
dpc-3921	93	5	|	|	ADV
dpc-3921	93	6	dermatol	dermatol	ADJ
dpc-3921	93	7	pract	pract	NOUN
dpc-3921	93	8	concept	concept	NOUN
dpc-3921	93	9	.	.	PUNCT
dpc-3921	94	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-3921	94	2	:	:	PUNCT
dpc-3921	94	3	e2023314s	e2023314s	PROPN
dpc-3921	94	4	7	7	X
dpc-3921	94	5	.	.	PUNCT
dpc-3921	94	6	jin	jin	PROPN
dpc-3921	94	7	y	y	PROPN
dpc-3921	94	8	,	,	PUNCT
dpc-3921	94	9	birlea	birlea	PROPN
dpc-3921	94	10	sa	sa	PROPN
dpc-3921	94	11	,	,	PUNCT
dpc-3921	94	12	fain	fain	PROPN
dpc-3921	94	13	pr	pr	PROPN
dpc-3921	94	14	,	,	PUNCT
dpc-3921	94	15	et	et	PROPN
dpc-3921	94	16	al	al	PROPN
dpc-3921	94	17	.	.	PUNCT
dpc-3921	94	18	genome	genome	NOUN
dpc-3921	94	19	-	-	PUNCT
dpc-3921	94	20	wide	wide	ADJ
dpc-3921	94	21	analysis	analysis	NOUN
dpc-3921	94	22	identifies	identify	VERB
dpc-3921	94	23	a	a	DET
dpc-3921	94	24	quantitative	quantitative	ADJ
dpc-3921	94	25	trait	trait	NOUN
dpc-3921	94	26	locus	locus	NOUN
dpc-3921	94	27	in	in	ADP
dpc-3921	94	28	the	the	DET
dpc-3921	94	29	mhc	mhc	PROPN
dpc-3921	94	30	class	class	PROPN
dpc-3921	94	31	ii	ii	PROPN
dpc-3921	94	32	region	region	NOUN
dpc-3921	94	33	associated	associate	VERB
dpc-3921	94	34	with	with	ADP
dpc-3921	94	35	generalized	generalized	ADJ
dpc-3921	94	36	vitiligo	vitiligo	NOUN
dpc-3921	94	37	age	age	NOUN
dpc-3921	94	38	of	of	ADP
dpc-3921	94	39	onset	onset	NOUN
dpc-3921	94	40	.	.	PUNCT
dpc-3921	95	1	j	j	PROPN
dpc-3921	95	2	invest	invest	VERB
dpc-3921	95	3	dermatol	dermatol	NOUN
dpc-3921	95	4	.	.	PUNCT
dpc-3921	96	1	2011;131:1308–12	2011;131:1308–12	NUM
dpc-3921	96	2	.	.	PUNCT
dpc-3921	97	1	[	[	X
dpc-3921	97	2	pmid	pmid	X
dpc-3921	97	3	:	:	PUNCT
dpc-3921	97	4	21326295	21326295	NUM
dpc-3921	97	5	]	]	PUNCT
dpc-3921	97	6	.	.	PUNCT
dpc-3921	98	1	8	8	X
dpc-3921	98	2	.	.	X
dpc-3921	99	1	chang	chang	PROPN
dpc-3921	99	2	w	w	PROPN
dpc-3921	99	3	-	-	PUNCT
dpc-3921	99	4	l	l	NOUN
dpc-3921	99	5	,	,	PUNCT
dpc-3921	99	6	ko	ko	PROPN
dpc-3921	99	7	c	c	PROPN
dpc-3921	99	8	-	-	PUNCT
dpc-3921	99	9	h.	h.	VERB
dpc-3921	99	10	the	the	DET
dpc-3921	99	11	role	role	NOUN
dpc-3921	99	12	of	of	ADP
dpc-3921	99	13	oxidative	oxidative	ADJ
dpc-3921	99	14	stress	stress	NOUN
dpc-3921	99	15	in	in	ADP
dpc-3921	99	16	vitiligo	vitiligo	NOUN
dpc-3921	99	17	:	:	PUNCT
dpc-3921	99	18	an	an	DET
dpc-3921	99	19	update	update	NOUN
dpc-3921	99	20	on	on	ADP
dpc-3921	99	21	its	its	PRON
dpc-3921	99	22	pathogenesis	pathogenesis	NOUN
dpc-3921	99	23	and	and	CCONJ
dpc-3921	99	24	therapeutic	therapeutic	ADJ
dpc-3921	99	25	implications	implication	NOUN
dpc-3921	99	26	.	.	PUNCT
dpc-3921	100	1	cells	cell	NOUN
dpc-3921	100	2	.	.	PUNCT
dpc-3921	101	1	2023;12:936	2023;12:936	X
dpc-3921	101	2	.	.	PUNCT
dpc-3921	102	1	[	[	X
dpc-3921	102	2	pmid	pmid	X
dpc-3921	102	3	:	:	PUNCT
dpc-3921	102	4	36980277	36980277	NUM
dpc-3921	102	5	]	]	PUNCT
dpc-3921	102	6	.	.	PUNCT
dpc-3921	103	1	9	9	X
dpc-3921	103	2	.	.	X
dpc-3921	103	3	kovacs	kovacs	PROPN
dpc-3921	103	4	d	d	X
dpc-3921	103	5	,	,	PUNCT
dpc-3921	103	6	bastonini	bastonini	PROPN
dpc-3921	103	7	e	e	PROPN
dpc-3921	103	8	,	,	PUNCT
dpc-3921	103	9	ottaviani	ottaviani	PROPN
dpc-3921	103	10	m	m	PROPN
dpc-3921	103	11	,	,	PUNCT
dpc-3921	103	12	et	et	PROPN
dpc-3921	103	13	al	al	PROPN
dpc-3921	103	14	.	.	PROPN
dpc-3921	104	1	vitiligo	vitiligo	PROPN
dpc-3921	104	2	skin	skin	NOUN
dpc-3921	104	3	:	:	PUNCT
dpc-3921	104	4	exploring	explore	VERB
dpc-3921	104	5	the	the	DET
dpc-3921	104	6	dermal	dermal	ADJ
dpc-3921	104	7	compartment	compartment	NOUN
dpc-3921	104	8	.	.	PUNCT
dpc-3921	105	1	j	j	PROPN
dpc-3921	105	2	invest	invest	VERB
dpc-3921	105	3	dermatol	dermatol	NOUN
dpc-3921	105	4	.	.	PUNCT
dpc-3921	106	1	2018;138	2018;138	NUM
dpc-3921	106	2	:	:	PUNCT
dpc-3921	106	3	394–404	394–404	NUM
dpc-3921	106	4	.	.	PUNCT
dpc-3921	107	1	[	[	X
dpc-3921	107	2	pmid	pmid	X
dpc-3921	107	3	:	:	PUNCT
dpc-3921	107	4	29024688	29024688	NUM
dpc-3921	107	5	]	]	PUNCT
dpc-3921	107	6	.	.	PUNCT
dpc-3921	108	1	10	10	NUM
dpc-3921	108	2	.	.	PUNCT
dpc-3921	109	1	zhang	zhang	PROPN
dpc-3921	109	2	y	y	PROPN
dpc-3921	109	3	,	,	PUNCT
dpc-3921	109	4	liu	liu	PROPN
dpc-3921	109	5	l	l	PROPN
dpc-3921	109	6	,	,	PUNCT
dpc-3921	109	7	jin	jin	PROPN
dpc-3921	109	8	l	l	PROPN
dpc-3921	109	9	,	,	PUNCT
dpc-3921	109	10	et	et	PROPN
dpc-3921	109	11	al	al	PROPN
dpc-3921	109	12	.	.	PROPN
dpc-3921	109	13	oxidative	oxidative	ADJ
dpc-3921	109	14	stress	stress	NOUN
dpc-3921	109	15	-	-	PUNCT
dpc-3921	109	16	induced	induce	VERB
dpc-3921	109	17	calreticulin	calreticulin	NOUN
dpc-3921	109	18	expression	expression	NOUN
dpc-3921	109	19	and	and	CCONJ
dpc-3921	109	20	translocation	translocation	NOUN
dpc-3921	109	21	:	:	PUNCT
dpc-3921	109	22	new	new	ADJ
dpc-3921	109	23	insights	insight	NOUN
dpc-3921	109	24	into	into	ADP
dpc-3921	109	25	the	the	DET
dpc-3921	109	26	destruction	destruction	NOUN
dpc-3921	109	27	of	of	ADP
dpc-3921	109	28	melanocytes	melanocyte	NOUN
dpc-3921	109	29	.	.	PUNCT
dpc-3921	110	1	j	j	PROPN
dpc-3921	110	2	invest	invest	VERB
dpc-3921	110	3	dermatol	dermatol	NOUN
dpc-3921	110	4	.	.	PUNCT
dpc-3921	111	1	2014;134:183–91	2014;134:183–91	NUM
dpc-3921	111	2	.	.	PUNCT
dpc-3921	112	1	[	[	X
dpc-3921	112	2	pmid	pmid	X
dpc-3921	112	3	:	:	PUNCT
dpc-3921	112	4	23771121	23771121	NUM
dpc-3921	112	5	]	]	PUNCT
dpc-3921	112	6	.	.	PUNCT
dpc-3921	113	1	11	11	NUM
dpc-3921	113	2	.	.	PUNCT
dpc-3921	113	3	cui	cui	PROPN
dpc-3921	113	4	t	t	PROPN
dpc-3921	113	5	,	,	PUNCT
dpc-3921	113	6	zhang	zhang	PROPN
dpc-3921	113	7	w	w	PROPN
dpc-3921	113	8	,	,	PUNCT
dpc-3921	113	9	li	li	PROPN
dpc-3921	113	10	s	s	PROPN
dpc-3921	113	11	,	,	PUNCT
dpc-3921	113	12	et	et	PROPN
dpc-3921	113	13	al	al	PROPN
dpc-3921	113	14	.	.	PROPN
dpc-3921	113	15	oxidative	oxidative	ADJ
dpc-3921	113	16	stress	stress	NOUN
dpc-3921	113	17	-	-	PUNCT
dpc-3921	113	18	induced	induce	VERB
dpc-3921	113	19	hmgb1	hmgb1	NOUN
dpc-3921	113	20	release	release	NOUN
dpc-3921	113	21	from	from	ADP
dpc-3921	113	22	  	  	SPACE
dpc-3921	113	23	melanocytes	melanocyte	NOUN
dpc-3921	113	24	:	:	PUNCT
dpc-3921	113	25	a	a	DET
dpc-3921	113	26	paracrine	paracrine	ADJ
dpc-3921	113	27	mechanism	mechanism	NOUN
dpc-3921	113	28	underlying	underlie	VERB
dpc-3921	113	29	the	the	DET
dpc-3921	113	30	cutaneous	cutaneous	ADJ
dpc-3921	113	31	inflammation	inflammation	NOUN
dpc-3921	113	32	in	in	ADP
dpc-3921	113	33	 	 	SPACE
dpc-3921	113	34	vitiligo	vitiligo	VERB
dpc-3921	113	35	.	.	PUNCT
dpc-3921	114	1	j	j	PROPN
dpc-3921	114	2	invest	invest	VERB
dpc-3921	114	3	dermatol	dermatol	NOUN
dpc-3921	114	4	.	.	PUNCT
dpc-3921	115	1	2019;139:2174	2019;139:2174	NUM
dpc-3921	115	2	-	-	PUNCT
dpc-3921	115	3	2184.e4	2184.e4	NOUN
dpc-3921	115	4	.	.	PUNCT
dpc-3921	116	1	[	[	X
dpc-3921	116	2	pmid	pmid	X
dpc-3921	116	3	:	:	PUNCT
dpc-3921	116	4	30998983	30998983	NUM
dpc-3921	116	5	]	]	PUNCT
dpc-3921	116	6	.	.	PUNCT
dpc-3921	117	1	12	12	NUM
dpc-3921	117	2	.	.	PUNCT
dpc-3921	118	1	zhang	zhang	PROPN
dpc-3921	118	2	k	k	PROPN
dpc-3921	118	3	,	,	PUNCT
dpc-3921	118	4	anumanthan	anumanthan	ADV
dpc-3921	118	5	g	g	NOUN
dpc-3921	118	6	,	,	PUNCT
dpc-3921	118	7	scheaffer	scheaffer	VERB
dpc-3921	118	8	s	s	PROPN
dpc-3921	118	9	,	,	PUNCT
dpc-3921	118	10	cornelius	cornelius	PROPN
dpc-3921	118	11	la	la	PROPN
dpc-3921	118	12	.	.	PUNCT
dpc-3921	119	1	hmgb1/	hmgb1/	PROPN
dpc-3921	119	2	rage	rage	NOUN
dpc-3921	119	3	mediates	mediate	VERB
dpc-3921	119	4	uvb	uvb	ADJ
dpc-3921	119	5	-	-	ADJ
dpc-3921	119	6	induced	induced	ADJ
dpc-3921	119	7	secretory	secretory	ADJ
dpc-3921	119	8	inflammatory	inflammatory	ADJ
dpc-3921	119	9	response	response	NOUN
dpc-3921	119	10	and	and	CCONJ
dpc-3921	119	11	resistance	resistance	NOUN
dpc-3921	119	12	to	to	ADP
dpc-3921	119	13	apoptosis	apoptosis	NOUN
dpc-3921	119	14	in	in	ADP
dpc-3921	119	15	human	human	ADJ
dpc-3921	119	16	melanocytes	melanocyte	NOUN
dpc-3921	119	17	.	.	PUNCT
dpc-3921	120	1	j	j	PROPN
dpc-3921	120	2	invest	invest	VERB
dpc-3921	120	3	dermatol	dermatol	NOUN
dpc-3921	120	4	.	.	PUNCT
dpc-3921	121	1	2019;139:202–12	2019;139:202–12	NUM
dpc-3921	121	2	.	.	PUNCT
dpc-3921	122	1	[	[	X
dpc-3921	122	2	pmid	pmid	X
dpc-3921	122	3	:	:	PUNCT
dpc-3921	122	4	30030153	30030153	NUM
dpc-3921	122	5	]	]	PUNCT
dpc-3921	122	6	.	.	PUNCT
dpc-3921	123	1	13	13	NUM
dpc-3921	123	2	.	.	PUNCT
dpc-3921	124	1	mosenson	mosenson	PROPN
dpc-3921	124	2	ja	ja	PROPN
dpc-3921	124	3	,	,	PUNCT
dpc-3921	124	4	zloza	zloza	PROPN
dpc-3921	124	5	a	a	PRON
dpc-3921	124	6	,	,	PUNCT
dpc-3921	124	7	nieland	nieland	PROPN
dpc-3921	124	8	jd	jd	PROPN
dpc-3921	124	9	,	,	PUNCT
dpc-3921	124	10	et	et	PROPN
dpc-3921	124	11	al	al	PROPN
dpc-3921	124	12	.	.	PROPN
dpc-3921	125	1	mutant	mutant	PROPN
dpc-3921	125	2	hsp70	hsp70	PROPN
dpc-3921	125	3	reverses	reverse	VERB
dpc-3921	125	4	autoimmune	autoimmune	ADJ
dpc-3921	125	5	depigmentation	depigmentation	NOUN
dpc-3921	125	6	in	in	ADP
dpc-3921	125	7	vitiligo	vitiligo	PROPN
dpc-3921	125	8	.	.	PUNCT
dpc-3921	126	1	sci	sci	PROPN
dpc-3921	126	2	transl	transl	PROPN
dpc-3921	126	3	med	med	PROPN
dpc-3921	126	4	.	.	PUNCT
dpc-3921	127	1	2013;5:174ra28	2013;5:174ra28	NUM
dpc-3921	127	2	.	.	PUNCT
dpc-3921	128	1	[	[	X
dpc-3921	128	2	pmid	pmid	X
dpc-3921	128	3	:	:	PUNCT
dpc-3921	128	4	23447019	23447019	NUM
dpc-3921	128	5	]	]	PUNCT
dpc-3921	128	6	.	.	PUNCT
dpc-3921	129	1	14	14	NUM
dpc-3921	129	2	.	.	PUNCT
dpc-3921	130	1	jacquemin	jacquemin	PROPN
dpc-3921	130	2	c	c	PROPN
dpc-3921	130	3	,	,	PUNCT
dpc-3921	130	4	rambert	rambert	PROPN
dpc-3921	130	5	j	j	PROPN
dpc-3921	130	6	,	,	PUNCT
dpc-3921	130	7	guillet	guillet	VERB
dpc-3921	130	8	s	s	PROPN
dpc-3921	130	9	,	,	PUNCT
dpc-3921	130	10	et	et	PROPN
dpc-3921	130	11	al	al	PROPN
dpc-3921	130	12	.	.	PROPN
dpc-3921	130	13	heat	heat	NOUN
dpc-3921	130	14	shock	shock	NOUN
dpc-3921	130	15	protein	protein	NOUN
dpc-3921	130	16	70	70	NUM
dpc-3921	130	17	potentiates	potentiate	VERB
dpc-3921	130	18	interferon	interferon	ADJ
dpc-3921	130	19	alpha	alpha	NOUN
dpc-3921	130	20	production	production	NOUN
dpc-3921	130	21	by	by	ADP
dpc-3921	130	22	plasmacytoid	plasmacytoid	NOUN
dpc-3921	130	23	dendritic	dendritic	ADJ
dpc-3921	130	24	cells	cell	NOUN
dpc-3921	130	25	:	:	PUNCT
dpc-3921	131	1	relevance	relevance	NOUN
dpc-3921	131	2	for	for	ADP
dpc-3921	131	3	cutaneous	cutaneous	ADJ
dpc-3921	131	4	lupus	lupus	NOUN
dpc-3921	131	5	and	and	CCONJ
dpc-3921	131	6	vitiligo	vitiligo	ADJ
dpc-3921	131	7	pathogenesis	pathogenesis	NOUN
dpc-3921	131	8	.	.	PUNCT
dpc-3921	132	1	br	br	PROPN
dpc-3921	132	2	j	j	PROPN
dpc-3921	132	3	dermatol	dermatol	NOUN
dpc-3921	132	4	.	.	PUNCT
dpc-3921	133	1	2017;177:1367–75	2017;177:1367–75	NUM
dpc-3921	133	2	.	.	PUNCT
dpc-3921	134	1	[	[	X
dpc-3921	134	2	pmid	pmid	X
dpc-3921	134	3	:	:	PUNCT
dpc-3921	134	4	28380264	28380264	NUM
dpc-3921	134	5	]	]	PUNCT
dpc-3921	134	6	.	.	PUNCT
dpc-3921	135	1	15	15	NUM
dpc-3921	135	2	.	.	PUNCT
dpc-3921	135	3	migayron	migayron	NOUN
dpc-3921	135	4	l	l	NOUN
dpc-3921	135	5	,	,	PUNCT
dpc-3921	135	6	boniface	boniface	PROPN
dpc-3921	135	7	k	k	PROPN
dpc-3921	135	8	,	,	PUNCT
dpc-3921	135	9	seneschal	seneschal	PROPN
dpc-3921	135	10	j.	j.	PROPN
dpc-3921	135	11	vitiligo	vitiligo	PROPN
dpc-3921	135	12	,	,	PUNCT
dpc-3921	135	13	from	from	ADP
dpc-3921	135	14	physiopathology	physiopathology	NOUN
dpc-3921	135	15	to	to	ADP
dpc-3921	135	16	emerging	emerge	VERB
dpc-3921	135	17	treatments	treatment	NOUN
dpc-3921	135	18	:	:	PUNCT
dpc-3921	135	19	a	a	DET
dpc-3921	135	20	review	review	NOUN
dpc-3921	135	21	.	.	PUNCT
dpc-3921	136	1	dermatol	dermatol	NOUN
dpc-3921	136	2	ther	ther	ADV
dpc-3921	136	3	.	.	PUNCT
dpc-3921	137	1	2020;10:1185–98	2020;10:1185–98	NUM
dpc-3921	137	2	.	.	PUNCT
dpc-3921	138	1	[	[	X
dpc-3921	138	2	pmid	pmid	X
dpc-3921	138	3	:	:	PUNCT
dpc-3921	138	4	32949337	32949337	NUM
dpc-3921	138	5	]	]	PUNCT
dpc-3921	138	6	.	.	PUNCT
dpc-3921	139	1	16	16	NUM
dpc-3921	139	2	.	.	PUNCT
dpc-3921	140	1	henning	henning	PROPN
dpc-3921	140	2	sw	sw	PROPN
dpc-3921	140	3	,	,	PUNCT
dpc-3921	140	4	fernandez	fernandez	PROPN
dpc-3921	140	5	mf	mf	PROPN
dpc-3921	140	6	,	,	PUNCT
dpc-3921	140	7	mahon	mahon	PROPN
dpc-3921	140	8	jp	jp	PROPN
dpc-3921	140	9	,	,	PUNCT
dpc-3921	140	10	et	et	PROPN
dpc-3921	140	11	al	al	PROPN
dpc-3921	140	12	.	.	PROPN
dpc-3921	140	13	hsp70iq435a	hsp70iq435a	NOUN
dpc-3921	140	14	encoding	encode	VERB
dpc-3921	140	15	dna	dna	PROPN
dpc-3921	140	16	repigments	repigment	NOUN
dpc-3921	140	17	vitiligo	vitiligo	VERB
dpc-3921	140	18	lesions	lesion	NOUN
dpc-3921	140	19	in	in	ADP
dpc-3921	140	20	sinclair	sinclair	NOUN
dpc-3921	140	21	swine	swine	PROPN
dpc-3921	140	22	.	.	PUNCT
dpc-3921	141	1	j	j	PROPN
dpc-3921	141	2	invest	invest	VERB
dpc-3921	141	3	dermatol	dermatol	NOUN
dpc-3921	141	4	.	.	PUNCT
dpc-3921	142	1	2018;138:2531–9	2018;138:2531–9	NOUN
dpc-3921	142	2	.	.	PUNCT
dpc-3921	143	1	[	[	X
dpc-3921	143	2	pmid	pmid	X
dpc-3921	143	3	:	:	PUNCT
dpc-3921	143	4	30031029	30031029	NUM
dpc-3921	143	5	]	]	PUNCT
dpc-3921	143	6	.	.	PUNCT
dpc-3921	144	1	17	17	NUM
dpc-3921	144	2	.	.	PUNCT
dpc-3921	144	3	mosenson	mosenson	PROPN
dpc-3921	144	4	ja	ja	PROPN
dpc-3921	144	5	,	,	PUNCT
dpc-3921	144	6	eby	eby	PROPN
dpc-3921	144	7	jm	jm	PROPN
dpc-3921	144	8	,	,	PUNCT
dpc-3921	144	9	hernandez	hernandez	PROPN
dpc-3921	144	10	c	c	PROPN
dpc-3921	144	11	,	,	PUNCT
dpc-3921	144	12	le	le	PROPN
dpc-3921	144	13	poole	poole	PROPN
dpc-3921	144	14	ic	ic	PROPN
dpc-3921	144	15	.	.	PUNCT
dpc-3921	145	1	a	a	DET
dpc-3921	145	2	central	central	ADJ
dpc-3921	145	3	role	role	NOUN
dpc-3921	145	4	for	for	ADP
dpc-3921	145	5	inducible	inducible	ADJ
dpc-3921	145	6	heat	heat	NOUN
dpc-3921	145	7	-	-	PUNCT
dpc-3921	145	8	shock	shock	NOUN
dpc-3921	145	9	protein	protein	NOUN
dpc-3921	145	10	70	70	NUM
dpc-3921	145	11	in	in	ADP
dpc-3921	145	12	autoimmune	autoimmune	ADJ
dpc-3921	145	13	vitiligo	vitiligo	NOUN
dpc-3921	145	14	.	.	PUNCT
dpc-3921	146	1	exp	exp	NOUN
dpc-3921	146	2	dermatol	dermatol	NOUN
dpc-3921	146	3	.	.	PUNCT
dpc-3921	147	1	2013;22:566–9	2013;22:566–9	NUM
dpc-3921	147	2	.	.	PUNCT
dpc-3921	148	1	[	[	X
dpc-3921	148	2	pmid	pmid	X
dpc-3921	148	3	:	:	PUNCT
dpc-3921	148	4	23786523	23786523	NUM
dpc-3921	148	5	]	]	PUNCT
dpc-3921	148	6	.	.	PUNCT
dpc-3921	149	1	18	18	NUM
dpc-3921	149	2	.	.	PUNCT
dpc-3921	150	1	denman	denman	PROPN
dpc-3921	150	2	cj	cj	PROPN
dpc-3921	150	3	,	,	PUNCT
dpc-3921	150	4	mccracken	mccracken	PROPN
dpc-3921	150	5	j	j	PROPN
dpc-3921	150	6	,	,	PUNCT
dpc-3921	150	7	hariharan	hariharan	PROPN
dpc-3921	150	8	v	v	PROPN
dpc-3921	150	9	,	,	PUNCT
dpc-3921	150	10	et	et	PROPN
dpc-3921	150	11	al	al	PROPN
dpc-3921	150	12	.	.	PUNCT
dpc-3921	151	1	hsp70i	hsp70i	PROPN
dpc-3921	151	2	accelerates	accelerate	VERB
dpc-3921	151	3	depigmentation	depigmentation	NOUN
dpc-3921	151	4	in	in	ADP
dpc-3921	151	5	a	a	DET
dpc-3921	151	6	mouse	mouse	NOUN
dpc-3921	151	7	model	model	NOUN
dpc-3921	151	8	of	of	ADP
dpc-3921	151	9	autoimmune	autoimmune	ADJ
dpc-3921	151	10	vitiligo	vitiligo	PROPN
dpc-3921	151	11	.	.	PUNCT
dpc-3921	152	1	j	j	PROPN
dpc-3921	152	2	invest	invest	VERB
dpc-3921	152	3	dermatol	dermatol	NOUN
dpc-3921	152	4	.	.	PUNCT
dpc-3921	153	1	2008;128:2041–8	2008;128:2041–8	NOUN
dpc-3921	153	2	.	.	PUNCT
dpc-3921	154	1	[	[	X
dpc-3921	154	2	pmid	pmid	X
dpc-3921	154	3	:	:	PUNCT
dpc-3921	154	4	18337834	18337834	NUM
dpc-3921	154	5	]	]	PUNCT
dpc-3921	154	6	.	.	PUNCT
dpc-3921	155	1	19	19	NUM
dpc-3921	155	2	.	.	PUNCT
dpc-3921	156	1	kovacs	kovacs	PROPN
dpc-3921	156	2	d	d	X
dpc-3921	156	3	,	,	PUNCT
dpc-3921	156	4	bastonini	bastonini	PROPN
dpc-3921	156	5	e	e	PROPN
dpc-3921	156	6	,	,	PUNCT
dpc-3921	156	7	briganti	briganti	PROPN
dpc-3921	156	8	s	s	PROPN
dpc-3921	156	9	,	,	PUNCT
dpc-3921	156	10	et	et	PROPN
dpc-3921	156	11	al	al	PROPN
dpc-3921	156	12	.	.	PROPN
dpc-3921	156	13	altered	alter	VERB
dpc-3921	156	14	epidermal	epidermal	ADJ
dpc-3921	156	15	proliferation	proliferation	NOUN
dpc-3921	156	16	,	,	PUNCT
dpc-3921	156	17	differentiation	differentiation	NOUN
dpc-3921	156	18	,	,	PUNCT
dpc-3921	156	19	and	and	CCONJ
dpc-3921	156	20	lipid	lipid	NOUN
dpc-3921	156	21	composition	composition	NOUN
dpc-3921	156	22	:	:	PUNCT
dpc-3921	156	23	novel	novel	ADJ
dpc-3921	156	24	key	key	ADJ
dpc-3921	156	25	elements	element	NOUN
dpc-3921	156	26	in	in	ADP
dpc-3921	156	27	the	the	DET
dpc-3921	156	28	vitiligo	vitiligo	NOUN
dpc-3921	156	29	puzzle	puzzle	NOUN
dpc-3921	156	30	.	.	PUNCT
dpc-3921	157	1	sci	sci	PROPN
dpc-3921	157	2	adv	adv	PROPN
dpc-3921	157	3	.	.	PUNCT
dpc-3921	158	1	2022;8	2022;8	NUM
dpc-3921	158	2	:	:	PUNCT
dpc-3921	158	3	eabn9299	eabn9299	NOUN
dpc-3921	158	4	.	.	PUNCT
dpc-3921	159	1	[	[	X
dpc-3921	159	2	pmid	pmid	X
dpc-3921	159	3	:	:	PUNCT
dpc-3921	159	4	36054352	36054352	NUM
dpc-3921	159	5	]	]	PUNCT
dpc-3921	159	6	.	.	PUNCT
dpc-3921	160	1	20	20	NUM
dpc-3921	160	2	.	.	PUNCT
dpc-3921	161	1	moellmann	moellmann	PROPN
dpc-3921	161	2	g	g	PROPN
dpc-3921	161	3	,	,	PUNCT
dpc-3921	161	4	klein	klein	PROPN
dpc-3921	161	5	-	-	PUNCT
dpc-3921	161	6	angerer	angerer	PROPN
dpc-3921	161	7	s	s	PROPN
dpc-3921	161	8	,	,	PUNCT
dpc-3921	161	9	scollay	scollay	NOUN
dpc-3921	161	10	da	da	PROPN
dpc-3921	161	11	,	,	PUNCT
dpc-3921	161	12	nordlund	nordlund	PROPN
dpc-3921	161	13	jj	jj	PROPN
dpc-3921	161	14	,	,	PUNCT
dpc-3921	161	15	lerner	lerner	PROPN
dpc-3921	161	16	ab	ab	PROPN
dpc-3921	161	17	.	.	PROPN
dpc-3921	161	18	extracellular	extracellular	ADJ
dpc-3921	161	19	granular	granular	ADJ
dpc-3921	161	20	material	material	NOUN
dpc-3921	161	21	and	and	CCONJ
dpc-3921	161	22	degeneration	degeneration	NOUN
dpc-3921	161	23	of	of	ADP
dpc-3921	161	24	keratinocytes	keratinocyte	NOUN
dpc-3921	161	25	in	in	ADP
dpc-3921	161	26	the	the	DET
dpc-3921	161	27	normally	normally	ADV
dpc-3921	161	28	pigmented	pigmented	ADJ
dpc-3921	161	29	epidermis	epidermis	NOUN
dpc-3921	161	30	of	of	ADP
dpc-3921	161	31	patients	patient	NOUN
dpc-3921	161	32	with	with	ADP
dpc-3921	161	33	vitiligo	vitiligo	PROPN
dpc-3921	161	34	.	.	PUNCT
dpc-3921	162	1	j	j	PROPN
dpc-3921	162	2	invest	invest	VERB
dpc-3921	162	3	dermatol	dermatol	NOUN
dpc-3921	162	4	.	.	PUNCT
dpc-3921	163	1	1982;79:321–30	1982;79:321–30	X
dpc-3921	163	2	.	.	PUNCT
dpc-3921	164	1	[	[	X
dpc-3921	164	2	pmid	pmid	X
dpc-3921	164	3	:	:	PUNCT
dpc-3921	164	4	7130745	7130745	NUM
dpc-3921	164	5	]	]	PUNCT
dpc-3921	164	6	.	.	PUNCT
dpc-3921	165	1	21	21	NUM
dpc-3921	165	2	.	.	PUNCT
dpc-3921	166	1	marie	marie	PROPN
dpc-3921	166	2	j	j	PROPN
dpc-3921	166	3	,	,	PUNCT
dpc-3921	166	4	kovacs	kovacs	PROPN
dpc-3921	166	5	d	d	PROPN
dpc-3921	166	6	,	,	PUNCT
dpc-3921	166	7	pain	pain	NOUN
dpc-3921	166	8	c	c	NOUN
dpc-3921	166	9	,	,	PUNCT
dpc-3921	166	10	et	et	PROPN
dpc-3921	166	11	al	al	PROPN
dpc-3921	166	12	.	.	PROPN
dpc-3921	166	13	inflammasome	inflammasome	PROPN
dpc-3921	166	14	activation	activation	NOUN
dpc-3921	166	15	and	and	CCONJ
dpc-3921	166	16	vitiligo	vitiligo	VERB
dpc-3921	166	17	/	/	SYM
dpc-3921	166	18	nonsegmental	nonsegmental	NOUN
dpc-3921	166	19	vitiligo	vitiligo	NOUN
dpc-3921	166	20	progression	progression	NOUN
dpc-3921	166	21	.	.	PUNCT
dpc-3921	167	1	br	br	PROPN
dpc-3921	167	2	j	j	PROPN
dpc-3921	167	3	dermatol	dermatol	NOUN
dpc-3921	167	4	.	.	PUNCT
dpc-3921	168	1	2014;170:816–23	2014;170:816–23	NUM
dpc-3921	168	2	.	.	PUNCT
dpc-3921	169	1	[	[	X
dpc-3921	169	2	pmid	pmid	X
dpc-3921	169	3	:	:	PUNCT
dpc-3921	169	4	24734946	24734946	NUM
dpc-3921	169	5	]	]	PUNCT
dpc-3921	169	6	.	.	PUNCT
dpc-3921	170	1	22	22	NUM
dpc-3921	170	2	.	.	PUNCT
dpc-3921	171	1	li	li	PROPN
dpc-3921	171	2	s	s	PROPN
dpc-3921	171	3	,	,	PUNCT
dpc-3921	171	4	zhu	zhu	PROPN
dpc-3921	171	5	g	g	PROPN
dpc-3921	171	6	,	,	PUNCT
dpc-3921	171	7	yang	yang	PROPN
dpc-3921	171	8	y	y	PROPN
dpc-3921	171	9	,	,	PUNCT
dpc-3921	171	10	et	et	PROPN
dpc-3921	171	11	al	al	PROPN
dpc-3921	171	12	.	.	PROPN
dpc-3921	171	13	oxidative	oxidative	ADJ
dpc-3921	171	14	stress	stress	NOUN
dpc-3921	171	15	drives	drive	VERB
dpc-3921	171	16	cd8	cd8	PROPN
dpc-3921	171	17	+	+	PROPN
dpc-3921	171	18	t	t	PROPN
dpc-3921	171	19	-	-	PUNCT
dpc-3921	171	20	cell	cell	NOUN
dpc-3921	171	21	skin	skin	NOUN
dpc-3921	171	22	trafficking	trafficking	NOUN
dpc-3921	171	23	in	in	ADP
dpc-3921	171	24	patients	patient	NOUN
dpc-3921	171	25	with	with	ADP
dpc-3921	171	26	vitiligo	vitiligo	NOUN
dpc-3921	171	27	through	through	ADP
dpc-3921	171	28	cxcl16	cxcl16	NOUN
dpc-3921	171	29	upregulation	upregulation	NOUN
dpc-3921	171	30	by	by	ADP
dpc-3921	171	31	activating	activate	VERB
dpc-3921	171	32	the	the	DET
dpc-3921	171	33	unfolded	unfolded	ADJ
dpc-3921	171	34	protein	protein	NOUN
dpc-3921	171	35	response	response	NOUN
dpc-3921	171	36	in	in	ADP
dpc-3921	171	37	keratinocytes	keratinocyte	NOUN
dpc-3921	171	38	.	.	PUNCT
dpc-3921	172	1	j	j	PROPN
dpc-3921	172	2	allergy	allergy	PROPN
dpc-3921	172	3	clin	clin	PROPN
dpc-3921	172	4	immunol	immunol	PROPN
dpc-3921	172	5	.	.	PUNCT
dpc-3921	173	1	2017;140:177	2017;140:177	NUM
dpc-3921	173	2	-	-	PUNCT
dpc-3921	173	3	189.e9	189.e9	NUM
dpc-3921	173	4	.	.	PUNCT
dpc-3921	174	1	[	[	X
dpc-3921	174	2	pmid	pmid	X
dpc-3921	174	3	:	:	PUNCT
dpc-3921	174	4	27826097	27826097	NUM
dpc-3921	174	5	]	]	PUNCT
dpc-3921	174	6	.	.	PUNCT
dpc-3921	175	1	23	23	NUM
dpc-3921	175	2	.	.	PUNCT
dpc-3921	176	1	richmond	richmond	PROPN
dpc-3921	176	2	jm	jm	PROPN
dpc-3921	176	3	,	,	PUNCT
dpc-3921	176	4	bangari	bangari	ADJ
dpc-3921	176	5	ds	ds	X
dpc-3921	176	6	,	,	PUNCT
dpc-3921	176	7	essien	essien	PROPN
dpc-3921	176	8	ki	ki	PROPN
dpc-3921	176	9	,	,	PUNCT
dpc-3921	176	10	et	et	PROPN
dpc-3921	176	11	al	al	PROPN
dpc-3921	176	12	.	.	PUNCT
dpc-3921	176	13	keratinocyte	keratinocyte	NOUN
dpc-3921	176	14	-	-	PUNCT
dpc-3921	176	15	derived	derive	VERB
dpc-3921	176	16	chemokines	chemokine	NOUN
dpc-3921	176	17	orchestrate	orchestrate	VERB
dpc-3921	176	18	t	t	NOUN
dpc-3921	176	19	-	-	PUNCT
dpc-3921	176	20	cell	cell	NOUN
dpc-3921	176	21	positioning	positioning	NOUN
dpc-3921	176	22	in	in	ADP
dpc-3921	176	23	the	the	DET
dpc-3921	176	24	epidermis	epidermis	NOUN
dpc-3921	176	25	the	the	DET
dpc-3921	176	26	precise	precise	ADJ
dpc-3921	176	27	role	role	NOUN
dpc-3921	176	28	of	of	ADP
dpc-3921	176	29	type-2	type-2	NUM
dpc-3921	176	30	related	related	ADJ
dpc-3921	176	31	cytokines	cytokine	NOUN
dpc-3921	176	32	in	in	ADP
dpc-3921	176	33	the	the	DET
dpc-3921	176	34	development	development	NOUN
dpc-3921	176	35	of	of	ADP
dpc-3921	176	36	vitiligo	vitiligo	NOUN
dpc-3921	176	37	remains	remain	VERB
dpc-3921	176	38	unclear	unclear	ADJ
dpc-3921	176	39	.	.	PUNCT
dpc-3921	177	1	defects	defect	NOUN
dpc-3921	177	2	in	in	ADP
dpc-3921	177	3	immune	immune	ADJ
dpc-3921	177	4	regulation	regulation	NOUN
dpc-3921	177	5	during	during	ADP
dpc-3921	177	6	vitiligo	vitiligo	NOUN
dpc-3921	177	7	like	like	ADP
dpc-3921	177	8	any	any	DET
dpc-3921	177	9	chronic	chronic	ADJ
dpc-3921	177	10	inflammatory	inflammatory	ADJ
dpc-3921	177	11	disease	disease	NOUN
dpc-3921	177	12	characterized	characterize	VERB
dpc-3921	177	13	by	by	ADP
dpc-3921	177	14	an	an	DET
dpc-3921	177	15	exaggerated	exaggerated	ADJ
dpc-3921	177	16	immune	immune	ADJ
dpc-3921	177	17	response	response	NOUN
dpc-3921	177	18	,	,	PUNCT
dpc-3921	177	19	vitiligo	vitiligo	PROPN
dpc-3921	177	20	is	be	AUX
dpc-3921	177	21	associated	associate	VERB
dpc-3921	177	22	with	with	ADP
dpc-3921	177	23	a	a	DET
dpc-3921	177	24	disruption	disruption	NOUN
dpc-3921	177	25	of	of	ADP
dpc-3921	177	26	immune	immune	ADJ
dpc-3921	177	27	regulatory	regulatory	ADJ
dpc-3921	177	28	systems	system	NOUN
dpc-3921	177	29	.	.	PUNCT
dpc-3921	178	1	indeed	indeed	ADV
dpc-3921	178	2	,	,	PUNCT
dpc-3921	178	3	gwas	gwas	PROPN
dpc-3921	178	4	identified	identify	VERB
dpc-3921	178	5	a	a	DET
dpc-3921	178	6	polymorphism	polymorphism	NOUN
dpc-3921	178	7	of	of	ADP
dpc-3921	178	8	foxp3	foxp3	PROPN
dpc-3921	178	9	gene	gene	NOUN
dpc-3921	178	10	,	,	PUNCT
dpc-3921	178	11	the	the	DET
dpc-3921	178	12	main	main	ADJ
dpc-3921	178	13	transcription	transcription	NOUN
dpc-3921	178	14	factor	factor	NOUN
dpc-3921	178	15	of	of	ADP
dpc-3921	178	16	regulatory	regulatory	ADJ
dpc-3921	178	17	t	t	NOUN
dpc-3921	178	18	cells	cell	NOUN
dpc-3921	178	19	(	(	PUNCT
dpc-3921	178	20	tregs	treg	NOUN
dpc-3921	178	21	)	)	PUNCT
dpc-3921	178	22	,	,	PUNCT
dpc-3921	178	23	in	in	ADP
dpc-3921	178	24	vitiligo	vitiligo	NOUN
dpc-3921	178	25	,	,	PUNCT
dpc-3921	178	26	but	but	CCONJ
dpc-3921	178	27	also	also	ADV
dpc-3921	178	28	of	of	ADP
dpc-3921	178	29	genes	gene	NOUN
dpc-3921	178	30	involved	involve	VERB
dpc-3921	178	31	in	in	ADP
dpc-3921	178	32	regulation	regulation	NOUN
dpc-3921	178	33	of	of	ADP
dpc-3921	178	34	the	the	DET
dpc-3921	178	35	immune	immune	ADJ
dpc-3921	178	36	response	response	NOUN
dpc-3921	178	37	,	,	PUNCT
dpc-3921	178	38	such	such	ADJ
dpc-3921	178	39	as	as	ADP
dpc-3921	178	40	ctla-4	ctla-4	NOUN
dpc-3921	178	41	(	(	PUNCT
dpc-3921	178	42	cytotoxic	cytotoxic	ADJ
dpc-3921	178	43	t	t	NOUN
dpc-3921	178	44	lymphocyte	lymphocyte	NOUN
dpc-3921	178	45	antigen	antigen	ADP
dpc-3921	178	46	4	4	NUM
dpc-3921	178	47	)	)	PUNCT
dpc-3921	178	48	,	,	PUNCT
dpc-3921	178	49	il-10	il-10	PRON
dpc-3921	178	50	,	,	PUNCT
dpc-3921	178	51	and	and	CCONJ
dpc-3921	178	52	tgfβ	tgfβ	X
dpc-3921	179	1	[	[	X
dpc-3921	179	2	3,64,65	3,64,65	NUM
dpc-3921	179	3	]	]	PUNCT
dpc-3921	179	4	.	.	PUNCT
dpc-3921	180	1	however	however	ADV
dpc-3921	180	2	,	,	PUNCT
dpc-3921	180	3	it	it	PRON
dpc-3921	180	4	is	be	AUX
dpc-3921	180	5	still	still	ADV
dpc-3921	180	6	unclear	unclear	ADJ
dpc-3921	180	7	whether	whether	SCONJ
dpc-3921	180	8	this	this	DET
dpc-3921	180	9	defect	defect	NOUN
dpc-3921	180	10	in	in	ADP
dpc-3921	180	11	the	the	DET
dpc-3921	180	12	regulation	regulation	NOUN
dpc-3921	180	13	mechanisms	mechanism	NOUN
dpc-3921	180	14	results	result	VERB
dpc-3921	180	15	from	from	ADP
dpc-3921	180	16	reduced	reduce	VERB
dpc-3921	180	17	migration	migration	NOUN
dpc-3921	180	18	of	of	ADP
dpc-3921	180	19	tregs	treg	NOUN
dpc-3921	180	20	into	into	ADP
dpc-3921	180	21	the	the	DET
dpc-3921	180	22	skin	skin	NOUN
dpc-3921	180	23	and/or	and/or	CCONJ
dpc-3921	180	24	loss	loss	NOUN
dpc-3921	180	25	of	of	ADP
dpc-3921	180	26	suppressive	suppressive	ADJ
dpc-3921	180	27	function	function	NOUN
dpc-3921	180	28	of	of	ADP
dpc-3921	180	29	these	these	DET
dpc-3921	180	30	cells	cell	NOUN
dpc-3921	180	31	,	,	PUNCT
dpc-3921	180	32	which	which	PRON
dpc-3921	180	33	would	would	AUX
dpc-3921	180	34	favor	favor	VERB
dpc-3921	180	35	the	the	DET
dpc-3921	180	36	exacerbated	exacerbate	VERB
dpc-3921	180	37	effector	effector	NOUN
dpc-3921	180	38	activity	activity	NOUN
dpc-3921	180	39	of	of	ADP
dpc-3921	180	40	cd8	cd8	PROPN
dpc-3921	180	41	t	t	PROPN
dpc-3921	180	42	cells	cell	NOUN
dpc-3921	180	43	[	[	X
dpc-3921	180	44	66,67	66,67	ADP
dpc-3921	180	45	]	]	PUNCT
dpc-3921	180	46	.	.	PUNCT
dpc-3921	181	1	chemokines	chemokine	NOUN
dpc-3921	181	2	and	and	CCONJ
dpc-3921	181	3	their	their	PRON
dpc-3921	181	4	receptors	receptor	NOUN
dpc-3921	181	5	appear	appear	VERB
dpc-3921	181	6	critical	critical	ADJ
dpc-3921	181	7	factors	factor	NOUN
dpc-3921	181	8	to	to	PART
dpc-3921	181	9	replenish	replenish	VERB
dpc-3921	181	10	tregs	treg	NOUN
dpc-3921	181	11	in	in	ADP
dpc-3921	181	12	the	the	DET
dpc-3921	181	13	skin	skin	NOUN
dpc-3921	181	14	and	and	CCONJ
dpc-3921	181	15	ensure	ensure	VERB
dpc-3921	181	16	their	their	PRON
dpc-3921	181	17	immunosuppressive	immunosuppressive	ADJ
dpc-3921	181	18	function	function	NOUN
dpc-3921	181	19	.	.	PUNCT
dpc-3921	182	1	for	for	ADP
dpc-3921	182	2	instance	instance	NOUN
dpc-3921	182	3	,	,	PUNCT
dpc-3921	182	4	enhanced	enhance	VERB
dpc-3921	182	5	skin	skin	NOUN
dpc-3921	182	6	expression	expression	NOUN
dpc-3921	182	7	of	of	ADP
dpc-3921	182	8	ccl22	ccl22	PROPN
dpc-3921	182	9	induced	induce	VERB
dpc-3921	182	10	migration	migration	NOUN
dpc-3921	182	11	of	of	ADP
dpc-3921	182	12	tregs	treg	NOUN
dpc-3921	182	13	into	into	ADP
dpc-3921	182	14	the	the	DET
dpc-3921	182	15	skin	skin	NOUN
dpc-3921	182	16	and	and	CCONJ
dpc-3921	182	17	reduced	reduce	VERB
dpc-3921	182	18	depigmentation	depigmentation	NOUN
dpc-3921	182	19	in	in	ADP
dpc-3921	182	20	vivo	vivo	NOUN
dpc-3921	182	21	in	in	ADP
dpc-3921	182	22	mice	mouse	NOUN
dpc-3921	182	23	[	[	X
dpc-3921	182	24	68	68	NUM
dpc-3921	182	25	]	]	PUNCT
dpc-3921	182	26	.	.	PUNCT
dpc-3921	183	1	in	in	ADP
dpc-3921	183	2	addition	addition	NOUN
dpc-3921	183	3	,	,	PUNCT
dpc-3921	183	4	gellatly	gellatly	ADV
dpc-3921	183	5	et	et	PROPN
dpc-3921	183	6	al	al	PROPN
dpc-3921	183	7	.	.	PROPN
dpc-3921	183	8	showed	show	VERB
dpc-3921	183	9	in	in	ADP
dpc-3921	183	10	a	a	DET
dpc-3921	183	11	vitiligo	vitiligo	NOUN
dpc-3921	183	12	mouse	mouse	NOUN
dpc-3921	183	13	model	model	NOUN
dpc-3921	183	14	that	that	SCONJ
dpc-3921	183	15	ccr5	ccr5	PROPN
dpc-3921	183	16	/	/	SYM
dpc-3921	183	17	ccl5	ccl5	PROPN
dpc-3921	183	18	axis	axis	NOUN
dpc-3921	183	19	facilitates	facilitate	VERB
dpc-3921	183	20	tregs	treg	NOUN
dpc-3921	183	21	function	function	NOUN
dpc-3921	183	22	in	in	ADP
dpc-3921	183	23	the	the	DET
dpc-3921	183	24	skin	skin	NOUN
dpc-3921	183	25	[	[	X
dpc-3921	183	26	69	69	NUM
dpc-3921	183	27	]	]	PUNCT
dpc-3921	183	28	.	.	PUNCT
dpc-3921	184	1	hence	hence	ADV
dpc-3921	184	2	,	,	PUNCT
dpc-3921	184	3	therapeutic	therapeutic	ADJ
dpc-3921	184	4	strategies	strategy	NOUN
dpc-3921	184	5	aiming	aim	VERB
dpc-3921	184	6	to	to	PART
dpc-3921	184	7	restore	restore	VERB
dpc-3921	184	8	tregs	treg	NOUN
dpc-3921	184	9	abundance	abundance	NOUN
dpc-3921	184	10	and	and	CCONJ
dpc-3921	184	11	function	function	NOUN
dpc-3921	184	12	in	in	ADP
dpc-3921	184	13	the	the	DET
dpc-3921	184	14	skin	skin	NOUN
dpc-3921	184	15	may	may	AUX
dpc-3921	184	16	be	be	AUX
dpc-3921	184	17	promising	promise	VERB
dpc-3921	184	18	for	for	ADP
dpc-3921	184	19	patients	patient	NOUN
dpc-3921	184	20	[	[	X
dpc-3921	184	21	70	70	NUM
dpc-3921	184	22	]	]	PUNCT
dpc-3921	184	23	.	.	PUNCT
dpc-3921	185	1	conclusion	conclusion	VERB
dpc-3921	185	2	the	the	DET
dpc-3921	185	3	development	development	NOUN
dpc-3921	185	4	of	of	ADP
dpc-3921	185	5	vitiligo	vitiligo	ADJ
dpc-3921	185	6	lesions	lesion	NOUN
dpc-3921	185	7	involves	involve	VERB
dpc-3921	185	8	a	a	DET
dpc-3921	185	9	complex	complex	ADJ
dpc-3921	185	10	crosstalk	crosstalk	NOUN
dpc-3921	185	11	between	between	ADP
dpc-3921	185	12	epidermal	epidermal	ADJ
dpc-3921	185	13	,	,	PUNCT
dpc-3921	185	14	dermal	dermal	ADJ
dpc-3921	185	15	,	,	PUNCT
dpc-3921	185	16	and	and	CCONJ
dpc-3921	185	17	immune	immune	ADJ
dpc-3921	185	18	cells	cell	NOUN
dpc-3921	185	19	.	.	PUNCT
dpc-3921	186	1	such	such	ADJ
dpc-3921	186	2	understanding	understanding	NOUN
dpc-3921	186	3	of	of	ADP
dpc-3921	186	4	the	the	DET
dpc-3921	186	5	mechanisms	mechanism	NOUN
dpc-3921	186	6	leading	lead	VERB
dpc-3921	186	7	to	to	ADP
dpc-3921	186	8	the	the	DET
dpc-3921	186	9	loss	loss	NOUN
dpc-3921	186	10	of	of	ADP
dpc-3921	186	11	melanocytes	melanocyte	NOUN
dpc-3921	186	12	led	lead	VERB
dpc-3921	186	13	to	to	ADP
dpc-3921	186	14	the	the	DET
dpc-3921	186	15	identification	identification	NOUN
dpc-3921	186	16	of	of	ADP
dpc-3921	186	17	several	several	ADJ
dpc-3921	186	18	targets	target	NOUN
dpc-3921	186	19	and	and	CCONJ
dpc-3921	186	20	the	the	DET
dpc-3921	186	21	development	development	NOUN
dpc-3921	186	22	of	of	ADP
dpc-3921	186	23	future	future	ADJ
dpc-3921	186	24	targeted	target	VERB
dpc-3921	186	25	therapies	therapy	NOUN
dpc-3921	186	26	that	that	PRON
dpc-3921	186	27	will	will	AUX
dpc-3921	186	28	undoubtedly	undoubtedly	ADV
dpc-3921	186	29	improve	improve	VERB
dpc-3921	186	30	the	the	DET
dpc-3921	186	31	management	management	NOUN
dpc-3921	186	32	of	of	ADP
dpc-3921	186	33	the	the	DET
dpc-3921	186	34	disease	disease	NOUN
dpc-3921	186	35	.	.	PUNCT
dpc-3921	187	1	references	reference	NOUN
dpc-3921	187	2	1	1	NUM
dpc-3921	187	3	.	.	X
dpc-3921	187	4	boniface	boniface	PROPN
dpc-3921	187	5	k	k	PROPN
dpc-3921	187	6	,	,	PUNCT
dpc-3921	187	7	seneschal	seneschal	PROPN
dpc-3921	187	8	j	j	PROPN
dpc-3921	187	9	,	,	PUNCT
dpc-3921	187	10	picardo	picardo	PROPN
dpc-3921	187	11	m	m	NOUN
dpc-3921	187	12	,	,	PUNCT
dpc-3921	187	13	taïeb	taïeb	NOUN
dpc-3921	187	14	a.	a.	NOUN
dpc-3921	187	15	vitiligo	vitiligo	PROPN
dpc-3921	187	16	:	:	PUNCT
dpc-3921	187	17	focus	focus	VERB
dpc-3921	187	18	on	on	ADP
dpc-3921	187	19	clinical	clinical	ADJ
dpc-3921	187	20	aspects	aspect	NOUN
dpc-3921	187	21	,	,	PUNCT
dpc-3921	187	22	immunopathogenesis	immunopathogenesis	NOUN
dpc-3921	187	23	,	,	PUNCT
dpc-3921	187	24	and	and	CCONJ
dpc-3921	187	25	therapy	therapy	NOUN
dpc-3921	187	26	.	.	PUNCT
dpc-3921	188	1	clin	clin	PROPN
dpc-3921	188	2	rev	rev	PROPN
dpc-3921	188	3	allergy	allergy	PROPN
dpc-3921	188	4	immunol	immunol	PROPN
dpc-3921	188	5	.	.	PUNCT
dpc-3921	189	1	2018;54:52–67	2018;54:52–67	NUM
dpc-3921	189	2	.	.	PUNCT
dpc-3921	190	1	[	[	X
dpc-3921	190	2	pmid	pmid	X
dpc-3921	190	3	:	:	PUNCT
dpc-3921	190	4	28685247	28685247	NUM
dpc-3921	190	5	]	]	PUNCT
dpc-3921	190	6	.	.	PUNCT
dpc-3921	191	1	2	2	X
dpc-3921	191	2	.	.	X
dpc-3921	191	3	spritz	spritz	PROPN
dpc-3921	191	4	ra	ra	PROPN
dpc-3921	191	5	.	.	PUNCT
dpc-3921	192	1	modern	modern	ADJ
dpc-3921	192	2	vitiligo	vitiligo	NOUN
dpc-3921	192	3	genetics	genetic	NOUN
dpc-3921	192	4	sheds	shed	VERB
dpc-3921	192	5	new	new	ADJ
dpc-3921	192	6	light	light	NOUN
dpc-3921	192	7	on	on	ADP
dpc-3921	192	8	an	an	DET
dpc-3921	192	9	ancient	ancient	ADJ
dpc-3921	192	10	disease	disease	NOUN
dpc-3921	192	11	.	.	PUNCT
dpc-3921	193	1	j	j	PROPN
dpc-3921	193	2	dermatol	dermatol	NOUN
dpc-3921	193	3	.	.	PUNCT
dpc-3921	194	1	2013;40:310–8	2013;40:310–8	NUM
dpc-3921	194	2	.	.	PUNCT
dpc-3921	195	1	[	[	X
dpc-3921	195	2	pmid	pmid	X
dpc-3921	195	3	:	:	PUNCT
dpc-3921	195	4	23668538	23668538	NUM
dpc-3921	195	5	]	]	PUNCT
dpc-3921	195	6	.	.	PUNCT
dpc-3921	196	1	3	3	X
dpc-3921	196	2	.	.	X
dpc-3921	196	3	spritz	spritz	PROPN
dpc-3921	196	4	ra	ra	PROPN
dpc-3921	196	5	,	,	PUNCT
dpc-3921	196	6	santorico	santorico	PROPN
dpc-3921	196	7	sa	sa	PROPN
dpc-3921	196	8	.	.	PUNCT
dpc-3921	197	1	the	the	DET
dpc-3921	197	2	genetic	genetic	ADJ
dpc-3921	197	3	basis	basis	NOUN
dpc-3921	197	4	of	of	ADP
dpc-3921	197	5	vitiligo	vitiligo	NOUN
dpc-3921	197	6	.	.	PUNCT
dpc-3921	198	1	j	j	PROPN
dpc-3921	198	2	invest	invest	VERB
dpc-3921	198	3	dermatol	dermatol	NOUN
dpc-3921	198	4	.	.	PUNCT
dpc-3921	199	1	2021;141:265–73	2021;141:265–73	NUM
dpc-3921	199	2	.	.	PUNCT
dpc-3921	200	1	[	[	X
dpc-3921	200	2	pmid	pmid	X
dpc-3921	200	3	:	:	PUNCT
dpc-3921	200	4	32778407	32778407	NUM
dpc-3921	200	5	]	]	PUNCT
dpc-3921	200	6	.	.	PUNCT
dpc-3921	201	1	4	4	X
dpc-3921	201	2	.	.	X
dpc-3921	201	3	jin	jin	PROPN
dpc-3921	201	4	y	y	PROPN
dpc-3921	201	5	,	,	PUNCT
dpc-3921	201	6	andersen	andersen	PROPN
dpc-3921	201	7	g	g	PROPN
dpc-3921	201	8	,	,	PUNCT
dpc-3921	201	9	yorgov	yorgov	PROPN
dpc-3921	201	10	d	d	NOUN
dpc-3921	201	11	,	,	PUNCT
dpc-3921	201	12	et	et	PROPN
dpc-3921	201	13	al	al	PROPN
dpc-3921	201	14	.	.	PUNCT
dpc-3921	201	15	genome	genome	NOUN
dpc-3921	201	16	-	-	PUNCT
dpc-3921	201	17	wide	wide	ADJ
dpc-3921	201	18	association	association	NOUN
dpc-3921	201	19	studies	study	NOUN
dpc-3921	201	20	of	of	ADP
dpc-3921	201	21	autoimmune	autoimmune	ADJ
dpc-3921	201	22	vitiligo	vitiligo	NOUN
dpc-3921	201	23	identify	identify	VERB
dpc-3921	201	24	23	23	NUM
dpc-3921	201	25	new	new	ADJ
dpc-3921	201	26	risk	risk	NOUN
dpc-3921	201	27	loci	loci	NOUN
dpc-3921	201	28	and	and	CCONJ
dpc-3921	201	29	highlight	highlight	VERB
dpc-3921	201	30	key	key	ADJ
dpc-3921	201	31	pathways	pathway	NOUN
dpc-3921	201	32	and	and	CCONJ
dpc-3921	201	33	regulatory	regulatory	ADJ
dpc-3921	201	34	variants	variant	NOUN
dpc-3921	201	35	.	.	PUNCT
dpc-3921	202	1	nat	nat	PROPN
dpc-3921	202	2	genet	genet	PROPN
dpc-3921	202	3	.	.	PUNCT
dpc-3921	203	1	2016;48:1418–24	2016;48:1418–24	NUM
dpc-3921	203	2	.	.	PUNCT
dpc-3921	204	1	[	[	X
dpc-3921	204	2	pmid	pmid	X
dpc-3921	204	3	:	:	PUNCT
dpc-3921	204	4	27723757	27723757	NUM
dpc-3921	204	5	]	]	PUNCT
dpc-3921	204	6	.	.	PUNCT
dpc-3921	205	1	5	5	X
dpc-3921	205	2	.	.	PUNCT
dpc-3921	205	3	jin	jin	PROPN
dpc-3921	205	4	y	y	PROPN
dpc-3921	205	5	,	,	PUNCT
dpc-3921	205	6	mailloux	mailloux	VERB
dpc-3921	205	7	cm	cm	NOUN
dpc-3921	205	8	,	,	PUNCT
dpc-3921	205	9	gowan	gowan	PROPN
dpc-3921	205	10	k	k	PROPN
dpc-3921	205	11	,	,	PUNCT
dpc-3921	205	12	et	et	PROPN
dpc-3921	205	13	al	al	PROPN
dpc-3921	205	14	.	.	PUNCT
dpc-3921	206	1	nalp1	nalp1	PROPN
dpc-3921	207	1	in	in	ADP
dpc-3921	207	2	vitiligo	vitiligo	NOUN
dpc-3921	207	3	-	-	PUNCT
dpc-3921	207	4	associated	associate	VERB
dpc-3921	207	5	multiple	multiple	ADJ
dpc-3921	207	6	autoimmune	autoimmune	ADJ
dpc-3921	207	7	disease	disease	NOUN
dpc-3921	207	8	.	.	PUNCT
dpc-3921	208	1	n	n	PROPN
dpc-3921	208	2	engl	engl	PROPN
dpc-3921	208	3	j	j	PROPN
dpc-3921	208	4	med	med	PROPN
dpc-3921	208	5	.	.	PUNCT
dpc-3921	209	1	2007;356	2007;356	NUM
dpc-3921	209	2	:	:	PUNCT
dpc-3921	209	3	1216–25	1216–25	NUM
dpc-3921	209	4	.	.	PUNCT
dpc-3921	210	1	[	[	X
dpc-3921	210	2	pmid	pmid	X
dpc-3921	210	3	:	:	PUNCT
dpc-3921	210	4	17377159	17377159	NUM
dpc-3921	210	5	]	]	PUNCT
dpc-3921	210	6	.	.	PUNCT
dpc-3921	211	1	6	6	X
dpc-3921	211	2	.	.	PUNCT
dpc-3921	211	3	jin	jin	PROPN
dpc-3921	211	4	y	y	PROPN
dpc-3921	211	5	,	,	PUNCT
dpc-3921	211	6	birlea	birlea	PROPN
dpc-3921	211	7	sa	sa	PROPN
dpc-3921	211	8	,	,	PUNCT
dpc-3921	211	9	fain	fain	PROPN
dpc-3921	211	10	pr	pr	PROPN
dpc-3921	211	11	,	,	PUNCT
dpc-3921	211	12	et	et	PROPN
dpc-3921	211	13	al	al	PROPN
dpc-3921	211	14	.	.	PUNCT
dpc-3921	211	15	genome	genome	NOUN
dpc-3921	211	16	-	-	PUNCT
dpc-3921	211	17	wide	wide	ADJ
dpc-3921	211	18	association	association	NOUN
dpc-3921	211	19	analyses	analysis	NOUN
dpc-3921	211	20	identify	identify	VERB
dpc-3921	211	21	13	13	NUM
dpc-3921	211	22	new	new	ADJ
dpc-3921	211	23	susceptibility	susceptibility	NOUN
dpc-3921	211	24	loci	locus	NOUN
dpc-3921	211	25	for	for	ADP
dpc-3921	211	26	generalized	generalized	ADJ
dpc-3921	211	27	vitiligo	vitiligo	NOUN
dpc-3921	211	28	.	.	PUNCT
dpc-3921	212	1	nat	nat	PROPN
dpc-3921	212	2	genet	genet	PROPN
dpc-3921	212	3	.	.	PUNCT
dpc-3921	213	1	2012;44:676–80	2012;44:676–80	X
dpc-3921	213	2	.	.	PUNCT
dpc-3921	214	1	[	[	X
dpc-3921	214	2	pmid	pmid	X
dpc-3921	214	3	:	:	PUNCT
dpc-3921	214	4	22561518	22561518	NUM
dpc-3921	214	5	]	]	PUNCT
dpc-3921	214	6	.	.	PUNCT
dpc-3921	215	1	review	review	VERB
dpc-3921	215	2	|	|	ADV
dpc-3921	215	3	dermatol	dermatol	ADJ
dpc-3921	215	4	pract	pract	NOUN
dpc-3921	215	5	concept	concept	NOUN
dpc-3921	215	6	.	.	PUNCT
dpc-3921	216	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-3921	216	2	:	:	PUNCT
dpc-3921	216	3	e2023314s	e2023314s	PROPN
dpc-3921	216	4	5	5	NUM
dpc-3921	216	5	41	41	NUM
dpc-3921	216	6	.	.	PUNCT
dpc-3921	217	1	seneschal	seneschal	PROPN
dpc-3921	217	2	j	j	PROPN
dpc-3921	217	3	,	,	PUNCT
dpc-3921	217	4	boniface	boniface	PROPN
dpc-3921	217	5	k	k	PROPN
dpc-3921	217	6	,	,	PUNCT
dpc-3921	217	7	d’arino	d’arino	PROPN
dpc-3921	217	8	a	a	PRON
dpc-3921	217	9	,	,	PUNCT
dpc-3921	217	10	picardo	picardo	X
dpc-3921	217	11	m.	m.	NOUN
dpc-3921	217	12	an	an	DET
dpc-3921	217	13	update	update	NOUN
dpc-3921	217	14	on	on	ADP
dpc-3921	217	15	vitiligo	vitiligo	ADJ
dpc-3921	217	16	pathogenesis	pathogenesis	NOUN
dpc-3921	217	17	.	.	PUNCT
dpc-3921	218	1	pigment	pigment	NOUN
dpc-3921	218	2	cell	cell	NOUN
dpc-3921	218	3	melanoma	melanoma	NOUN
dpc-3921	218	4	res	re	NOUN
dpc-3921	218	5	.	.	PUNCT
dpc-3921	219	1	2021;34	2021;34	NUM
dpc-3921	219	2	:	:	PUNCT
dpc-3921	220	1	236–43	236–43	NUM
dpc-3921	220	2	.	.	PUNCT
dpc-3921	221	1	[	[	X
dpc-3921	221	2	pmid	pmid	X
dpc-3921	221	3	:	:	PUNCT
dpc-3921	221	4	33278065	33278065	NUM
dpc-3921	221	5	]	]	PUNCT
dpc-3921	221	6	.	.	PUNCT
dpc-3921	222	1	42	42	NUM
dpc-3921	222	2	.	.	PUNCT
dpc-3921	223	1	martins	martin	NOUN
dpc-3921	223	2	c	c	PROPN
dpc-3921	223	3	,	,	PUNCT
dpc-3921	223	4	darrigade	darrigade	VERB
dpc-3921	223	5	a	a	DET
dpc-3921	223	6	-	-	PUNCT
dpc-3921	223	7	s	s	NOUN
dpc-3921	223	8	,	,	PUNCT
dpc-3921	223	9	jacquemin	jacquemin	PROPN
dpc-3921	223	10	c	c	PROPN
dpc-3921	223	11	,	,	PUNCT
dpc-3921	223	12	et	et	PROPN
dpc-3921	223	13	al	al	PROPN
dpc-3921	223	14	.	.	PROPN
dpc-3921	223	15	phenotype	phenotype	NOUN
dpc-3921	223	16	and	and	CCONJ
dpc-3921	223	17	function	function	NOUN
dpc-3921	223	18	of	of	ADP
dpc-3921	223	19	circulating	circulate	VERB
dpc-3921	223	20	memory	memory	NOUN
dpc-3921	223	21	t	t	NOUN
dpc-3921	223	22	cells	cell	NOUN
dpc-3921	223	23	in	in	ADP
dpc-3921	223	24	human	human	ADJ
dpc-3921	223	25	vitiligo	vitiligo	NOUN
dpc-3921	223	26	.	.	PUNCT
dpc-3921	224	1	br	br	PROPN
dpc-3921	224	2	j	j	PROPN
dpc-3921	224	3	dermatol	dermatol	NOUN
dpc-3921	224	4	.	.	PUNCT
dpc-3921	225	1	2020;183:899–908	2020;183:899–908	NUM
dpc-3921	225	2	.	.	PUNCT
dpc-3921	226	1	[	[	X
dpc-3921	226	2	pmid	pmid	X
dpc-3921	226	3	:	:	PUNCT
dpc-3921	226	4	32012221	32012221	NUM
dpc-3921	226	5	]	]	PUNCT
dpc-3921	226	6	.	.	PUNCT
dpc-3921	227	1	43	43	NUM
dpc-3921	227	2	.	.	PUNCT
dpc-3921	228	1	rashighi	rashighi	PROPN
dpc-3921	228	2	m	m	PROPN
dpc-3921	228	3	,	,	PUNCT
dpc-3921	228	4	agarwal	agarwal	PROPN
dpc-3921	228	5	p	p	PROPN
dpc-3921	228	6	,	,	PUNCT
dpc-3921	228	7	richmond	richmond	PROPN
dpc-3921	228	8	jm	jm	PROPN
dpc-3921	228	9	,	,	PUNCT
dpc-3921	228	10	et	et	PROPN
dpc-3921	228	11	al	al	PROPN
dpc-3921	228	12	.	.	PUNCT
dpc-3921	228	13	cxcl10	cxcl10	NOUN
dpc-3921	228	14	is	be	AUX
dpc-3921	228	15	critical	critical	ADJ
dpc-3921	228	16	for	for	ADP
dpc-3921	228	17	the	the	DET
dpc-3921	228	18	progression	progression	NOUN
dpc-3921	228	19	and	and	CCONJ
dpc-3921	228	20	maintenance	maintenance	NOUN
dpc-3921	228	21	of	of	ADP
dpc-3921	228	22	depigmentation	depigmentation	NOUN
dpc-3921	228	23	in	in	ADP
dpc-3921	228	24	a	a	DET
dpc-3921	228	25	mouse	mouse	NOUN
dpc-3921	228	26	model	model	NOUN
dpc-3921	228	27	of	of	ADP
dpc-3921	228	28	vitiligo	vitiligo	PROPN
dpc-3921	228	29	.	.	PUNCT
dpc-3921	229	1	sci	sci	PROPN
dpc-3921	229	2	transl	transl	PROPN
dpc-3921	229	3	med	med	PROPN
dpc-3921	229	4	.	.	PUNCT
dpc-3921	230	1	2014;6:223ra23	2014;6:223ra23	NUM
dpc-3921	230	2	.	.	PUNCT
dpc-3921	231	1	[	[	X
dpc-3921	231	2	pmid	pmid	X
dpc-3921	231	3	:	:	PUNCT
dpc-3921	231	4	24523323	24523323	NUM
dpc-3921	231	5	]	]	PUNCT
dpc-3921	231	6	.	.	PUNCT
dpc-3921	232	1	44	44	NUM
dpc-3921	232	2	.	.	PUNCT
dpc-3921	233	1	regazzetti	regazzetti	VERB
dpc-3921	233	2	c	c	X
dpc-3921	233	3	,	,	PUNCT
dpc-3921	233	4	joly	joly	PROPN
dpc-3921	233	5	f	f	PROPN
dpc-3921	233	6	,	,	PUNCT
dpc-3921	233	7	marty	marty	PROPN
dpc-3921	233	8	c	c	AUX
dpc-3921	233	9	,	,	PUNCT
dpc-3921	233	10	et	et	PROPN
dpc-3921	233	11	al	al	PROPN
dpc-3921	233	12	.	.	PUNCT
dpc-3921	234	1	transcriptional	transcriptional	ADJ
dpc-3921	234	2	analysis	analysis	NOUN
dpc-3921	234	3	of	of	ADP
dpc-3921	234	4	vitiligo	vitiligo	ADJ
dpc-3921	234	5	skin	skin	NOUN
dpc-3921	234	6	reveals	reveal	VERB
dpc-3921	234	7	the	the	DET
dpc-3921	234	8	alteration	alteration	NOUN
dpc-3921	234	9	of	of	ADP
dpc-3921	234	10	wnt	wnt	PROPN
dpc-3921	234	11	pathway	pathway	NOUN
dpc-3921	234	12	:	:	PUNCT
dpc-3921	234	13	a	a	DET
dpc-3921	234	14	promising	promising	ADJ
dpc-3921	234	15	target	target	NOUN
dpc-3921	234	16	for	for	ADP
dpc-3921	234	17	repigmenting	repigmente	VERB
dpc-3921	234	18	vitiligo	vitiligo	NOUN
dpc-3921	234	19	patients	patient	NOUN
dpc-3921	234	20	.	.	PUNCT
dpc-3921	235	1	j	j	PROPN
dpc-3921	235	2	invest	invest	VERB
dpc-3921	235	3	dermatol	dermatol	NOUN
dpc-3921	235	4	.	.	PUNCT
dpc-3921	236	1	2015;135:3105–14	2015;135:3105–14	NUM
dpc-3921	236	2	.	.	PUNCT
dpc-3921	237	1	[	[	X
dpc-3921	237	2	pmid	pmid	X
dpc-3921	237	3	:	:	PUNCT
dpc-3921	237	4	26322948	26322948	NUM
dpc-3921	237	5	]	]	PUNCT
dpc-3921	237	6	.	.	PUNCT
dpc-3921	238	1	45	45	NUM
dpc-3921	238	2	.	.	PUNCT
dpc-3921	239	1	richmond	richmond	PROPN
dpc-3921	239	2	jm	jm	PROPN
dpc-3921	239	3	,	,	PUNCT
dpc-3921	239	4	masterjohn	masterjohn	PROPN
dpc-3921	239	5	e	e	PROPN
dpc-3921	239	6	,	,	PUNCT
dpc-3921	239	7	chu	chu	PROPN
dpc-3921	239	8	r	r	PROPN
dpc-3921	239	9	,	,	PUNCT
dpc-3921	239	10	et	et	PROPN
dpc-3921	239	11	al	al	PROPN
dpc-3921	239	12	.	.	PUNCT
dpc-3921	240	1	cxcr3	cxcr3	PROPN
dpc-3921	241	1	depleting	deplete	VERB
dpc-3921	241	2	antibodies	antibody	NOUN
dpc-3921	241	3	prevent	prevent	VERB
dpc-3921	241	4	and	and	CCONJ
dpc-3921	241	5	reverse	reverse	VERB
dpc-3921	241	6	vitiligo	vitiligo	NOUN
dpc-3921	241	7	in	in	ADP
dpc-3921	241	8	mice	mouse	NOUN
dpc-3921	241	9	.	.	PUNCT
dpc-3921	242	1	j	j	PROPN
dpc-3921	242	2	invest	invest	VERB
dpc-3921	242	3	dermatol	dermatol	NOUN
dpc-3921	242	4	.	.	PUNCT
dpc-3921	243	1	2017;137:982–5	2017;137:982–5	NOUN
dpc-3921	243	2	.	.	PUNCT
dpc-3921	244	1	[	[	X
dpc-3921	244	2	pmid	pmid	X
dpc-3921	244	3	:	:	PUNCT
dpc-3921	244	4	28126463	28126463	NUM
dpc-3921	244	5	]	]	PUNCT
dpc-3921	244	6	.	.	PUNCT
dpc-3921	245	1	46	46	NUM
dpc-3921	245	2	.	.	PUNCT
dpc-3921	246	1	jacquemin	jacquemin	PROPN
dpc-3921	246	2	c	c	PROPN
dpc-3921	246	3	,	,	PUNCT
dpc-3921	246	4	martins	martin	VERB
dpc-3921	246	5	c	c	NOUN
dpc-3921	246	6	,	,	PUNCT
dpc-3921	246	7	lucchese	lucchese	PROPN
dpc-3921	246	8	f	f	PROPN
dpc-3921	246	9	,	,	PUNCT
dpc-3921	247	1	et	et	PROPN
dpc-3921	247	2	al	al	PROPN
dpc-3921	247	3	.	.	PUNCT
dpc-3921	247	4	nkg2d	nkg2d	PROPN
dpc-3921	247	5	defines	define	VERB
dpc-3921	247	6	a	a	DET
dpc-3921	247	7	subset	subset	NOUN
dpc-3921	247	8	of	of	ADP
dpc-3921	247	9	skin	skin	NOUN
dpc-3921	247	10	effector	effector	NOUN
dpc-3921	247	11	memory	memory	NOUN
dpc-3921	247	12	cd8	cd8	PROPN
dpc-3921	247	13	t	t	PROPN
dpc-3921	247	14	cells	cell	NOUN
dpc-3921	247	15	with	with	ADP
dpc-3921	247	16	proinflammatory	proinflammatory	ADJ
dpc-3921	247	17	functions	function	NOUN
dpc-3921	247	18	in	in	ADP
dpc-3921	247	19	vitiligo	vitiligo	NOUN
dpc-3921	247	20	.	.	PUNCT
dpc-3921	248	1	j	j	PROPN
dpc-3921	248	2	invest	invest	VERB
dpc-3921	248	3	dermatol	dermatol	NOUN
dpc-3921	248	4	.	.	PUNCT
dpc-3921	249	1	2020;140	2020;140	NUM
dpc-3921	249	2	:	:	PUNCT
dpc-3921	249	3	1143	1143	NUM
dpc-3921	249	4	-	-	SYM
dpc-3921	249	5	1153.e5	1153.e5	PRON
dpc-3921	249	6	.	.	PUNCT
dpc-3921	250	1	[	[	X
dpc-3921	250	2	pmid	pmid	X
dpc-3921	250	3	:	:	PUNCT
dpc-3921	250	4	31877315	31877315	NUM
dpc-3921	250	5	]	]	PUNCT
dpc-3921	250	6	.	.	PUNCT
dpc-3921	251	1	47	47	NUM
dpc-3921	251	2	.	.	PUNCT
dpc-3921	252	1	qi	qi	PROPN
dpc-3921	252	2	f	f	PROPN
dpc-3921	252	3	,	,	PUNCT
dpc-3921	252	4	liu	liu	PROPN
dpc-3921	252	5	f	f	PROPN
dpc-3921	252	6	,	,	PUNCT
dpc-3921	252	7	gao	gao	PROPN
dpc-3921	252	8	l.	l.	PROPN
dpc-3921	252	9	janus	janus	PROPN
dpc-3921	252	10	kinase	kinase	PROPN
dpc-3921	252	11	inhibitors	inhibitor	NOUN
dpc-3921	252	12	in	in	ADP
dpc-3921	252	13	the	the	DET
dpc-3921	252	14	treatment	treatment	NOUN
dpc-3921	252	15	of	of	ADP
dpc-3921	252	16	vitiligo	vitiligo	NOUN
dpc-3921	252	17	:	:	PUNCT
dpc-3921	252	18	a	a	DET
dpc-3921	252	19	review	review	NOUN
dpc-3921	252	20	.	.	PUNCT
dpc-3921	253	1	front	front	ADJ
dpc-3921	253	2	immunol	immunol	NOUN
dpc-3921	253	3	.	.	PUNCT
dpc-3921	254	1	2021;12:790125	2021;12:790125	NUM
dpc-3921	254	2	.	.	PUNCT
dpc-3921	255	1	[	[	X
dpc-3921	255	2	pmid	pmid	X
dpc-3921	255	3	:	:	PUNCT
dpc-3921	255	4	34868078	34868078	NUM
dpc-3921	255	5	]	]	PUNCT
dpc-3921	255	6	.	.	PUNCT
dpc-3921	256	1	48	48	NUM
dpc-3921	256	2	.	.	PUNCT
dpc-3921	257	1	rosmarin	rosmarin	PROPN
dpc-3921	257	2	d	d	PROPN
dpc-3921	257	3	,	,	PUNCT
dpc-3921	257	4	pandya	pandya	PROPN
dpc-3921	257	5	ag	ag	PROPN
dpc-3921	257	6	,	,	PUNCT
dpc-3921	257	7	lebwohl	lebwohl	PROPN
dpc-3921	257	8	m	m	PROPN
dpc-3921	257	9	,	,	PUNCT
dpc-3921	257	10	et	et	PROPN
dpc-3921	257	11	al	al	PROPN
dpc-3921	257	12	.	.	PROPN
dpc-3921	257	13	ruxolitinib	ruxolitinib	PROPN
dpc-3921	257	14	cream	cream	NOUN
dpc-3921	257	15	for	for	ADP
dpc-3921	257	16	treatment	treatment	NOUN
dpc-3921	257	17	of	of	ADP
dpc-3921	257	18	vitiligo	vitiligo	NOUN
dpc-3921	257	19	:	:	PUNCT
dpc-3921	257	20	a	a	DET
dpc-3921	257	21	randomised	randomised	ADJ
dpc-3921	257	22	,	,	PUNCT
dpc-3921	257	23	controlled	control	VERB
dpc-3921	257	24	,	,	PUNCT
dpc-3921	257	25	phase	phase	NOUN
dpc-3921	257	26	2	2	NUM
dpc-3921	257	27	trial	trial	NOUN
dpc-3921	257	28	.	.	PUNCT
dpc-3921	258	1	lancet	lancet	PROPN
dpc-3921	258	2	lond	lond	PROPN
dpc-3921	258	3	engl	engl	PROPN
dpc-3921	258	4	.	.	PUNCT
dpc-3921	259	1	2020;396:110–20	2020;396:110–20	X
dpc-3921	259	2	.	.	PUNCT
dpc-3921	260	1	[	[	X
dpc-3921	260	2	pmid	pmid	X
dpc-3921	260	3	:	:	PUNCT
dpc-3921	260	4	32653055	32653055	NUM
dpc-3921	260	5	]	]	PUNCT
dpc-3921	260	6	.	.	PUNCT
dpc-3921	261	1	49	49	NUM
dpc-3921	261	2	.	.	PUNCT
dpc-3921	262	1	rosmarin	rosmarin	PROPN
dpc-3921	262	2	d	d	PROPN
dpc-3921	262	3	,	,	PUNCT
dpc-3921	262	4	passeron	passeron	PROPN
dpc-3921	262	5	t	t	PROPN
dpc-3921	262	6	,	,	PUNCT
dpc-3921	262	7	pandya	pandya	PROPN
dpc-3921	262	8	ag	ag	PROPN
dpc-3921	262	9	,	,	PUNCT
dpc-3921	262	10	et	et	PROPN
dpc-3921	262	11	al	al	PROPN
dpc-3921	262	12	.	.	PROPN
dpc-3921	263	1	two	two	NUM
dpc-3921	263	2	phase	phase	NOUN
dpc-3921	263	3	3	3	NUM
dpc-3921	263	4	,	,	PUNCT
dpc-3921	263	5	randomized	randomize	VERB
dpc-3921	263	6	,	,	PUNCT
dpc-3921	263	7	controlled	control	VERB
dpc-3921	263	8	trials	trial	NOUN
dpc-3921	263	9	of	of	ADP
dpc-3921	263	10	ruxolitinib	ruxolitinib	NOUN
dpc-3921	263	11	cream	cream	NOUN
dpc-3921	263	12	for	for	ADP
dpc-3921	263	13	vitiligo	vitiligo	NOUN
dpc-3921	263	14	.	.	PUNCT
dpc-3921	264	1	n	n	PROPN
dpc-3921	264	2	engl	engl	PROPN
dpc-3921	264	3	j	j	PROPN
dpc-3921	264	4	med	med	PROPN
dpc-3921	264	5	.	.	PUNCT
dpc-3921	264	6	2022;387:1445–55	2022;387:1445–55	X
dpc-3921	264	7	.	.	PUNCT
dpc-3921	265	1	[	[	X
dpc-3921	265	2	pmid	pmid	X
dpc-3921	265	3	:	:	PUNCT
dpc-3921	265	4	36260792	36260792	NUM
dpc-3921	265	5	]	]	PUNCT
dpc-3921	265	6	.	.	PUNCT
dpc-3921	266	1	50	50	NUM
dpc-3921	266	2	.	.	X
dpc-3921	267	1	englaro	englaro	PROPN
dpc-3921	267	2	w	w	PROPN
dpc-3921	267	3	,	,	PUNCT
dpc-3921	267	4	bahadoran	bahadoran	NOUN
dpc-3921	267	5	p	p	NOUN
dpc-3921	267	6	,	,	PUNCT
dpc-3921	267	7	bertolotto	bertolotto	PROPN
dpc-3921	267	8	c	c	AUX
dpc-3921	267	9	,	,	PUNCT
dpc-3921	267	10	et	et	PROPN
dpc-3921	267	11	al	al	PROPN
dpc-3921	267	12	.	.	PROPN
dpc-3921	267	13	tumor	tumor	PROPN
dpc-3921	267	14	necrosis	necrosis	NOUN
dpc-3921	267	15	factor	factor	NOUN
dpc-3921	267	16	alpha	alpha	NOUN
dpc-3921	267	17	-	-	PUNCT
dpc-3921	267	18	mediated	mediate	VERB
dpc-3921	267	19	inhibition	inhibition	NOUN
dpc-3921	267	20	of	of	ADP
dpc-3921	267	21	melanogenesis	melanogenesis	NOUN
dpc-3921	267	22	is	be	AUX
dpc-3921	267	23	dependent	dependent	ADJ
dpc-3921	267	24	on	on	ADP
dpc-3921	267	25	nuclear	nuclear	ADJ
dpc-3921	267	26	factor	factor	NOUN
dpc-3921	267	27	kappa	kappa	NOUN
dpc-3921	267	28	b	b	PROPN
dpc-3921	267	29	activation	activation	NOUN
dpc-3921	267	30	.	.	PUNCT
dpc-3921	268	1	oncogene	oncogene	NOUN
dpc-3921	268	2	.	.	PUNCT
dpc-3921	269	1	1999;18:1553–9	1999;18:1553–9	X
dpc-3921	269	2	.	.	PUNCT
dpc-3921	270	1	[	[	X
dpc-3921	270	2	pmid	pmid	X
dpc-3921	270	3	:	:	PUNCT
dpc-3921	270	4	10102625	10102625	NUM
dpc-3921	270	5	]	]	PUNCT
dpc-3921	270	6	.	.	PUNCT
dpc-3921	271	1	51	51	NUM
dpc-3921	271	2	.	.	X
dpc-3921	271	3	son	son	PROPN
dpc-3921	271	4	j	j	PROPN
dpc-3921	271	5	,	,	PUNCT
dpc-3921	271	6	kim	kim	PROPN
dpc-3921	271	7	m	m	PROPN
dpc-3921	271	8	,	,	PUNCT
dpc-3921	271	9	jou	jou	PROPN
dpc-3921	271	10	i	i	PROPN
dpc-3921	271	11	,	,	PUNCT
dpc-3921	271	12	park	park	PROPN
dpc-3921	271	13	kc	kc	PROPN
dpc-3921	271	14	,	,	PUNCT
dpc-3921	271	15	kang	kang	PROPN
dpc-3921	271	16	hy	hy	PROPN
dpc-3921	271	17	.	.	PUNCT
dpc-3921	272	1	ifn	ifn	PROPN
dpc-3921	272	2	-	-	PUNCT
dpc-3921	272	3	γ	γ	NOUN
dpc-3921	272	4	inhibits	inhibit	VERB
dpc-3921	272	5	basal	basal	NOUN
dpc-3921	272	6	and	and	CCONJ
dpc-3921	272	7	α	α	PROPN
dpc-3921	272	8	-	-	PUNCT
dpc-3921	272	9	msh	msh	VERB
dpc-3921	272	10	-	-	PUNCT
dpc-3921	272	11	induced	induce	VERB
dpc-3921	272	12	melanogenesis	melanogenesis	NOUN
dpc-3921	272	13	.	.	PUNCT
dpc-3921	273	1	pigment	pigment	ADJ
dpc-3921	273	2	cell	cell	NOUN
dpc-3921	273	3	melanoma	melanoma	NOUN
dpc-3921	273	4	res	re	NOUN
dpc-3921	273	5	.	.	PUNCT
dpc-3921	274	1	2014;27:201–8	2014;27:201–8	NUM
dpc-3921	274	2	.	.	PUNCT
dpc-3921	275	1	[	[	X
dpc-3921	275	2	pmid	pmid	X
dpc-3921	275	3	:	:	PUNCT
dpc-3921	275	4	24267286	24267286	NUM
dpc-3921	275	5	]	]	PUNCT
dpc-3921	275	6	.	.	PUNCT
dpc-3921	276	1	52	52	NUM
dpc-3921	276	2	.	.	PUNCT
dpc-3921	277	1	yang	yang	PROPN
dpc-3921	277	2	l	l	PROPN
dpc-3921	277	3	,	,	PUNCT
dpc-3921	277	4	wei	wei	PROPN
dpc-3921	277	5	y	y	PROPN
dpc-3921	277	6	,	,	PUNCT
dpc-3921	277	7	sun	sun	PROPN
dpc-3921	277	8	y	y	PROPN
dpc-3921	277	9	,	,	PUNCT
dpc-3921	277	10	et	et	PROPN
dpc-3921	277	11	al	al	PROPN
dpc-3921	277	12	.	.	PROPN
dpc-3921	277	13	interferon	interferon	PROPN
dpc-3921	277	14	-	-	PUNCT
dpc-3921	277	15	gamma	gamma	NOUN
dpc-3921	277	16	inhibits	inhibit	VERB
dpc-3921	277	17	melanogenesis	melanogenesis	NOUN
dpc-3921	277	18	and	and	CCONJ
dpc-3921	277	19	induces	induce	VERB
dpc-3921	277	20	apoptosis	apoptosis	NOUN
dpc-3921	277	21	in	in	ADP
dpc-3921	277	22	melanocytes	melanocyte	NOUN
dpc-3921	277	23	:	:	PUNCT
dpc-3921	277	24	a	a	DET
dpc-3921	277	25	pivotal	pivotal	ADJ
dpc-3921	277	26	role	role	NOUN
dpc-3921	277	27	of	of	ADP
dpc-3921	277	28	cd8	cd8	PROPN
dpc-3921	277	29	+	+	PROPN
dpc-3921	277	30	cytotoxic	cytotoxic	ADJ
dpc-3921	277	31	t	t	NOUN
dpc-3921	277	32	lymphocytes	lymphocyte	VERB
dpc-3921	277	33	in	in	ADP
dpc-3921	277	34	vitiligo	vitiligo	NOUN
dpc-3921	277	35	.	.	PUNCT
dpc-3921	278	1	acta	acta	PROPN
dpc-3921	278	2	derm	derm	PROPN
dpc-3921	278	3	venereol	venereol	NOUN
dpc-3921	278	4	.	.	PUNCT
dpc-3921	279	1	2015;95:664–70	2015;95:664–70	NOUN
dpc-3921	279	2	.	.	PUNCT
dpc-3921	280	1	[	[	X
dpc-3921	280	2	pmid	pmid	X
dpc-3921	280	3	:	:	PUNCT
dpc-3921	280	4	25721262	25721262	NUM
dpc-3921	280	5	]	]	PUNCT
dpc-3921	280	6	.	.	PUNCT
dpc-3921	281	1	53	53	NUM
dpc-3921	281	2	.	.	PUNCT
dpc-3921	281	3	boukhedouni	boukhedouni	PROPN
dpc-3921	281	4	n	n	CCONJ
dpc-3921	281	5	,	,	PUNCT
dpc-3921	281	6	martins	martin	VERB
dpc-3921	281	7	c	c	NUM
dpc-3921	281	8	,	,	PUNCT
dpc-3921	281	9	darrigade	darrigade	VERB
dpc-3921	281	10	a	a	DET
dpc-3921	281	11	-	-	PUNCT
dpc-3921	281	12	s	s	NOUN
dpc-3921	281	13	,	,	PUNCT
dpc-3921	281	14	et	et	PROPN
dpc-3921	281	15	al	al	PROPN
dpc-3921	281	16	.	.	PUNCT
dpc-3921	282	1	type-1	type-1	NUM
dpc-3921	282	2	cytokines	cytokine	NOUN
dpc-3921	282	3	regulate	regulate	VERB
dpc-3921	282	4	mmp-9	mmp-9	NOUN
dpc-3921	282	5	production	production	NOUN
dpc-3921	282	6	and	and	CCONJ
dpc-3921	282	7	e	e	NOUN
dpc-3921	282	8	-	-	NOUN
dpc-3921	282	9	cadherin	cadherin	NOUN
dpc-3921	282	10	disruption	disruption	NOUN
dpc-3921	282	11	to	to	PART
dpc-3921	282	12	promote	promote	VERB
dpc-3921	282	13	melanocyte	melanocyte	NOUN
dpc-3921	282	14	loss	loss	NOUN
dpc-3921	282	15	in	in	ADP
dpc-3921	282	16	vitiligo	vitiligo	NOUN
dpc-3921	282	17	.	.	PUNCT
dpc-3921	283	1	jci	jci	PROPN
dpc-3921	283	2	insight	insight	PROPN
dpc-3921	283	3	.	.	PUNCT
dpc-3921	284	1	2020;5	2020;5	NUM
dpc-3921	284	2	:	:	PUNCT
dpc-3921	284	3	e133772	e133772	NUM
dpc-3921	284	4	,	,	PUNCT
dpc-3921	284	5	133772	133772	NUM
dpc-3921	284	6	.	.	PUNCT
dpc-3921	285	1	[	[	X
dpc-3921	285	2	pmid	pmid	X
dpc-3921	285	3	:	:	PUNCT
dpc-3921	285	4	32369451	32369451	NUM
dpc-3921	285	5	]	]	PUNCT
dpc-3921	285	6	.	.	PUNCT
dpc-3921	286	1	54	54	NUM
dpc-3921	286	2	.	.	PUNCT
dpc-3921	287	1	natarajan	natarajan	PROPN
dpc-3921	287	2	vt	vt	PROPN
dpc-3921	287	3	,	,	PUNCT
dpc-3921	287	4	ganju	ganju	PROPN
dpc-3921	287	5	p	p	X
dpc-3921	287	6	,	,	PUNCT
dpc-3921	287	7	singh	singh	PROPN
dpc-3921	287	8	a	a	X
dpc-3921	287	9	,	,	PUNCT
dpc-3921	287	10	et	et	PROPN
dpc-3921	287	11	al	al	PROPN
dpc-3921	287	12	.	.	PUNCT
dpc-3921	288	1	ifn	ifn	PROPN
dpc-3921	288	2	-	-	PUNCT
dpc-3921	288	3	γ	γ	NOUN
dpc-3921	288	4	signaling	signal	VERB
dpc-3921	288	5	maintains	maintain	VERB
dpc-3921	288	6	skin	skin	NOUN
dpc-3921	288	7	pigmentation	pigmentation	NOUN
dpc-3921	288	8	homeostasis	homeostasis	NOUN
dpc-3921	288	9	through	through	ADP
dpc-3921	288	10	regulation	regulation	NOUN
dpc-3921	288	11	of	of	ADP
dpc-3921	288	12	melanosome	melanosome	NOUN
dpc-3921	288	13	maturation	maturation	NOUN
dpc-3921	288	14	.	.	PUNCT
dpc-3921	289	1	proc	proc	PROPN
dpc-3921	289	2	natl	natl	PROPN
dpc-3921	289	3	acad	acad	PROPN
dpc-3921	289	4	sci	sci	PROPN
dpc-3921	289	5	u	u	PROPN
dpc-3921	289	6	s	s	NOUN
dpc-3921	289	7	a.	a.	NOUN
dpc-3921	289	8	2014;111:2301–6	2014;111:2301–6	NOUN
dpc-3921	289	9	.	.	PUNCT
dpc-3921	290	1	[	[	X
dpc-3921	290	2	pmid	pmid	X
dpc-3921	290	3	:	:	PUNCT
dpc-3921	290	4	24474804	24474804	NUM
dpc-3921	290	5	]	]	PUNCT
dpc-3921	290	6	.	.	PUNCT
dpc-3921	291	1	55	55	NUM
dpc-3921	291	2	.	.	PUNCT
dpc-3921	292	1	ng	ng	PROPN
dpc-3921	292	2	cy	cy	PROPN
dpc-3921	292	3	,	,	PUNCT
dpc-3921	292	4	chan	chan	PROPN
dpc-3921	292	5	y	y	PROPN
dpc-3921	292	6	-	-	PUNCT
dpc-3921	292	7	p	p	PROPN
dpc-3921	292	8	,	,	PUNCT
dpc-3921	292	9	chiu	chiu	PROPN
dpc-3921	292	10	y	y	PROPN
dpc-3921	292	11	-	-	PUNCT
dpc-3921	292	12	c	c	PROPN
dpc-3921	292	13	,	,	PUNCT
dpc-3921	292	14	et	et	PROPN
dpc-3921	292	15	al	al	PROPN
dpc-3921	292	16	.	.	PUNCT
dpc-3921	293	1	targeting	target	VERB
dpc-3921	293	2	the	the	DET
dpc-3921	293	3	elevated	elevated	ADJ
dpc-3921	293	4	ifn	ifn	NOUN
dpc-3921	293	5	-	-	PUNCT
dpc-3921	293	6	γ	γ	NOUN
dpc-3921	293	7	in	in	ADP
dpc-3921	293	8	vitiligo	vitiligo	NOUN
dpc-3921	293	9	patients	patient	NOUN
dpc-3921	293	10	by	by	ADP
dpc-3921	293	11	human	human	ADJ
dpc-3921	293	12	antiifn	antiifn	ADJ
dpc-3921	293	13	-	-	PUNCT
dpc-3921	293	14	γ	γ	NOUN
dpc-3921	293	15	monoclonal	monoclonal	NOUN
dpc-3921	293	16	antibody	antibody	NOUN
dpc-3921	293	17	hampers	hamper	VERB
dpc-3921	293	18	direct	direct	ADJ
dpc-3921	293	19	cytotoxicity	cytotoxicity	NOUN
dpc-3921	293	20	in	in	ADP
dpc-3921	293	21	melanocyte	melanocyte	NOUN
dpc-3921	293	22	.	.	PUNCT
dpc-3921	294	1	j	j	PROPN
dpc-3921	294	2	dermatol	dermatol	NOUN
dpc-3921	294	3	sci	sci	PROPN
dpc-3921	294	4	.	.	PUNCT
dpc-3921	295	1	2023;110:78–88	2023;110:78–88	NUM
dpc-3921	295	2	.	.	PUNCT
dpc-3921	296	1	[	[	X
dpc-3921	296	2	pmid	pmid	X
dpc-3921	296	3	:	:	PUNCT
dpc-3921	296	4	37221109	37221109	NUM
dpc-3921	296	5	]	]	PUNCT
dpc-3921	296	6	.	.	PUNCT
dpc-3921	297	1	56	56	NUM
dpc-3921	297	2	.	.	X
dpc-3921	298	1	singh	singh	PROPN
dpc-3921	298	2	rk	rk	PROPN
dpc-3921	298	3	,	,	PUNCT
dpc-3921	298	4	lee	lee	PROPN
dpc-3921	298	5	km	km	PROPN
dpc-3921	298	6	,	,	PUNCT
dpc-3921	298	7	vujkovic	vujkovic	ADJ
dpc-3921	298	8	-	-	PUNCT
dpc-3921	298	9	cvijin	cvijin	NOUN
dpc-3921	298	10	i	i	PRON
dpc-3921	298	11	,	,	PUNCT
dpc-3921	298	12	et	et	PROPN
dpc-3921	298	13	al	al	PROPN
dpc-3921	298	14	.	.	PUNCT
dpc-3921	299	1	the	the	DET
dpc-3921	299	2	role	role	NOUN
dpc-3921	299	3	of	of	ADP
dpc-3921	299	4	il-17	il-17	X
dpc-3921	299	5	in	in	ADP
dpc-3921	299	6	vitiligo	vitiligo	NOUN
dpc-3921	299	7	:	:	PUNCT
dpc-3921	299	8	a	a	DET
dpc-3921	299	9	review	review	NOUN
dpc-3921	299	10	.	.	PUNCT
dpc-3921	300	1	autoimmun	autoimmun	PROPN
dpc-3921	300	2	rev	rev	PROPN
dpc-3921	300	3	.	.	PROPN
dpc-3921	300	4	2016;15:397–404	2016;15:397–404	PROPN
dpc-3921	300	5	.	.	PUNCT
dpc-3921	301	1	[	[	X
dpc-3921	301	2	pmid	pmid	X
dpc-3921	301	3	:	:	PUNCT
dpc-3921	301	4	26804758	26804758	NUM
dpc-3921	301	5	]	]	PUNCT
dpc-3921	301	6	.	.	PUNCT
dpc-3921	302	1	57	57	NUM
dpc-3921	302	2	.	.	PUNCT
dpc-3921	303	1	speeckaert	speeckaert	PROPN
dpc-3921	303	2	r	r	NOUN
dpc-3921	303	3	,	,	PUNCT
dpc-3921	303	4	mylle	mylle	NOUN
dpc-3921	303	5	s	s	PART
dpc-3921	303	6	,	,	PUNCT
dpc-3921	303	7	van	van	PROPN
dpc-3921	303	8	geel	geel	PROPN
dpc-3921	303	9	n.	n.	PROPN
dpc-3921	303	10	il-17a	il-17a	PROPN
dpc-3921	303	11	is	be	AUX
dpc-3921	303	12	not	not	PART
dpc-3921	303	13	a	a	DET
dpc-3921	303	14	treatment	treatment	NOUN
dpc-3921	303	15	target	target	NOUN
dpc-3921	303	16	in	in	ADP
dpc-3921	303	17	progressive	progressive	ADJ
dpc-3921	303	18	vitiligo	vitiligo	NOUN
dpc-3921	303	19	.	.	PUNCT
dpc-3921	304	1	pigment	pigment	ADJ
dpc-3921	304	2	cell	cell	NOUN
dpc-3921	304	3	melanoma	melanoma	NOUN
dpc-3921	304	4	res	re	NOUN
dpc-3921	304	5	.	.	PROPN
dpc-3921	304	6	2019	2019	NUM
dpc-3921	304	7	;	;	PUNCT
dpc-3921	304	8	32:842–7	32:842–7	NUM
dpc-3921	304	9	.	.	PUNCT
dpc-3921	305	1	[	[	X
dpc-3921	305	2	pmid	pmid	X
dpc-3921	305	3	:	:	PUNCT
dpc-3921	305	4	31063266	31063266	NUM
dpc-3921	305	5	]	]	PUNCT
dpc-3921	305	6	.	.	PUNCT
dpc-3921	306	1	during	during	ADP
dpc-3921	306	2	vitiligo	vitiligo	PROPN
dpc-3921	306	3	and	and	CCONJ
dpc-3921	306	4	may	may	AUX
dpc-3921	306	5	serve	serve	VERB
dpc-3921	306	6	as	as	ADP
dpc-3921	306	7	biomarkers	biomarker	NOUN
dpc-3921	306	8	of	of	ADP
dpc-3921	306	9	disease	disease	NOUN
dpc-3921	306	10	.	.	PUNCT
dpc-3921	307	1	j	j	PROPN
dpc-3921	307	2	invest	invest	VERB
dpc-3921	307	3	dermatol	dermatol	NOUN
dpc-3921	307	4	.	.	PUNCT
dpc-3921	308	1	2017;137:350–8	2017;137:350–8	X
dpc-3921	308	2	.	.	PUNCT
dpc-3921	309	1	[	[	X
dpc-3921	309	2	pmid	pmid	X
dpc-3921	309	3	:	:	PUNCT
dpc-3921	309	4	27686391	27686391	NUM
dpc-3921	309	5	]	]	PUNCT
dpc-3921	309	6	.	.	PUNCT
dpc-3921	310	1	24	24	NUM
dpc-3921	310	2	.	.	X
dpc-3921	310	3	boniface	boniface	PROPN
dpc-3921	310	4	k	k	PROPN
dpc-3921	310	5	,	,	PUNCT
dpc-3921	310	6	jacquemin	jacquemin	PROPN
dpc-3921	310	7	c	c	PROPN
dpc-3921	310	8	,	,	PUNCT
dpc-3921	310	9	darrigade	darrigade	VERB
dpc-3921	310	10	a	a	DET
dpc-3921	310	11	-	-	PUNCT
dpc-3921	310	12	s	s	NOUN
dpc-3921	310	13	,	,	PUNCT
dpc-3921	310	14	et	et	PROPN
dpc-3921	310	15	al	al	PROPN
dpc-3921	310	16	.	.	PROPN
dpc-3921	311	1	vitiligo	vitiligo	PROPN
dpc-3921	311	2	skin	skin	NOUN
dpc-3921	311	3	is	be	AUX
dpc-3921	311	4	imprinted	imprint	VERB
dpc-3921	311	5	with	with	ADP
dpc-3921	311	6	resident	resident	ADJ
dpc-3921	311	7	memory	memory	NOUN
dpc-3921	311	8	cd8	cd8	PROPN
dpc-3921	311	9	t	t	PROPN
dpc-3921	311	10	cells	cell	NOUN
dpc-3921	311	11	expressing	express	VERB
dpc-3921	311	12	cxcr3	cxcr3	PROPN
dpc-3921	311	13	.	.	PUNCT
dpc-3921	312	1	j	j	PROPN
dpc-3921	312	2	invest	invest	VERB
dpc-3921	312	3	dermatol	dermatol	NOUN
dpc-3921	312	4	.	.	PUNCT
dpc-3921	313	1	2018;138:355–64	2018;138:355–64	NUM
dpc-3921	313	2	.	.	PUNCT
dpc-3921	314	1	[	[	X
dpc-3921	314	2	pmid	pmid	X
dpc-3921	314	3	:	:	PUNCT
dpc-3921	314	4	28927891	28927891	NUM
dpc-3921	314	5	]	]	PUNCT
dpc-3921	314	6	.	.	PUNCT
dpc-3921	315	1	25	25	NUM
dpc-3921	315	2	.	.	PUNCT
dpc-3921	316	1	xu	xu	PROPN
dpc-3921	317	1	z	z	PROPN
dpc-3921	317	2	,	,	PUNCT
dpc-3921	317	3	chen	chen	PROPN
dpc-3921	317	4	d	d	PROPN
dpc-3921	317	5	,	,	PUNCT
dpc-3921	317	6	hu	hu	PROPN
dpc-3921	317	7	y	y	PROPN
dpc-3921	317	8	,	,	PUNCT
dpc-3921	317	9	et	et	PROPN
dpc-3921	317	10	al	al	PROPN
dpc-3921	317	11	.	.	PUNCT
dpc-3921	318	1	anatomically	anatomically	ADV
dpc-3921	318	2	distinct	distinct	ADJ
dpc-3921	318	3	fibroblast	fibroblast	ADJ
dpc-3921	318	4	subsets	subset	NOUN
dpc-3921	318	5	determine	determine	VERB
dpc-3921	318	6	skin	skin	NOUN
dpc-3921	318	7	autoimmune	autoimmune	ADJ
dpc-3921	318	8	patterns	pattern	NOUN
dpc-3921	318	9	.	.	PUNCT
dpc-3921	319	1	nature	nature	NOUN
dpc-3921	319	2	.	.	PUNCT
dpc-3921	320	1	2022;601:118–24	2022;601:118–24	ADV
dpc-3921	320	2	.	.	PUNCT
dpc-3921	321	1	[	[	X
dpc-3921	321	2	pmid	pmid	X
dpc-3921	321	3	:	:	PUNCT
dpc-3921	321	4	34912121	34912121	NUM
dpc-3921	321	5	]	]	PUNCT
dpc-3921	321	6	.	.	PUNCT
dpc-3921	322	1	26	26	NUM
dpc-3921	322	2	.	.	PUNCT
dpc-3921	322	3	bertolotti	bertolotti	VERB
dpc-3921	322	4	a	a	PRON
dpc-3921	322	5	,	,	PUNCT
dpc-3921	322	6	boniface	boniface	PROPN
dpc-3921	322	7	k	k	PROPN
dpc-3921	322	8	,	,	PUNCT
dpc-3921	322	9	vergier	vergier	NOUN
dpc-3921	322	10	b	b	NOUN
dpc-3921	322	11	,	,	PUNCT
dpc-3921	323	1	et	et	PROPN
dpc-3921	323	2	al	al	PROPN
dpc-3921	323	3	.	.	PROPN
dpc-3921	323	4	type	type	PROPN
dpc-3921	323	5	i	i	PRON
dpc-3921	323	6	interferon	interferon	ADJ
dpc-3921	323	7	signature	signature	NOUN
dpc-3921	323	8	in	in	ADP
dpc-3921	323	9	the	the	DET
dpc-3921	323	10	initiation	initiation	NOUN
dpc-3921	323	11	of	of	ADP
dpc-3921	323	12	the	the	DET
dpc-3921	323	13	immune	immune	ADJ
dpc-3921	323	14	response	response	NOUN
dpc-3921	323	15	in	in	ADP
dpc-3921	323	16	vitiligo	vitiligo	PROPN
dpc-3921	323	17	.	.	PUNCT
dpc-3921	324	1	pigment	pigment	ADJ
dpc-3921	324	2	cell	cell	NOUN
dpc-3921	324	3	melanoma	melanoma	NOUN
dpc-3921	324	4	res	re	NOUN
dpc-3921	324	5	.	.	PUNCT
dpc-3921	325	1	2014;27:398–407	2014;27:398–407	NOUN
dpc-3921	325	2	.	.	PUNCT
dpc-3921	326	1	[	[	X
dpc-3921	326	2	pmid	pmid	X
dpc-3921	326	3	:	:	PUNCT
dpc-3921	326	4	24438589	24438589	NUM
dpc-3921	326	5	]	]	PUNCT
dpc-3921	326	6	.	.	PUNCT
dpc-3921	327	1	27	27	NUM
dpc-3921	327	2	.	.	PUNCT
dpc-3921	328	1	martins	martin	NOUN
dpc-3921	328	2	c	c	NOUN
dpc-3921	328	3	,	,	PUNCT
dpc-3921	328	4	migayron	migayron	X
dpc-3921	328	5	l	l	NOUN
dpc-3921	328	6	,	,	PUNCT
dpc-3921	328	7	drullion	drullion	NOUN
dpc-3921	328	8	c	c	PROPN
dpc-3921	328	9	,	,	PUNCT
dpc-3921	328	10	et	et	PROPN
dpc-3921	328	11	al	al	PROPN
dpc-3921	328	12	.	.	PROPN
dpc-3921	329	1	vitiligo	vitiligo	PROPN
dpc-3921	329	2	skin	skin	NOUN
dpc-3921	329	3	t	t	PROPN
dpc-3921	329	4	cells	cell	NOUN
dpc-3921	329	5	are	be	AUX
dpc-3921	329	6	prone	prone	ADJ
dpc-3921	329	7	to	to	PART
dpc-3921	329	8	produce	produce	VERB
dpc-3921	329	9	type	type	NOUN
dpc-3921	329	10	1	1	NUM
dpc-3921	329	11	and	and	CCONJ
dpc-3921	329	12	type	type	NOUN
dpc-3921	329	13	2	2	NUM
dpc-3921	329	14	cytokines	cytokine	NOUN
dpc-3921	329	15	to	to	PART
dpc-3921	329	16	induce	induce	VERB
dpc-3921	329	17	melanocyte	melanocyte	ADJ
dpc-3921	329	18	dysfunction	dysfunction	NOUN
dpc-3921	329	19	and	and	CCONJ
dpc-3921	329	20	epidermal	epidermal	ADJ
dpc-3921	329	21	inflammatory	inflammatory	ADJ
dpc-3921	329	22	response	response	NOUN
dpc-3921	329	23	through	through	ADP
dpc-3921	329	24	jak	jak	PROPN
dpc-3921	329	25	signaling	signaling	PROPN
dpc-3921	329	26	.	.	PUNCT
dpc-3921	330	1	j	j	PROPN
dpc-3921	330	2	invest	invest	VERB
dpc-3921	330	3	dermatol	dermatol	NOUN
dpc-3921	330	4	.	.	PUNCT
dpc-3921	331	1	2022;142:1194	2022;142:1194	NUM
dpc-3921	331	2	-	-	SYM
dpc-3921	331	3	1205	1205	NUM
dpc-3921	331	4	.	.	PUNCT
dpc-3921	332	1	e7	e7	PROPN
dpc-3921	332	2	.	.	PUNCT
dpc-3921	333	1	[	[	X
dpc-3921	333	2	pmid	pmid	X
dpc-3921	333	3	:	:	PUNCT
dpc-3921	333	4	34655610	34655610	NUM
dpc-3921	333	5	]	]	PUNCT
dpc-3921	333	6	.	.	PUNCT
dpc-3921	334	1	28	28	NUM
dpc-3921	334	2	.	.	PUNCT
dpc-3921	334	3	tulic	tulic	PROPN
dpc-3921	334	4	mk	mk	PROPN
dpc-3921	334	5	,	,	PUNCT
dpc-3921	334	6	cavazza	cavazza	VERB
dpc-3921	334	7	e	e	NOUN
dpc-3921	334	8	,	,	PUNCT
dpc-3921	334	9	cheli	cheli	PROPN
dpc-3921	334	10	y	y	PROPN
dpc-3921	334	11	,	,	PUNCT
dpc-3921	334	12	et	et	PROPN
dpc-3921	334	13	al	al	PROPN
dpc-3921	334	14	.	.	PUNCT
dpc-3921	335	1	innate	innate	ADJ
dpc-3921	335	2	lymphocyte	lymphocyte	NOUN
dpc-3921	335	3	-	-	PUNCT
dpc-3921	335	4	induced	induce	VERB
dpc-3921	335	5	cxcr3b	cxcr3b	NOUN
dpc-3921	335	6	-	-	PUNCT
dpc-3921	335	7	mediated	mediate	VERB
dpc-3921	335	8	melanocyte	melanocyte	NOUN
dpc-3921	335	9	apoptosis	apoptosis	NOUN
dpc-3921	335	10	is	be	AUX
dpc-3921	335	11	a	a	DET
dpc-3921	335	12	potential	potential	ADJ
dpc-3921	335	13	initiator	initiator	NOUN
dpc-3921	335	14	of	of	ADP
dpc-3921	335	15	t	t	PROPN
dpc-3921	335	16	-	-	PUNCT
dpc-3921	335	17	cell	cell	NOUN
dpc-3921	335	18	autoreactivity	autoreactivity	NOUN
dpc-3921	335	19	in	in	ADP
dpc-3921	335	20	vitiligo	vitiligo	NOUN
dpc-3921	335	21	.	.	PUNCT
dpc-3921	336	1	nat	nat	PROPN
dpc-3921	336	2	commun	commun	PROPN
dpc-3921	336	3	.	.	PUNCT
dpc-3921	337	1	2019;10:2178	2019;10:2178	NUM
dpc-3921	337	2	.	.	PUNCT
dpc-3921	338	1	[	[	X
dpc-3921	338	2	pmid	pmid	X
dpc-3921	338	3	:	:	PUNCT
dpc-3921	338	4	31097717	31097717	NUM
dpc-3921	338	5	]	]	PUNCT
dpc-3921	338	6	.	.	PUNCT
dpc-3921	339	1	29	29	NUM
dpc-3921	339	2	.	.	PUNCT
dpc-3921	340	1	cheuk	cheuk	PROPN
dpc-3921	340	2	s	s	PART
dpc-3921	340	3	,	,	PUNCT
dpc-3921	340	4	schlums	schlum	NOUN
dpc-3921	340	5	h	h	NOUN
dpc-3921	340	6	,	,	PUNCT
dpc-3921	341	1	gallais	gallais	PROPN
dpc-3921	341	2	sérézal	sérézal	PROPN
dpc-3921	341	3	i	i	PROPN
dpc-3921	341	4	,	,	PUNCT
dpc-3921	341	5	et	et	PROPN
dpc-3921	341	6	al	al	PROPN
dpc-3921	341	7	.	.	PROPN
dpc-3921	341	8	cd49a	cd49a	PROPN
dpc-3921	341	9	expression	expression	NOUN
dpc-3921	341	10	defines	define	VERB
dpc-3921	341	11	tissue	tissue	NOUN
dpc-3921	341	12	-	-	PUNCT
dpc-3921	341	13	resident	resident	NOUN
dpc-3921	341	14	cd8	cd8	PROPN
dpc-3921	341	15	+	+	PROPN
dpc-3921	341	16	t	t	NOUN
dpc-3921	341	17	cells	cell	NOUN
dpc-3921	341	18	poised	poise	VERB
dpc-3921	341	19	for	for	ADP
dpc-3921	341	20	cytotoxic	cytotoxic	ADJ
dpc-3921	341	21	function	function	NOUN
dpc-3921	341	22	in	in	ADP
dpc-3921	341	23	human	human	ADJ
dpc-3921	341	24	skin	skin	NOUN
dpc-3921	341	25	.	.	PUNCT
dpc-3921	342	1	immunity	immunity	NOUN
dpc-3921	342	2	.	.	PUNCT
dpc-3921	343	1	2017;46:287–300	2017;46:287–300	NUM
dpc-3921	343	2	.	.	PUNCT
dpc-3921	344	1	[	[	X
dpc-3921	344	2	pmid	pmid	X
dpc-3921	344	3	:	:	PUNCT
dpc-3921	344	4	28214226	28214226	NUM
dpc-3921	344	5	]	]	PUNCT
dpc-3921	344	6	.	.	PUNCT
dpc-3921	345	1	30	30	NUM
dpc-3921	345	2	.	.	PUNCT
dpc-3921	346	1	richmond	richmond	PROPN
dpc-3921	346	2	jm	jm	PROPN
dpc-3921	346	3	,	,	PUNCT
dpc-3921	346	4	strassner	strassner	PROPN
dpc-3921	346	5	jp	jp	PROPN
dpc-3921	346	6	,	,	PUNCT
dpc-3921	346	7	zapata	zapata	PROPN
dpc-3921	346	8	l	l	PROPN
dpc-3921	346	9	,	,	PUNCT
dpc-3921	346	10	et	et	PROPN
dpc-3921	346	11	al	al	PROPN
dpc-3921	346	12	.	.	PUNCT
dpc-3921	346	13	antibody	antibody	NOUN
dpc-3921	346	14	blockade	blockade	NOUN
dpc-3921	346	15	of	of	ADP
dpc-3921	346	16	il-15	il-15	NOUN
dpc-3921	346	17	signaling	signal	VERB
dpc-3921	346	18	has	have	VERB
dpc-3921	346	19	the	the	DET
dpc-3921	346	20	potential	potential	NOUN
dpc-3921	346	21	to	to	PART
dpc-3921	346	22	durably	durably	ADV
dpc-3921	346	23	reverse	reverse	VERB
dpc-3921	346	24	vitiligo	vitiligo	NOUN
dpc-3921	346	25	.	.	PUNCT
dpc-3921	347	1	sci	sci	PROPN
dpc-3921	347	2	transl	transl	PROPN
dpc-3921	347	3	med	med	PROPN
dpc-3921	347	4	.	.	PUNCT
dpc-3921	348	1	2018;10	2018;10	NUM
dpc-3921	348	2	:	:	PUNCT
dpc-3921	348	3	eaam7710	eaam7710	ADJ
dpc-3921	348	4	.	.	PUNCT
dpc-3921	349	1	[	[	X
dpc-3921	349	2	pmid	pmid	X
dpc-3921	349	3	:	:	PUNCT
dpc-3921	349	4	30021889	30021889	NUM
dpc-3921	349	5	]	]	PUNCT
dpc-3921	349	6	.	.	PUNCT
dpc-3921	350	1	31	31	NUM
dpc-3921	350	2	.	.	PUNCT
dpc-3921	351	1	richmond	richmond	PROPN
dpc-3921	351	2	jm	jm	PROPN
dpc-3921	351	3	,	,	PUNCT
dpc-3921	351	4	strassner	strassner	PROPN
dpc-3921	351	5	jp	jp	PROPN
dpc-3921	351	6	,	,	PUNCT
dpc-3921	351	7	rashighi	rashighi	PROPN
dpc-3921	351	8	m	m	PROPN
dpc-3921	351	9	,	,	PUNCT
dpc-3921	351	10	et	et	PROPN
dpc-3921	351	11	al	al	PROPN
dpc-3921	351	12	.	.	PROPN
dpc-3921	351	13	resident	resident	PROPN
dpc-3921	351	14	memory	memory	NOUN
dpc-3921	351	15	and	and	CCONJ
dpc-3921	351	16	recirculating	recirculating	NOUN
dpc-3921	351	17	memory	memory	NOUN
dpc-3921	351	18	t	t	PROPN
dpc-3921	351	19	cells	cell	NOUN
dpc-3921	351	20	cooperate	cooperate	VERB
dpc-3921	351	21	to	to	PART
dpc-3921	351	22	maintain	maintain	VERB
dpc-3921	351	23	disease	disease	NOUN
dpc-3921	351	24	in	in	ADP
dpc-3921	351	25	a	a	DET
dpc-3921	351	26	mouse	mouse	NOUN
dpc-3921	351	27	model	model	NOUN
dpc-3921	351	28	of	of	ADP
dpc-3921	351	29	vitiligo	vitiligo	PROPN
dpc-3921	351	30	.	.	PUNCT
dpc-3921	352	1	j	j	PROPN
dpc-3921	352	2	invest	invest	VERB
dpc-3921	352	3	dermatol	dermatol	NOUN
dpc-3921	352	4	.	.	PUNCT
dpc-3921	353	1	2019;139:769–78	2019;139:769–78	NUM
dpc-3921	353	2	.	.	PUNCT
dpc-3921	354	1	[	[	X
dpc-3921	354	2	pmid	pmid	X
dpc-3921	354	3	:	:	PUNCT
dpc-3921	354	4	30423329	30423329	NUM
dpc-3921	354	5	]	]	PUNCT
dpc-3921	354	6	.	.	PUNCT
dpc-3921	355	1	32	32	NUM
dpc-3921	355	2	.	.	X
dpc-3921	356	1	strobl	strobl	NOUN
dpc-3921	356	2	j	j	PROPN
dpc-3921	356	3	,	,	PUNCT
dpc-3921	356	4	haniffa	haniffa	PROPN
dpc-3921	356	5	m.	m.	NOUN
dpc-3921	356	6	functional	functional	ADJ
dpc-3921	356	7	heterogeneity	heterogeneity	NOUN
dpc-3921	356	8	of	of	ADP
dpc-3921	356	9	human	human	ADJ
dpc-3921	356	10	skin	skin	NOUN
dpc-3921	356	11	resident	resident	NOUN
dpc-3921	356	12	memory	memory	NOUN
dpc-3921	356	13	t	t	PROPN
dpc-3921	356	14	cells	cell	NOUN
dpc-3921	356	15	in	in	ADP
dpc-3921	356	16	health	health	NOUN
dpc-3921	356	17	and	and	CCONJ
dpc-3921	356	18	disease	disease	NOUN
dpc-3921	356	19	.	.	PUNCT
dpc-3921	357	1	immunol	immunol	PROPN
dpc-3921	357	2	rev	rev	PROPN
dpc-3921	357	3	.	.	PUNCT
dpc-3921	358	1	2023;316:104–19	2023;316:104–19	NOUN
dpc-3921	358	2	.	.	PUNCT
dpc-3921	359	1	[	[	X
dpc-3921	359	2	pmid	pmid	X
dpc-3921	359	3	:	:	PUNCT
dpc-3921	359	4	37144705	37144705	NUM
dpc-3921	359	5	]	]	PUNCT
dpc-3921	359	6	.	.	PUNCT
dpc-3921	360	1	33	33	NUM
dpc-3921	360	2	.	.	PUNCT
dpc-3921	361	1	milner	milner	PROPN
dpc-3921	361	2	jj	jj	PROPN
dpc-3921	361	3	,	,	PUNCT
dpc-3921	361	4	goldrath	goldrath	ADP
dpc-3921	361	5	aw	aw	INTJ
dpc-3921	361	6	.	.	PUNCT
dpc-3921	361	7	transcriptional	transcriptional	ADJ
dpc-3921	361	8	programming	programming	NOUN
dpc-3921	361	9	of	of	ADP
dpc-3921	361	10	tissue	tissue	NOUN
dpc-3921	361	11	resident	resident	NOUN
dpc-3921	361	12	memory	memory	NOUN
dpc-3921	361	13	cd8	cd8	PROPN
dpc-3921	361	14	+	+	PROPN
dpc-3921	361	15	t	t	NOUN
dpc-3921	361	16	cells	cell	NOUN
dpc-3921	361	17	.	.	PUNCT
dpc-3921	362	1	curr	curr	PROPN
dpc-3921	362	2	opin	opin	PROPN
dpc-3921	362	3	immunol	immunol	NOUN
dpc-3921	362	4	.	.	PUNCT
dpc-3921	362	5	2018	2018	NUM
dpc-3921	362	6	;	;	PUNCT
dpc-3921	362	7	51:162–9	51:162–9	NUM
dpc-3921	362	8	.	.	PUNCT
dpc-3921	363	1	[	[	X
dpc-3921	363	2	pmid	pmid	X
dpc-3921	363	3	:	:	PUNCT
dpc-3921	363	4	29621697	29621697	NUM
dpc-3921	363	5	]	]	PUNCT
dpc-3921	363	6	.	.	PUNCT
dpc-3921	364	1	34	34	NUM
dpc-3921	364	2	.	.	PUNCT
dpc-3921	365	1	rotrosen	rotrosen	PROPN
dpc-3921	365	2	e	e	PROPN
dpc-3921	365	3	,	,	PUNCT
dpc-3921	365	4	kupper	kupper	PROPN
dpc-3921	365	5	ts	ts	NOUN
dpc-3921	365	6	.	.	PUNCT
dpc-3921	366	1	assessing	assess	VERB
dpc-3921	366	2	the	the	DET
dpc-3921	366	3	generation	generation	NOUN
dpc-3921	366	4	of	of	ADP
dpc-3921	366	5	tissue	tissue	NOUN
dpc-3921	366	6	resident	resident	NOUN
dpc-3921	366	7	memory	memory	NOUN
dpc-3921	366	8	t	t	NOUN
dpc-3921	366	9	cells	cell	NOUN
dpc-3921	366	10	by	by	ADP
dpc-3921	366	11	vaccines	vaccine	NOUN
dpc-3921	366	12	.	.	PUNCT
dpc-3921	367	1	nat	nat	PROPN
dpc-3921	367	2	rev	rev	VERB
dpc-3921	367	3	immunol	immunol	NOUN
dpc-3921	367	4	.	.	PUNCT
dpc-3921	368	1	2023:1–11	2023:1–11	X
dpc-3921	368	2	.	.	PUNCT
dpc-3921	369	1	[	[	X
dpc-3921	369	2	pmid	pmid	X
dpc-3921	369	3	:	:	PUNCT
dpc-3921	369	4	37002288	37002288	NUM
dpc-3921	369	5	]	]	PUNCT
dpc-3921	369	6	.	.	PUNCT
dpc-3921	370	1	35	35	NUM
dpc-3921	370	2	.	.	PUNCT
dpc-3921	371	1	clark	clark	PROPN
dpc-3921	371	2	ra	ra	PROPN
dpc-3921	371	3	,	,	PUNCT
dpc-3921	371	4	chong	chong	PROPN
dpc-3921	371	5	b	b	PROPN
dpc-3921	371	6	,	,	PUNCT
dpc-3921	371	7	mirchandani	mirchandani	PROPN
dpc-3921	371	8	n	n	CCONJ
dpc-3921	371	9	,	,	PUNCT
dpc-3921	371	10	et	et	PROPN
dpc-3921	371	11	al	al	PROPN
dpc-3921	371	12	.	.	PUNCT
dpc-3921	372	1	the	the	DET
dpc-3921	372	2	vast	vast	ADJ
dpc-3921	372	3	majority	majority	NOUN
dpc-3921	372	4	of	of	ADP
dpc-3921	372	5	cla+	cla+	NOUN
dpc-3921	372	6	t	t	NOUN
dpc-3921	372	7	cells	cell	NOUN
dpc-3921	372	8	are	be	AUX
dpc-3921	372	9	resident	resident	ADJ
dpc-3921	372	10	in	in	ADP
dpc-3921	372	11	normal	normal	ADJ
dpc-3921	372	12	skin	skin	NOUN
dpc-3921	372	13	.	.	PUNCT
dpc-3921	373	1	j	j	PROPN
dpc-3921	373	2	immunol	immunol	PROPN
dpc-3921	373	3	baltim	baltim	PROPN
dpc-3921	373	4	md	md	PROPN
dpc-3921	373	5	1950	1950	NUM
dpc-3921	373	6	.	.	PUNCT
dpc-3921	374	1	2006;176:4431–9	2006;176:4431–9	NOUN
dpc-3921	374	2	.	.	PUNCT
dpc-3921	375	1	[	[	X
dpc-3921	375	2	pmid	pmid	X
dpc-3921	375	3	:	:	PUNCT
dpc-3921	375	4	16547281	16547281	NUM
dpc-3921	375	5	]	]	PUNCT
dpc-3921	375	6	.	.	PUNCT
dpc-3921	376	1	36	36	NUM
dpc-3921	376	2	.	.	PUNCT
dpc-3921	377	1	mackay	mackay	PROPN
dpc-3921	377	2	lk	lk	PROPN
dpc-3921	377	3	,	,	PUNCT
dpc-3921	377	4	rahimpour	rahimpour	NOUN
dpc-3921	377	5	a	a	PRON
dpc-3921	377	6	,	,	PUNCT
dpc-3921	377	7	ma	ma	PROPN
dpc-3921	377	8	jz	jz	PROPN
dpc-3921	377	9	,	,	PUNCT
dpc-3921	377	10	et	et	PROPN
dpc-3921	377	11	al	al	PROPN
dpc-3921	377	12	.	.	PUNCT
dpc-3921	378	1	the	the	DET
dpc-3921	378	2	developmental	developmental	ADJ
dpc-3921	378	3	pathway	pathway	NOUN
dpc-3921	378	4	for	for	ADP
dpc-3921	378	5	cd103(+)cd8	cd103(+)cd8	PROPN
dpc-3921	378	6	+	+	SYM
dpc-3921	378	7	tissue	tissue	NOUN
dpc-3921	378	8	-	-	PUNCT
dpc-3921	378	9	resident	resident	NOUN
dpc-3921	378	10	memory	memory	NOUN
dpc-3921	378	11	t	t	NOUN
dpc-3921	378	12	cells	cell	NOUN
dpc-3921	378	13	of	of	ADP
dpc-3921	378	14	skin	skin	NOUN
dpc-3921	378	15	.	.	PUNCT
dpc-3921	379	1	nat	nat	PROPN
dpc-3921	379	2	immunol	immunol	NOUN
dpc-3921	379	3	.	.	PUNCT
dpc-3921	380	1	2013;14:1294–301	2013;14:1294–301	X
dpc-3921	380	2	.	.	PUNCT
dpc-3921	381	1	[	[	X
dpc-3921	381	2	pmid	pmid	X
dpc-3921	381	3	:	:	PUNCT
dpc-3921	381	4	24162776	24162776	NUM
dpc-3921	381	5	]	]	PUNCT
dpc-3921	381	6	.	.	PUNCT
dpc-3921	382	1	37	37	NUM
dpc-3921	382	2	.	.	PUNCT
dpc-3921	383	1	nicolaidou	nicolaidou	PROPN
dpc-3921	383	2	e	e	PROPN
dpc-3921	383	3	,	,	PUNCT
dpc-3921	383	4	antoniou	antoniou	PROPN
dpc-3921	383	5	c	c	PROPN
dpc-3921	383	6	,	,	PUNCT
dpc-3921	383	7	stratigos	stratigos	PROPN
dpc-3921	383	8	aj	aj	PROPN
dpc-3921	383	9	,	,	PUNCT
dpc-3921	383	10	stefanaki	stefanaki	PROPN
dpc-3921	383	11	c	c	PROPN
dpc-3921	383	12	,	,	PUNCT
dpc-3921	383	13	katsambas	katsambas	PROPN
dpc-3921	383	14	ad	ad	NOUN
dpc-3921	383	15	.	.	PUNCT
dpc-3921	384	1	efficacy	efficacy	NOUN
dpc-3921	384	2	,	,	PUNCT
dpc-3921	384	3	predictors	predictor	NOUN
dpc-3921	384	4	of	of	ADP
dpc-3921	384	5	response	response	NOUN
dpc-3921	384	6	,	,	PUNCT
dpc-3921	384	7	and	and	CCONJ
dpc-3921	384	8	long	long	ADJ
dpc-3921	384	9	-	-	PUNCT
dpc-3921	384	10	term	term	NOUN
dpc-3921	384	11	follow	follow	NOUN
dpc-3921	384	12	-	-	PUNCT
dpc-3921	384	13	up	up	NOUN
dpc-3921	384	14	in	in	ADP
dpc-3921	384	15	patients	patient	NOUN
dpc-3921	384	16	with	with	ADP
dpc-3921	384	17	vitiligo	vitiligo	PROPN
dpc-3921	384	18	treated	treat	VERB
dpc-3921	384	19	with	with	ADP
dpc-3921	384	20	narrowband	narrowband	NOUN
dpc-3921	384	21	uvb	uvb	ADJ
dpc-3921	384	22	phototherapy	phototherapy	NOUN
dpc-3921	384	23	.	.	PUNCT
dpc-3921	385	1	j	j	PROPN
dpc-3921	385	2	am	be	AUX
dpc-3921	385	3	acad	acad	ADJ
dpc-3921	385	4	dermatol	dermatol	NOUN
dpc-3921	385	5	.	.	PUNCT
dpc-3921	386	1	2007;56:274–8	2007;56:274–8	NUM
dpc-3921	386	2	.	.	PUNCT
dpc-3921	387	1	[	[	X
dpc-3921	387	2	pmid	pmid	X
dpc-3921	387	3	:	:	PUNCT
dpc-3921	387	4	17224369	17224369	NUM
dpc-3921	387	5	]	]	PUNCT
dpc-3921	387	6	.	.	PUNCT
dpc-3921	388	1	38	38	NUM
dpc-3921	388	2	.	.	PUNCT
dpc-3921	389	1	matos	matos	PROPN
dpc-3921	389	2	tr	tr	VERB
dpc-3921	389	3	,	,	PUNCT
dpc-3921	389	4	o’malley	o’malley	PROPN
dpc-3921	389	5	jt	jt	PROPN
dpc-3921	389	6	,	,	PUNCT
dpc-3921	389	7	lowry	lowry	PROPN
dpc-3921	389	8	el	el	PROPN
dpc-3921	389	9	,	,	PUNCT
dpc-3921	389	10	et	et	PROPN
dpc-3921	389	11	al	al	PROPN
dpc-3921	389	12	.	.	PROPN
dpc-3921	389	13	clinically	clinically	ADV
dpc-3921	389	14	resolved	resolve	VERB
dpc-3921	389	15	psoriatic	psoriatic	ADJ
dpc-3921	389	16	lesions	lesion	NOUN
dpc-3921	389	17	contain	contain	VERB
dpc-3921	389	18	psoriasis	psoriasis	NOUN
dpc-3921	389	19	-	-	PUNCT
dpc-3921	389	20	specific	specific	ADJ
dpc-3921	389	21	il-17	il-17	ADV
dpc-3921	389	22	-	-	PUNCT
dpc-3921	389	23	producing	produce	VERB
dpc-3921	389	24	αβ	αβ	NOUN
dpc-3921	389	25	t	t	NOUN
dpc-3921	389	26	cell	cell	NOUN
dpc-3921	389	27	clones	clone	NOUN
dpc-3921	389	28	.	.	PUNCT
dpc-3921	390	1	j	j	PROPN
dpc-3921	390	2	clin	clin	PROPN
dpc-3921	390	3	invest	invest	PROPN
dpc-3921	390	4	.	.	PUNCT
dpc-3921	391	1	2017;127:4031–41	2017;127:4031–41	X
dpc-3921	391	2	.	.	PUNCT
dpc-3921	392	1	[	[	X
dpc-3921	392	2	pmid	pmid	X
dpc-3921	392	3	:	:	PUNCT
dpc-3921	392	4	28945199	28945199	NUM
dpc-3921	392	5	]	]	PUNCT
dpc-3921	392	6	.	.	PUNCT
dpc-3921	393	1	39	39	NUM
dpc-3921	393	2	.	.	PUNCT
dpc-3921	394	1	cheuk	cheuk	PROPN
dpc-3921	394	2	s	s	NOUN
dpc-3921	394	3	,	,	PUNCT
dpc-3921	394	4	wikén	wikén	VERB
dpc-3921	394	5	m	m	PROPN
dpc-3921	394	6	,	,	PUNCT
dpc-3921	394	7	blomqvist	blomqvist	ADJ
dpc-3921	394	8	l	l	NOUN
dpc-3921	394	9	,	,	PUNCT
dpc-3921	394	10	et	et	PROPN
dpc-3921	394	11	al	al	PROPN
dpc-3921	394	12	.	.	PROPN
dpc-3921	394	13	epidermal	epidermal	ADJ
dpc-3921	394	14	th22	th22	PROPN
dpc-3921	394	15	and	and	CCONJ
dpc-3921	394	16	tc17	tc17	PROPN
dpc-3921	394	17	cells	cell	NOUN
dpc-3921	394	18	form	form	VERB
dpc-3921	394	19	a	a	DET
dpc-3921	394	20	localized	localize	VERB
dpc-3921	394	21	disease	disease	NOUN
dpc-3921	394	22	memory	memory	NOUN
dpc-3921	394	23	in	in	ADP
dpc-3921	394	24	clinically	clinically	ADV
dpc-3921	394	25	healed	heal	VERB
dpc-3921	394	26	psoriasis	psoriasis	NOUN
dpc-3921	394	27	.	.	PUNCT
dpc-3921	395	1	j	j	PROPN
dpc-3921	395	2	immunol	immunol	PROPN
dpc-3921	395	3	baltim	baltim	PROPN
dpc-3921	395	4	md	md	PROPN
dpc-3921	395	5	1950	1950	NUM
dpc-3921	395	6	.	.	PUNCT
dpc-3921	396	1	2014;192:3111–20	2014;192:3111–20	NUM
dpc-3921	396	2	.	.	PUNCT
dpc-3921	397	1	[	[	X
dpc-3921	397	2	pmid	pmid	X
dpc-3921	397	3	:	:	PUNCT
dpc-3921	397	4	24610014	24610014	NUM
dpc-3921	397	5	]	]	PUNCT
dpc-3921	397	6	.	.	PUNCT
dpc-3921	398	1	40	40	NUM
dpc-3921	398	2	.	.	PUNCT
dpc-3921	399	1	brunner	brunner	PROPN
dpc-3921	399	2	pm	pm	PROPN
dpc-3921	399	3	,	,	PUNCT
dpc-3921	399	4	emerson	emerson	PROPN
dpc-3921	399	5	ro	ro	PROPN
dpc-3921	399	6	,	,	PUNCT
dpc-3921	399	7	tipton	tipton	PROPN
dpc-3921	399	8	c	c	AUX
dpc-3921	399	9	,	,	PUNCT
dpc-3921	399	10	et	et	PROPN
dpc-3921	399	11	al	al	PROPN
dpc-3921	399	12	.	.	PROPN
dpc-3921	399	13	nonlesional	nonlesional	ADJ
dpc-3921	399	14	atopic	atopic	NOUN
dpc-3921	399	15	dermatitis	dermatitis	PROPN
dpc-3921	399	16	skin	skin	NOUN
dpc-3921	399	17	shares	share	NOUN
dpc-3921	399	18	similar	similar	ADJ
dpc-3921	399	19	t	t	NOUN
dpc-3921	399	20	-	-	PUNCT
dpc-3921	399	21	cell	cell	NOUN
dpc-3921	399	22	clones	clone	NOUN
dpc-3921	399	23	with	with	ADP
dpc-3921	399	24	lesional	lesional	ADJ
dpc-3921	399	25	tissues	tissue	NOUN
dpc-3921	399	26	.	.	PUNCT
dpc-3921	400	1	allergy	allergy	NOUN
dpc-3921	400	2	.	.	PUNCT
dpc-3921	401	1	2017;72:2017–25	2017;72:2017–25	NUM
dpc-3921	401	2	.	.	PUNCT
dpc-3921	402	1	[	[	X
dpc-3921	402	2	pmid	pmid	X
dpc-3921	402	3	:	:	PUNCT
dpc-3921	402	4	28599078	28599078	NUM
dpc-3921	402	5	]	]	PUNCT
dpc-3921	402	6	.	.	PUNCT
dpc-3921	403	1	6	6	NUM
dpc-3921	403	2	review	review	NOUN
dpc-3921	403	3	|	|	ADV
dpc-3921	403	4	dermatol	dermatol	ADJ
dpc-3921	403	5	pract	pract	NOUN
dpc-3921	403	6	concept	concept	NOUN
dpc-3921	403	7	.	.	PUNCT
dpc-3921	404	1	2023;13(4)s2	2023;13(4)s2	NOUN
dpc-3921	404	2	:	:	PUNCT
dpc-3921	404	3	e2023314s	e2023314s	PROPN
dpc-3921	404	4	xbp1	xbp1	PROPN
dpc-3921	404	5	,	,	PUNCT
dpc-3921	404	6	foxp3	foxp3	NOUN
dpc-3921	404	7	,	,	PUNCT
dpc-3921	404	8	and	and	CCONJ
dpc-3921	404	9	tslp	tslp	VERB
dpc-3921	404	10	.	.	PUNCT
dpc-3921	405	1	j	j	PROPN
dpc-3921	405	2	invest	invest	VERB
dpc-3921	405	3	dermatol	dermatol	NOUN
dpc-3921	405	4	.	.	PUNCT
dpc-3921	406	1	2011;131:371–81	2011;131:371–81	NUM
dpc-3921	406	2	.	.	PUNCT
dpc-3921	407	1	[	[	X
dpc-3921	407	2	pmid	pmid	X
dpc-3921	407	3	:	:	PUNCT
dpc-3921	407	4	21085187	21085187	NUM
dpc-3921	407	5	]	]	PUNCT
dpc-3921	407	6	.	.	PUNCT
dpc-3921	408	1	65	65	NUM
dpc-3921	408	2	.	.	PUNCT
dpc-3921	409	1	aydıngöz	aydıngöz	VERB
dpc-3921	409	2	ie	ie	NOUN
dpc-3921	409	3	,	,	PUNCT
dpc-3921	409	4	kanmaz	kanmaz	NOUN
dpc-3921	409	5	-	-	PUNCT
dpc-3921	409	6	özer	özer	NOUN
dpc-3921	409	7	m	m	PROPN
dpc-3921	409	8	,	,	PUNCT
dpc-3921	409	9	gedikbaşi	gedikbaşi	VERB
dpc-3921	409	10	a	a	NOUN
dpc-3921	409	11	,	,	PUNCT
dpc-3921	409	12	et	et	PROPN
dpc-3921	409	13	al	al	PROPN
dpc-3921	409	14	.	.	PUNCT
dpc-3921	410	1	the	the	DET
dpc-3921	410	2	combination	combination	NOUN
dpc-3921	410	3	of	of	ADP
dpc-3921	410	4	tumour	tumour	NOUN
dpc-3921	410	5	necrosis	necrosis	NOUN
dpc-3921	410	6	factor	factor	NOUN
dpc-3921	410	7	-	-	PUNCT
dpc-3921	410	8	α	α	NOUN
dpc-3921	410	9	-308a	-308a	PROPN
dpc-3921	410	10	and	and	CCONJ
dpc-3921	410	11	interleukin-10	interleukin-10	PROPN
dpc-3921	410	12	-1082	-1082	PROPN
dpc-3921	410	13	g	g	PROPN
dpc-3921	410	14	gene	gene	NOUN
dpc-3921	410	15	polymorphisms	polymorphism	NOUN
dpc-3921	410	16	and	and	CCONJ
dpc-3921	410	17	increased	increase	VERB
dpc-3921	410	18	serum	serum	NOUN
dpc-3921	410	19	levels	level	NOUN
dpc-3921	410	20	of	of	ADP
dpc-3921	410	21	related	related	ADJ
dpc-3921	410	22	cytokines	cytokine	NOUN
dpc-3921	410	23	:	:	PUNCT
dpc-3921	410	24	susceptibility	susceptibility	NOUN
dpc-3921	410	25	to	to	PART
dpc-3921	410	26	vitiligo	vitiligo	VERB
dpc-3921	410	27	.	.	PUNCT
dpc-3921	411	1	clin	clin	PROPN
dpc-3921	411	2	exp	exp	NOUN
dpc-3921	411	3	dermatol	dermatol	NOUN
dpc-3921	411	4	.	.	PUNCT
dpc-3921	412	1	2015;40:71–7	2015;40:71–7	NUM
dpc-3921	412	2	.	.	PUNCT
dpc-3921	413	1	[	[	X
dpc-3921	413	2	pmid	pmid	X
dpc-3921	413	3	:	:	PUNCT
dpc-3921	413	4	25283497	25283497	NUM
dpc-3921	413	5	]	]	PUNCT
dpc-3921	413	6	.	.	PUNCT
dpc-3921	414	1	66	66	NUM
dpc-3921	414	2	.	.	PUNCT
dpc-3921	415	1	dwivedi	dwivedi	PROPN
dpc-3921	415	2	m	m	PROPN
dpc-3921	415	3	,	,	PUNCT
dpc-3921	415	4	kemp	kemp	PROPN
dpc-3921	415	5	eh	eh	PROPN
dpc-3921	415	6	,	,	PUNCT
dpc-3921	415	7	laddha	laddha	PROPN
dpc-3921	415	8	nc	nc	PROPN
dpc-3921	415	9	,	,	PUNCT
dpc-3921	415	10	et	et	PROPN
dpc-3921	415	11	al	al	PROPN
dpc-3921	415	12	.	.	PROPN
dpc-3921	415	13	regulatory	regulatory	PROPN
dpc-3921	415	14	t	t	PROPN
dpc-3921	415	15	cells	cell	NOUN
dpc-3921	415	16	in	in	ADP
dpc-3921	415	17	vitiligo	vitiligo	NOUN
dpc-3921	415	18	:	:	PUNCT
dpc-3921	415	19	implications	implication	NOUN
dpc-3921	415	20	for	for	ADP
dpc-3921	415	21	pathogenesis	pathogenesis	NOUN
dpc-3921	415	22	and	and	CCONJ
dpc-3921	415	23	therapeutics	therapeutic	NOUN
dpc-3921	415	24	.	.	PUNCT
dpc-3921	416	1	autoimmun	autoimmun	PROPN
dpc-3921	416	2	rev	rev	PROPN
dpc-3921	416	3	.	.	PROPN
dpc-3921	417	1	2015;14:49–56	2015;14:49–56	NUM
dpc-3921	417	2	.	.	PUNCT
dpc-3921	418	1	[	[	X
dpc-3921	418	2	pmid	pmid	X
dpc-3921	418	3	:	:	PUNCT
dpc-3921	418	4	25308528	25308528	NUM
dpc-3921	418	5	]	]	PUNCT
dpc-3921	418	6	.	.	PUNCT
dpc-3921	419	1	67	67	NUM
dpc-3921	419	2	.	.	PUNCT
dpc-3921	420	1	giri	giri	PROPN
dpc-3921	420	2	ps	ps	PROPN
dpc-3921	420	3	,	,	PUNCT
dpc-3921	420	4	mistry	mistry	PROPN
dpc-3921	420	5	j	j	PROPN
dpc-3921	420	6	,	,	PUNCT
dpc-3921	420	7	dwivedi	dwivedi	PROPN
dpc-3921	420	8	m.	m.	PROPN
dpc-3921	420	9	meta	meta	VERB
dpc-3921	420	10	-	-	PUNCT
dpc-3921	420	11	analysis	analysis	NOUN
dpc-3921	420	12	of	of	ADP
dpc-3921	420	13	alterations	alteration	NOUN
dpc-3921	420	14	in	in	ADP
dpc-3921	420	15	regulatory	regulatory	ADJ
dpc-3921	420	16	t	t	PROPN
dpc-3921	420	17	cells	cell	NOUN
dpc-3921	420	18	’	’	PART
dpc-3921	420	19	frequency	frequency	NOUN
dpc-3921	420	20	and	and	CCONJ
dpc-3921	420	21	suppressive	suppressive	ADJ
dpc-3921	420	22	capacity	capacity	NOUN
dpc-3921	420	23	in	in	ADP
dpc-3921	420	24	patients	patient	NOUN
dpc-3921	420	25	with	with	ADP
dpc-3921	420	26	vitiligo	vitiligo	PROPN
dpc-3921	420	27	.	.	PUNCT
dpc-3921	421	1	j	j	PROPN
dpc-3921	421	2	immunol	immunol	NOUN
dpc-3921	421	3	res	re	NOUN
dpc-3921	421	4	.	.	PUNCT
dpc-3921	422	1	2022;2022:6952299	2022;2022:6952299	NUM
dpc-3921	422	2	.	.	PUNCT
dpc-3921	423	1	[	[	X
dpc-3921	423	2	pmid	pmid	X
dpc-3921	423	3	:	:	PUNCT
dpc-3921	423	4	36164321	36164321	NUM
dpc-3921	423	5	]	]	PUNCT
dpc-3921	423	6	.	.	PUNCT
dpc-3921	424	1	68	68	NUM
dpc-3921	424	2	.	.	PUNCT
dpc-3921	425	1	eby	eby	PROPN
dpc-3921	425	2	jm	jm	PROPN
dpc-3921	425	3	,	,	PUNCT
dpc-3921	425	4	kang	kang	PROPN
dpc-3921	425	5	h	h	PROPN
dpc-3921	425	6	-	-	PUNCT
dpc-3921	425	7	k	k	NOUN
dpc-3921	425	8	,	,	PUNCT
dpc-3921	425	9	tully	tully	PROPN
dpc-3921	425	10	st	st	PROPN
dpc-3921	425	11	,	,	PUNCT
dpc-3921	425	12	et	et	PROPN
dpc-3921	425	13	al	al	PROPN
dpc-3921	425	14	.	.	PUNCT
dpc-3921	425	15	ccl22	ccl22	PROPN
dpc-3921	425	16	to	to	PART
dpc-3921	425	17	activate	activate	VERB
dpc-3921	425	18	treg	treg	PROPN
dpc-3921	425	19	migration	migration	NOUN
dpc-3921	425	20	and	and	CCONJ
dpc-3921	425	21	suppress	suppress	VERB
dpc-3921	425	22	depigmentation	depigmentation	NOUN
dpc-3921	425	23	in	in	ADP
dpc-3921	425	24	vitiligo	vitiligo	NOUN
dpc-3921	425	25	.	.	PUNCT
dpc-3921	426	1	j	j	PROPN
dpc-3921	426	2	invest	invest	VERB
dpc-3921	426	3	dermatol	dermatol	NOUN
dpc-3921	426	4	.	.	PUNCT
dpc-3921	427	1	2015;135:1574–80	2015;135:1574–80	NUM
dpc-3921	427	2	.	.	PUNCT
dpc-3921	428	1	[	[	X
dpc-3921	428	2	pmid	pmid	X
dpc-3921	428	3	:	:	PUNCT
dpc-3921	428	4	25634358	25634358	NUM
dpc-3921	428	5	]	]	PUNCT
dpc-3921	428	6	.	.	PUNCT
dpc-3921	429	1	69	69	NUM
dpc-3921	429	2	.	.	PUNCT
dpc-3921	430	1	gellatly	gellatly	ADV
dpc-3921	430	2	kj	kj	PROPN
dpc-3921	430	3	,	,	PUNCT
dpc-3921	430	4	strassner	strassner	PROPN
dpc-3921	430	5	jp	jp	PROPN
dpc-3921	430	6	,	,	PUNCT
dpc-3921	430	7	essien	essien	PROPN
dpc-3921	430	8	k	k	PROPN
dpc-3921	430	9	,	,	PUNCT
dpc-3921	430	10	et	et	PROPN
dpc-3921	430	11	al	al	PROPN
dpc-3921	430	12	.	.	PROPN
dpc-3921	430	13	scrna	scrna	PROPN
dpc-3921	430	14	-	-	PUNCT
dpc-3921	430	15	seq	seq	NOUN
dpc-3921	430	16	of	of	ADP
dpc-3921	430	17	human	human	ADJ
dpc-3921	430	18	vitiligo	vitiligo	NOUN
dpc-3921	430	19	reveals	reveal	VERB
dpc-3921	430	20	complex	complex	ADJ
dpc-3921	430	21	networks	network	NOUN
dpc-3921	430	22	of	of	ADP
dpc-3921	430	23	subclinical	subclinical	ADJ
dpc-3921	430	24	immune	immune	ADJ
dpc-3921	430	25	activation	activation	NOUN
dpc-3921	430	26	and	and	CCONJ
dpc-3921	430	27	a	a	DET
dpc-3921	430	28	role	role	NOUN
dpc-3921	430	29	for	for	ADP
dpc-3921	430	30	ccr5	ccr5	NOUN
dpc-3921	430	31	in	in	ADP
dpc-3921	430	32	treg	treg	PROPN
dpc-3921	430	33	function	function	PROPN
dpc-3921	430	34	.	.	PUNCT
dpc-3921	431	1	sci	sci	PROPN
dpc-3921	431	2	transl	transl	PROPN
dpc-3921	431	3	med	med	PROPN
dpc-3921	431	4	.	.	PUNCT
dpc-3921	432	1	2021;13	2021;13	NUM
dpc-3921	432	2	:	:	PUNCT
dpc-3921	432	3	eabd8995	eabd8995	NUM
dpc-3921	432	4	.	.	PUNCT
dpc-3921	433	1	[	[	X
dpc-3921	433	2	pmid	pmid	X
dpc-3921	433	3	:	:	PUNCT
dpc-3921	433	4	34516831	34516831	NUM
dpc-3921	433	5	]	]	PUNCT
dpc-3921	433	6	.	.	PUNCT
dpc-3921	434	1	70	70	NUM
dpc-3921	434	2	.	.	X
dpc-3921	434	3	le	le	PROPN
dpc-3921	434	4	poole	poole	PROPN
dpc-3921	434	5	ic	ic	PROPN
dpc-3921	434	6	,	,	PUNCT
dpc-3921	434	7	mehrotra	mehrotra	ADJ
dpc-3921	434	8	s.	s.	PROPN
dpc-3921	434	9	replenishing	replenish	VERB
dpc-3921	434	10	regulatory	regulatory	ADJ
dpc-3921	434	11	t	t	NOUN
dpc-3921	434	12	cells	cell	NOUN
dpc-3921	434	13	to	to	PART
dpc-3921	434	14	halt	halt	VERB
dpc-3921	434	15	 	 	SPACE
dpc-3921	434	16	depigmentation	depigmentation	NOUN
dpc-3921	434	17	in	in	ADP
dpc-3921	434	18	vitiligo	vitiligo	PROPN
dpc-3921	434	19	.	.	PUNCT
dpc-3921	435	1	j	j	PROPN
dpc-3921	435	2	investig	investig	NOUN
dpc-3921	435	3	dermatol	dermatol	NOUN
dpc-3921	435	4	symp	symp	PROPN
dpc-3921	435	5	proc	proc	NOUN
dpc-3921	435	6	.	.	PUNCT
dpc-3921	436	1	2017;18	2017;18	NUM
dpc-3921	436	2	:	:	PUNCT
dpc-3921	436	3	s38–45	s38–45	NOUN
dpc-3921	436	4	.	.	PUNCT
dpc-3921	437	1	[	[	X
dpc-3921	437	2	pmid	pmid	X
dpc-3921	437	3	:	:	PUNCT
dpc-3921	437	4	28941492	28941492	NUM
dpc-3921	437	5	]	]	PUNCT
dpc-3921	437	6	.	.	PUNCT
dpc-3921	438	1	58	58	NUM
dpc-3921	438	2	.	.	PUNCT
dpc-3921	439	1	khan	khan	PROPN
dpc-3921	439	2	r	r	PROPN
dpc-3921	439	3	,	,	PUNCT
dpc-3921	439	4	gupta	gupta	PROPN
dpc-3921	439	5	s	s	PART
dpc-3921	439	6	,	,	PUNCT
dpc-3921	439	7	sharma	sharma	PROPN
dpc-3921	439	8	a.	a.	NOUN
dpc-3921	439	9	circulatory	circulatory	ADJ
dpc-3921	439	10	levels	level	NOUN
dpc-3921	439	11	of	of	ADP
dpc-3921	439	12	t	t	PROPN
dpc-3921	439	13	-	-	PUNCT
dpc-3921	439	14	cell	cell	NOUN
dpc-3921	439	15	cytokines	cytokine	NOUN
dpc-3921	439	16	(	(	PUNCT
dpc-3921	439	17	interleukin	interleukin	NOUN
dpc-3921	439	18	[	[	X
dpc-3921	439	19	il]-2	il]-2	PROPN
dpc-3921	439	20	,	,	PUNCT
dpc-3921	439	21	il-4	il-4	PRON
dpc-3921	439	22	,	,	PUNCT
dpc-3921	439	23	il-17	il-17	X
dpc-3921	439	24	,	,	PUNCT
dpc-3921	439	25	and	and	CCONJ
dpc-3921	439	26	transforming	transform	VERB
dpc-3921	439	27	growth	growth	NOUN
dpc-3921	439	28	factor	factor	NOUN
dpc-3921	439	29	-	-	PUNCT
dpc-3921	439	30	β	β	NOUN
dpc-3921	439	31	)	)	PUNCT
dpc-3921	439	32	in	in	ADP
dpc-3921	439	33	patients	patient	NOUN
dpc-3921	439	34	with	with	ADP
dpc-3921	439	35	vitiligo	vitiligo	PROPN
dpc-3921	439	36	.	.	PUNCT
dpc-3921	440	1	j	j	PROPN
dpc-3921	440	2	am	be	AUX
dpc-3921	440	3	acad	acad	ADJ
dpc-3921	440	4	dermatol	dermatol	NOUN
dpc-3921	440	5	.	.	PUNCT
dpc-3921	441	1	2012;66:510–1	2012;66:510–1	NUM
dpc-3921	441	2	.	.	PUNCT
dpc-3921	442	1	[	[	X
dpc-3921	442	2	pmid	pmid	X
dpc-3921	442	3	:	:	PUNCT
dpc-3921	442	4	22342018	22342018	NUM
dpc-3921	442	5	]	]	PUNCT
dpc-3921	442	6	.	.	PUNCT
dpc-3921	443	1	59	59	NUM
dpc-3921	443	2	.	.	PUNCT
dpc-3921	443	3	vaccaro	vaccaro	PROPN
dpc-3921	443	4	m	m	PROPN
dpc-3921	443	5	,	,	PUNCT
dpc-3921	443	6	cicero	cicero	PROPN
dpc-3921	443	7	f	f	PROPN
dpc-3921	443	8	,	,	PUNCT
dpc-3921	443	9	mannucci	mannucci	PROPN
dpc-3921	443	10	c	c	AUX
dpc-3921	443	11	,	,	PUNCT
dpc-3921	443	12	et	et	PROPN
dpc-3921	443	13	al	al	PROPN
dpc-3921	443	14	.	.	PROPN
dpc-3921	443	15	il-33	il-33	VERB
dpc-3921	443	16	circulating	circulate	VERB
dpc-3921	443	17	serum	serum	NOUN
dpc-3921	443	18	levels	level	NOUN
dpc-3921	443	19	are	be	AUX
dpc-3921	443	20	increased	increase	VERB
dpc-3921	443	21	in	in	ADP
dpc-3921	443	22	patients	patient	NOUN
dpc-3921	443	23	with	with	ADP
dpc-3921	443	24	non	non	ADJ
dpc-3921	443	25	-	-	ADJ
dpc-3921	443	26	segmental	segmental	ADJ
dpc-3921	443	27	generalized	generalized	ADJ
dpc-3921	443	28	vitiligo	vitiligo	NOUN
dpc-3921	443	29	.	.	PUNCT
dpc-3921	444	1	arch	arch	ADJ
dpc-3921	444	2	dermatol	dermatol	NOUN
dpc-3921	444	3	res	re	NOUN
dpc-3921	444	4	.	.	PUNCT
dpc-3921	445	1	2016;308:527–30	2016;308:527–30	PROPN
dpc-3921	445	2	.	.	PUNCT
dpc-3921	446	1	[	[	X
dpc-3921	446	2	pmid	pmid	X
dpc-3921	446	3	:	:	PUNCT
dpc-3921	446	4	27388717	27388717	NUM
dpc-3921	446	5	]	]	PUNCT
dpc-3921	446	6	.	.	PUNCT
dpc-3921	447	1	60	60	NUM
dpc-3921	447	2	.	.	PUNCT
dpc-3921	448	1	choi	choi	PROPN
dpc-3921	448	2	h	h	PROPN
dpc-3921	448	3	,	,	PUNCT
dpc-3921	448	4	choi	choi	NOUN
dpc-3921	448	5	h	h	PROPN
dpc-3921	448	6	,	,	PUNCT
dpc-3921	448	7	han	han	PROPN
dpc-3921	448	8	j	j	PROPN
dpc-3921	448	9	,	,	PUNCT
dpc-3921	448	10	et	et	PROPN
dpc-3921	448	11	al	al	PROPN
dpc-3921	448	12	.	.	PROPN
dpc-3921	448	13	il-4	il-4	PART
dpc-3921	448	14	inhibits	inhibit	VERB
dpc-3921	448	15	the	the	DET
dpc-3921	448	16	melanogenesis	melanogenesis	NOUN
dpc-3921	448	17	of	of	ADP
dpc-3921	448	18	normal	normal	ADJ
dpc-3921	448	19	human	human	ADJ
dpc-3921	448	20	melanocytes	melanocyte	NOUN
dpc-3921	448	21	through	through	ADP
dpc-3921	448	22	the	the	DET
dpc-3921	448	23	jak2	jak2	PROPN
dpc-3921	448	24	-	-	PUNCT
dpc-3921	448	25	stat6	stat6	NOUN
dpc-3921	448	26	signaling	signal	VERB
dpc-3921	448	27	pathway	pathway	NOUN
dpc-3921	448	28	.	.	PUNCT
dpc-3921	449	1	j	j	PROPN
dpc-3921	449	2	invest	invest	VERB
dpc-3921	449	3	dermatol	dermatol	NOUN
dpc-3921	449	4	.	.	PUNCT
dpc-3921	450	1	2013;133:528–36	2013;133:528–36	NUM
dpc-3921	450	2	.	.	PUNCT
dpc-3921	451	1	[	[	X
dpc-3921	451	2	pmid	pmid	X
dpc-3921	451	3	:	:	PUNCT
dpc-3921	451	4	22992805	22992805	NUM
dpc-3921	451	5	]	]	PUNCT
dpc-3921	451	6	.	.	PUNCT
dpc-3921	452	1	61	61	NUM
dpc-3921	452	2	.	.	PUNCT
dpc-3921	452	3	han	han	PROPN
dpc-3921	452	4	j	j	PROPN
dpc-3921	452	5	,	,	PUNCT
dpc-3921	452	6	lee	lee	PROPN
dpc-3921	452	7	e	e	PROPN
dpc-3921	452	8	,	,	PUNCT
dpc-3921	452	9	kim	kim	PROPN
dpc-3921	452	10	e	e	PROPN
dpc-3921	452	11	,	,	PUNCT
dpc-3921	452	12	et	et	PROPN
dpc-3921	452	13	al	al	PROPN
dpc-3921	452	14	.	.	PROPN
dpc-3921	452	15	role	role	NOUN
dpc-3921	452	16	of	of	ADP
dpc-3921	452	17	epidermal	epidermal	ADJ
dpc-3921	452	18	γδ	γδ	ADP
dpc-3921	452	19	t	t	NOUN
dpc-3921	452	20	-	-	PUNCT
dpc-3921	452	21	cell	cell	NOUN
dpc-3921	452	22	-	-	PUNCT
dpc-3921	452	23	derived	derive	VERB
dpc-3921	452	24	interleukin	interleukin	NOUN
dpc-3921	452	25	13	13	NUM
dpc-3921	452	26	in	in	ADP
dpc-3921	452	27	the	the	DET
dpc-3921	452	28	skin	skin	NOUN
dpc-3921	452	29	-	-	PUNCT
dpc-3921	452	30	whitening	whiten	VERB
dpc-3921	452	31	effect	effect	NOUN
dpc-3921	452	32	of	of	ADP
dpc-3921	452	33	ginsenoside	ginsenoside	ADJ
dpc-3921	452	34	f1	f1	NOUN
dpc-3921	452	35	.	.	PUNCT
dpc-3921	453	1	exp	exp	NOUN
dpc-3921	453	2	dermatol	dermatol	NOUN
dpc-3921	453	3	.	.	PUNCT
dpc-3921	454	1	2014;23:860–2	2014;23:860–2	NUM
dpc-3921	454	2	.	.	PUNCT
dpc-3921	455	1	[	[	X
dpc-3921	455	2	pmid	pmid	X
dpc-3921	455	3	:	:	PUNCT
dpc-3921	455	4	25091975	25091975	NUM
dpc-3921	455	5	]	]	PUNCT
dpc-3921	455	6	.	.	PUNCT
dpc-3921	456	1	62	62	NUM
dpc-3921	456	2	.	.	PUNCT
dpc-3921	457	1	czarnowicki	czarnowicki	PROPN
dpc-3921	457	2	t	t	PROPN
dpc-3921	457	3	,	,	PUNCT
dpc-3921	457	4	he	he	PRON
dpc-3921	457	5	h	h	NOUN
dpc-3921	457	6	,	,	PUNCT
dpc-3921	457	7	leonard	leonard	PROPN
dpc-3921	457	8	a	a	PROPN
dpc-3921	457	9	,	,	PUNCT
dpc-3921	457	10	et	et	PROPN
dpc-3921	457	11	al	al	PROPN
dpc-3921	457	12	.	.	PUNCT
dpc-3921	458	1	blood	blood	NOUN
dpc-3921	458	2	endotyping	endotype	VERB
dpc-3921	458	3	distinguishes	distinguish	VERB
dpc-3921	458	4	the	the	DET
dpc-3921	458	5	profile	profile	NOUN
dpc-3921	458	6	of	of	ADP
dpc-3921	458	7	vitiligo	vitiligo	NOUN
dpc-3921	458	8	from	from	ADP
dpc-3921	458	9	that	that	PRON
dpc-3921	458	10	of	of	ADP
dpc-3921	458	11	other	other	ADJ
dpc-3921	458	12	inflammatory	inflammatory	ADJ
dpc-3921	458	13	and	and	CCONJ
dpc-3921	458	14	autoimmune	autoimmune	ADJ
dpc-3921	458	15	skin	skin	NOUN
dpc-3921	458	16	diseases	disease	NOUN
dpc-3921	458	17	.	.	PUNCT
dpc-3921	459	1	j	j	PROPN
dpc-3921	459	2	allergy	allergy	PROPN
dpc-3921	459	3	clin	clin	PROPN
dpc-3921	459	4	immunol	immunol	PROPN
dpc-3921	459	5	.	.	PUNCT
dpc-3921	460	1	2019;143:2095–107	2019;143:2095–107	NUM
dpc-3921	460	2	.	.	PUNCT
dpc-3921	461	1	[	[	X
dpc-3921	461	2	pmid	pmid	X
dpc-3921	461	3	:	:	PUNCT
dpc-3921	461	4	30576756	30576756	NUM
dpc-3921	461	5	]	]	PUNCT
dpc-3921	461	6	.	.	PUNCT
dpc-3921	462	1	63	63	NUM
dpc-3921	462	2	.	.	PUNCT
dpc-3921	463	1	jin	jin	NOUN
dpc-3921	463	2	r	r	PROPN
dpc-3921	463	3	,	,	PUNCT
dpc-3921	463	4	zhou	zhou	PROPN
dpc-3921	463	5	m	m	PROPN
dpc-3921	463	6	,	,	PUNCT
dpc-3921	463	7	lin	lin	PROPN
dpc-3921	463	8	f	f	PROPN
dpc-3921	463	9	,	,	PUNCT
dpc-3921	463	10	xu	xu	PROPN
dpc-3921	464	1	w	w	PROPN
dpc-3921	464	2	,	,	PUNCT
dpc-3921	464	3	xu	xu	PROPN
dpc-3921	464	4	a.	a.	NOUN
dpc-3921	464	5	pathogenic	pathogenic	PROPN
dpc-3921	464	6	th2	th2	PROPN
dpc-3921	464	7	cytokine	cytokine	VERB
dpc-3921	464	8	profile	profile	NOUN
dpc-3921	464	9	skewing	skew	VERB
dpc-3921	464	10	by	by	ADP
dpc-3921	464	11	ifn	ifn	PROPN
dpc-3921	464	12	-	-	PUNCT
dpc-3921	464	13	γ	γ	NOUN
dpc-3921	464	14	-	-	PUNCT
dpc-3921	464	15	responding	respond	VERB
dpc-3921	464	16	vitiligo	vitiligo	NOUN
dpc-3921	464	17	fibroblasts	fibroblast	NOUN
dpc-3921	464	18	via	via	ADP
dpc-3921	464	19	ccl2	ccl2	PROPN
dpc-3921	464	20	/	/	SYM
dpc-3921	464	21	ccl8	ccl8	PROPN
dpc-3921	464	22	.	.	PUNCT
dpc-3921	465	1	cells	cell	NOUN
dpc-3921	465	2	.	.	PUNCT
dpc-3921	466	1	2023;12:217	2023;12:217	NOUN
dpc-3921	466	2	.	.	PUNCT
dpc-3921	467	1	[	[	X
dpc-3921	467	2	pmid	pmid	X
dpc-3921	467	3	:	:	PUNCT
dpc-3921	467	4	36672151	36672151	NUM
dpc-3921	467	5	]	]	PUNCT
dpc-3921	467	6	.	.	PUNCT
dpc-3921	468	1	64	64	NUM
dpc-3921	468	2	.	.	PUNCT
dpc-3921	468	3	birlea	birlea	PROPN
dpc-3921	468	4	sa	sa	PROPN
dpc-3921	468	5	,	,	PUNCT
dpc-3921	468	6	jin	jin	PROPN
dpc-3921	468	7	y	y	PROPN
dpc-3921	468	8	,	,	PUNCT
dpc-3921	468	9	bennett	bennett	PROPN
dpc-3921	468	10	dc	dc	PROPN
dpc-3921	468	11	,	,	PUNCT
dpc-3921	468	12	et	et	PROPN
dpc-3921	468	13	al	al	PROPN
dpc-3921	468	14	.	.	PROPN
dpc-3921	468	15	comprehensive	comprehensive	PROPN
dpc-3921	468	16	association	association	PROPN
dpc-3921	468	17	analysis	analysis	NOUN
dpc-3921	468	18	of	of	ADP
dpc-3921	468	19	candidate	candidate	NOUN
dpc-3921	468	20	genes	gene	NOUN
dpc-3921	468	21	for	for	ADP
dpc-3921	468	22	generalized	generalized	ADJ
dpc-3921	468	23	vitiligo	vitiligo	NOUN
dpc-3921	468	24	supports	support	VERB